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ABSTRACT 
An existing compartmental model of human calcium 
metabolism able to describe successfully the dynamics of 
stable and radioactive calcium administered both orally 
and intravenously, is extended to include the bone calcium 
and its protein matrix, collagen, the secretion and cata-
bolism of the hormones calcitonin and parathyroid hormone, 
and the hormonal control of calcium excretion by the kidney. 
Data selected from a literature survey of the rates and 
calcium contents of the major intestinal secretions, and 
of sweat, are incorporated into the model. Allowance is 
made for the increased secretion of calcium into the 
intestine during meals. 
By means of a digital computer program (CAMET2) 15 
simplified simulations are carried out, corresponding to 
a variety of real situations including calcium and ethylene-
diamine tetraacetic acid infusions, the removal of the 
parathyroid glands, fasting, a low calcium diet and the 
intestinal absorption of radioactive calcium. The results 
emphasize the importance of renal calcium excretion in the 
overall control of calcium homeostasis. The roles of the 
skeleton, on which much emphasis has been placed in the 
past, and of the soft tissue calcium in buffering pertur-
bations to the plasma calcium are considered. Common 
methods of calculating the total calcium secreted into 
the gut and of the endogenous faecal calcium are simulated 
and sources of error exposed. A meal subsequent to an oral 
tracer dose is shown to depress tracer absorption. The 
responses to a range of dietary calcium intake are considered. 
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INTRODUCTION i 
Living systems have evolved with a hierachy of linked 
regulatory control systems necessary to the maintenance of 
life. ·One of these systems is concerned with the regulat-
ion of calcium; its distribution, chemical status and ex-
cretion. Control is known to be principally exerted through 
an important group of endocrinological agents - calcitonin, 
parathyroid hormone and vitamin 0. The regulation of cal-
cium is essential to its dual roles of mechanical support 
(as a component of bone mineral) and its participation in 
numerous intra- and extra-cellular biochemical processes, 
and is such that calcium is present within the one organism 
at local concentrations as low as 10-8 moles/litre and 
simultaneously as a calcium phosphate mineral. Breakdown 
in the regulation at various points results in disorders 
ranging from rickets in children to osteoporosis in the 
elderly. 
A research program into calcium metabolism was begun 
at the University of Canterbury by Dr. w.s. Metcalf to 
examine the more important aspects - with a view to clari-
fying the causes of some of the commoner medical complaints 
such as osteoporosis. To date the work has been theoretical 
in that no direct experimental investigations have been 
undertaken. Rather, the medical literature has been sur-
veyed and the best clinical data incorporated into a 
mathematical model describing calcium metabolism in man. 
The initial work in setting up the model and the development 
of the computer program CAMET was carried outby 
J.H. Livesey as research towards a Ph.D. degree. Subsequently 
the computer program was rewritten by A.E. McKinnon of the 
Electrical Engineering Department of this university 
ii 
to improve its efficiency and to facilitate further 
additions and alterations. 
In order to avoid confusion the present model, 
whose development from CAMET is discussed in this volume, 
is referred to as CAMET2. The symbol '±' is used 
throughout to denote one standard deviation 
n 
a = ( t: (x - xi) 21 (n - 1) ) ~ 
i=l 
where x is the mean of then observations (xi). 
The purposes of modelling are four-fold : to describe 
the system in mathematical terms, to critically examine 
present methods and conclusions, to suggest new experiments, 
and, where possible, to use the model as a cheap and 
convenient (though approximate) exploratory tool. Hopefully 
the usefulness of this approach is illustrated in the 
following pages. 
1.1 
CHAPTER 1 
A REVIEW OF THE MODEL CAMET 
Over the last 50 years the kinetics of 
numerous metabolites have been investigated by 
observing the dynamics of a tracer following its 
introduction to the biological system. Usually the 
1 
tracer is an isotopic form of an element, either radio-
active or stable, although in some cases dyes and 
other readily detectable substances have been used 
(Atkins 1969). Radioactive ca45 and ca47 , stable 
ca48 (detected by neutron activation analysis) and 
t . t t' d 't d' t' . t s 85 some 1mes s ron 1um an 1 s ra 1oac 1ve 1so opes r , 
sr89 and sr90 , have all been used as prob~s for calcium. 
Such experiments are dependent on the tracer not per-
turbing the system under investigation and on the 
tracer being handled in a manner similar to or identic-
al with the unlabelled substance. 
The measured specific activity s(t) of the tracer 
(where t is the time) in many biological systems has 
been found to be fitted satisfactorily by a sum of 
exponentials of the form 
The set of 
s (t) = 
a.'s and 
1 
e.'s and n are required to be 
1 
determined from the experimental data. Such a system 
can be represented by a multicompartmental model where 
the substance present (in our case calcium) can be con-
sidered to be distributed between a number of distinct, 
completely mixed compartments, and where the rate of 
transfer of the substance out of a given compartment is 
proportional to the amount or concentration of the sub-
stance within that compartment. If the additional 
assumption is made that the system is in a steady state 
(that is, that the sizes of the metabolic pools are con-
stant, or at least are changing negligibly during the 
course of the experiment) then the model consists of a 
set of simultaneous, linear differential equations whose 
solution is a sum of exponentials (Atkins 1969, Acker-
man et al. 196 7) • 
A number of multicompartmental models of calcium 
metabolism, of varying complexity have been published 
(table 1.1). Of those based on the disappearance of 
injected tracer calcium from the blood, that of Neer et 
al. (1967) is especially important to the present model, 
as many of the model parameters have been derived from 
Neer's experimental data. Also listed in table 1.1 are 
a number of models relating to the ki~etics of ingested 
tracer calcium as well as others representing the 
regulation of calcium concentration in the blood. The 
non-compartmental models proposed include the use of 
power functions and probability density functions to 
describe radiocalcium turnover in man. 
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Table 1.1 Models of Calcium Metabolism 
[A] Plasma Compartmental Models 
Bauer et al. (1957) 
Aubert & Milhaud (1960) 
Bronner & Aubert (1965) 
Cohn et al. (1965) 
Neer et al. ( 196 7) 
Phang et al. (1969) 
Gonick & Brown ( 1970) 
Ramberg et al. ( 1970) 
[B] Intestinal Compartmental Models 
Birge et al. (1969) 
Marshall & Nordin {1969) 
[c] Regulatory Models 
Roston (1959) 
Copp et al. {1960b) 
Aubert & Bronner (1'965) 
Ri9gs (1966) 
[o] Noncompartmental Models 
Marshall (1964) 
Ackerman et al. (1967) 
Anderson et al. (1967) 
Marshall & Onkelinx (1968) 
Burkinshaw et al. (1969) 
3 
4 
As the basis of most of these models, the 
approximations involved, and the results achieved have 
already been reviewed in detail (Livesey 1970) , this 
chapter is confined to describing the structure, 
derivation and capabilities of the model CAMET. 
1. 2 · The Calcium Metabolism Model CAMET 
CAMET is comprised of 11 homogeneous compart-
ments and one unmixed compartment (fig. 1.1). An 
unmixed compartment is defined to be one which mixes 
so slowly over the duration of the tracer experiment 
(Neer's data was collected over twenty days) that an 
insignificant fraction of the material entering the 
compartment is found to leave it. 
As the homogeneous compartments contain less than 
10 grams of calcium between them out of a total cal-
cium content of more than 1000 grams in the adult 
(Mitchell et al. 1945, Forbes et al. 1953), the unmixed 
compartment can be identified with slowly exchanging 
bone calcium comprising over 99% of the total body 
calcium. The movement of calcium to and from this 
compartment (Race and Rdec> represents the processes , 
of bone formation (accretion), bo~e resorption (de-
cretion) and also some very slow exchange where one 
calcium ion replaces another ion with no net change 
in the number of ions (Chapter 6). It is because 
the quantity of calcium involved in these processes 
is small in comparison with the amount of skeletal 
calcium over the experimental period that tracer 
entering the unmixed compartment is considered 
' 
I 
' 
~ 
5 -I......., 
\ v Race Unmixed ........ .... 
6 Com part men 
......... 
'Rdec ~ 1 
Ill 
I 
Ill 
Ill 
J 
...... _ ........ ..... 
11 2 3 
....... ......... ~ 1-... 
\V \ II 
· Figure 1.1 CAMET compartmental 
structure 
~ 
4 
5 
t 
lost to the system. 
The remaining rapidly exchanging bone calcium 
and the calcium present in the soft tissues (apart 
from intestinal calcium) is distributed between four 
homogeneous compartments in the model (labelled 1 to 
6 
4 in fig. 1.1). Because simultaneous exchange process-
es in the bone and distributive processes occurring 
in the soft tissues with similar rates are unresolved 
by compartmental analysis, compartments 1 to 4 do 
not correspond in a one to one manner with any 
anatomical region of the body. Neer (1967) concluded 
that the rapidly exchanging compartments 1 and 2 
were predominantly composed of soft tissue calcium 
while the more slowly exchanging compa~tments 3 and 4 
were mainly exchangeable bone calcium - although no 
compartment could be considered exclusively either as 
bone or soft tissue calcium. Nevertheless as the 
isotope is injected into the blood and subsequent 
samples for analysis are taken from the blood, com-
partment 1 includes vascular space. 
Compartments 5 to 11 represent the digestive 
tract from the stomach to the distal ileum. The 
stomach is modelled by compartment 5 and the remain-
ing small intestine, divided by length, is represent-
ed by the other six compartments; six being the 
minimum number necessary to describe the experimental 
data (Birge et al. 1969) • The duodenum can be 
7 
identified with compartment 6, the jejunum with 
compartment 7 and the ileum with 8 to 11 inclusive. 
Although the movement of water and of electrolytes, 
particularly sodium, potassium and chloride ions, 
across the walls of the colon is considerable (Fordtran 
& Ingelfinger 1968) little net absorption of calcium 
is usually considered to occur, but this conclusion 
has been questioned (Brooke 1958). While the colon 
has not been included in the model more information 
is required on this aspect of calcium metabolism. 
1. 3 Model Eq.uations 
The set of equations describing the movement of 
stable and radioactive calcium between and out of the 
model compartments and the movement of fluid in the 
gut is presented in table 1.2. The equations proposed 
by Livesey (1970) are more complex in form than those 
tabulated below as provision was made for the actions 
of calcitonin (CT), parathyroid hormone (PTH) and 
vitamin D. However as pardme~ers relating to these 
substances, for example thS cbncentrations of CT and 
PTH, could not be determined they were set equal to 
zero. As a result there was no hormonal regulation 
of any metabolic process in the CAMET simulations. 
Under these circumstances those parts of the equations 
relating to these substances have been excluded here 
for simplicity, without any change in the predictions 
of the CAMET model. 
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Implicit in the tracer equations is the 
assumption that tracer calcium is handled in a 
manner identical with stable calcium. This has 
some experimental basis (Neer et al. 1967). 
A full explanation of the symbols used below 
and in subsequent chapters appears in Appendix I, 
but at this point we may note that 
MI is the quantity of calcium in compartment I. 
MTI is the quantity of tracer in compartment 
RI,J is the rate of transfer of calcium from 
compartment I to compartment J. 
RTI,J is the rate of transfer of tracer from 
compartment I to compartment J. 
x is the first derivative of x with respect 
to time (dx/dt) 
Table 1. 2 Model Equations 
Differential Equations 
-R - R . gsec ur1.n 
-RT - RT . gsec ur1.n 
11 
where Rabs = l: RI 1 
I=6 , 
11 
Rgsec = l: R I=S l,I 
11 
RTabs = l: RTI 1 
I=6 , 
11 
RT = l: RTl I gsec I=S ' 
I. 
9 
(1. 3) A 2 = R1,2 + R3,2 R2,1 R2,3 
(1. 4) ~T2 = RT1,2 + RT3,2 - RT2, 1 - RT2, 3 
. 
(1. 5) M3 = R2,3 + R4,3 R3,2 R3,4 
. 
(1. 6} MT3 = RT2,3 + RT4,3 - RT3,2 - RT3 ,4 
(1. 7) M4 = R3,4 - R4,3 
. 
(1. 8) MT 4 ::::: RT3 ,4 - RT4,3 
Stomach 
. 
(1. 9) Ms = Rdiet + Rl,S R5,6 
( 1.10) MTS = RTdiet + RT1,5 - RT5,6 
. 
(1.11} vs = RFdiet + RF1,5 - RFs 6 , 
Intestine 
. ( 1..12) MI == R(I-1) ,I - RI, (I+1) + R1,I - RI,l 6 ~I ~ 10 
. 
( 1.13) MTI = RT(I-l),I- RTI,(I+1) + RTl,I - RTI 1 6 ~I ~ 10 , 
( 1.14) M11 == R10 ,11 - Rfec1 + R1,11 - R11,1 
( 1.15) MT11 = RT10,11 - RTfec1 + RT 1 , 11 - RT 11 I 1 
Rate Ex2ressions 
( 1.16) RI,J = MIKI,J 1 ~ I .:;; 4, 1 ~ J ~ 4, J = I ± 1· 
( 1. 17} RTI,J = MTIKI,J 1 .,; I 
" 
4, 1 ~ J ;:;; 4, J = I ± 1 
Non Exchanging Calcium 
(1.18) Race = Kacccl 
(1.19) RTacc = Racc8 A1 
(1.20} Rdec = Al 
10 
Urinary Excretion of Calcium 
(1. 21) 
(1.22) 
(1. 24} 
(1. 25) 
(1.26} 
R . = A6c1 - A7 ur~n 
Stomach 
RF = FV~ 5,6 5 
Small Intestine 
' 
Cl < (A7 - All}/(A6 - AlO} 
Cl ~ (A7 - All)/(A6 - AlO) 
(1.27) RFI,(I+l) = RF(I-l},I (1- AFI,l) + RFl,I 6~I~ 10 
(1.28) RFfecl = RF10,11 ( 1 - AFll,l) + RFl,ll 
(1.29} VI = BI,1 RFI,(I+1)/(BI,2 + RFI,{I+l)) 
(1.30) v11 
( 1. 31) RI , (I+ 1) = RF I , (I+ 1) CI 
(1.32) RTI,(I+l) = RI,(I+1) SAI 
(1.33} Rfecl 
( 1. 34) RTfecl 
(1.35) RI,l 
( 1. 3 6 ) RT I , l 
(1.37) 
(1.38) CI 
(1. 39) SAI 
= RF feel ell 
= Ml/Vl 
= MI/VI 
= MTI/MI 
Calcium: Balance 
6 ~I ~ 10 
6 ·~ I "110 
6 ~ I ~ 10 
6 ~I~ 11 
6 ~I~ 11 
5 ~ I ·~ 11 
1" I~ 11 
1.4 Derivation of Model Parameters and Equations. 
On the basis of the four term exponential 
function 
4 
s(t) = E 
i=l 
-s.t ~ 
a.e 
~ 
fitted to the data from a single isotope study over 
twenty days following the tracer injection, Neer et 
al. ( 1967) proposed a four compartment model. The 
same number of compartments, with the arrangement of 
fig. 1.·2, were adopted by Livesey, although the 
arrangement of the compartments is arbitrary (Berman 
1963, Neer et aL 1967). 
Tracer specific activities generated by Neer's 
model, based on the average model parameters of 10 
normal men were fitted to the model in fig. 1.2. 
11 
Least-squares fitting was carried out using the comput-
er program ORGLS (Busing & Levey 1962). In this way the 
rate constants between the four rapidly exchanging 
compartments (K1 2 K2 1 etc.) and the rate constant , , , 
KE for the loss of calcium from compartment 1 via 
other routes (urinary and digestive juice calcium as 
well as loss to the unmixed compartment) were derived 
by Livesey. M1 , the mass of calcium in compartment 1 
was calculated by Neer et al, ( 196 7) from the plasma 
specific activity at zero time, obtained by back extra-
polation from the initial measurements. With this 
value the set of steady state simultaneous equations 
MlKl 2 = M2K2 1 
' ' 
M2K2,3 = M3K3 2 , 
M3K3,4 = M4K4,3 
12 
Tracer dose 
\~ K1,2 .... K2,3, K3,4, 
MTI MT2 MT3 MT4 
i' r""' 
"""' K2,1 K3,2 K4,3 
KE 
,, 
Tracer loss 
··"' 
Figure 1.2 Model fitted to specific activity 
data of Neer et al. 1967 
13 
was solved for M2 , M3 and M4• These values and the rate 
constants for the rapidly exchanging calcium pools given 
by Livesey are adopted in the present work. 
In contrast to the techniques of compartmental 
analysis employed to this point the intestinal model was 
built up largely on physiological grounds. The square 
root relationship between the volume of the stomach and 
its rate of emptying given by equation (1.24) is approxim-
ate (Hopkins 1966), but adequate for the purposes of the 
model. Each compartment from 6 to 11 represents 48 em 
of the small intestine (based on a total length of 
285 ± 43 em measured by Hirsch et al. (1956) in ten sub-
jects). To avoid confusion the terms 'calcium absorpt-
ion' and • calcium secretion' refer, in tt.is volume, to 
the unidirectional flows of calcium across the intestinal 
membranes from the lumen to the blood and the blood to 
the lumen respectively. Mathematically they are defined 
in equation 1.2. Into the stomach and each of the 
intestinal compartments there is a flow of calcium Rl,I 
(5 ~ I ~ 11) and fluid RFl,I (5 ~ I ~ 11) from the plasma 
compartment. Some of the calcium that is secreted into 
the gut in this way is reabsorbed but the fraction that 
is ultimately excreted is the 'endo~enous faecal calcium'. 
Recently the rate of absorption of calcium from 
buffered solutions of calcium gluconate in various seg-
ments of the human intestine was measured by Wensel et 
al. (1969). The parameters of Michaelis-Menten type 
equations for the rate of absorption of calcium from the 
gut (equation 1.35) were fitted to his data using the 
least squares program ORGLS. 
As far as the fluid dynamics are concerned the o.ut-
flow of fluid from an intestinal compartment is assumed 
to be always equal to the inflow minus what is absorbed 
(equation 1. 27) which implies that the segment volume is 
constant, and it is further assumed that the flow is 
unidirectional from the stomach to the distal ileum. The 
absorption of fluid from each compartment, through the 
gut wall is calculated as a constant fraction of the in-
flow into the compartment (equation le27). Finally the 
equations relating to the volume of the intestinal com-
partments (equations 1.29 and 1.30) are based on the 
relationships between the fluid flow and the apparent 
volume of human intestinal segments (Dillard et al.l965), 
which removes the restriction of constant volume, and is 
therefore inconsistent. The fluid flow equations are 
of such form as to make computation rapid, but as will 
be seen in Chapter 5, the inconsistency produces anomalies 
in the simulation of a meal. 
Equation 1.40 calculates the calcium balance through-
out a simulation and is defined as the total simulated 
excretion of calcium by all routes subtracted from the in-
take of calcium (dietary and/or infused calcium) since 
the beginning of .the simulation. 
1. 4 CAMET Parameter Values 
CAMET model parameters corresponding to the equations 
of table 1.2 are given below. 
14 
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Table 1.3 Parameter s 
Parameter Value units 
Al 0.33 m.moles/kg/day 
A6 0.09 li tres/kg/day 
A7 0.17 m.moles/kg/day 
Ala 1.10 litres/kg/day 
All 2.60 m.moles/kg/day 
AF6,1 -2.5 
AF7,1 to AFll,l 0.5 
B6,1 to BB,l 0.004 li tres/kg 
B9, 1 to Bll, 1 0.0025 II 
B6,2 to B8,2 0.14 1i tres/kg/day 
B9,2 to B11,2 0.12 II 
E6,1 to E8,1 0.19 m.moles/kg/day 
E9,1 to E11,1 0.10 
II 
E6,2 to E8,2 2.2 m.mo1es/1itre 
E9,2 to E11,2 5.0 
II 
F 4.5 1itres~jkg~/day 
Kacc 0.08 1itres/kg/day 
K1,2 28.9 day-
1 
K2 1 25.2 " , 
K2,3 3.10 II 
K3,2 1. 30 
II 
16 
Parameter Value Units 
K3,4 0.127 day 
-1 
K4,3 0.180 II 
Ml 0.45 m.moles/kg 
1M2 0.52 II 
M3 1.23 II 
M4 0.87 " 
M5 0.01 II 
M6 0.8 X 10-3 II 
M7 & MB 0.1 X 10-2 II 
Mg to M11 0.6 X 10-
3 II 
MT1 to MTll o.o m.moles/kg 
R1,5 0.07 m.moles/kg/day 
R1,6 0.05 II 
R1,7 & Rl,B 0 .. 02 II 
Rl,9 to R1,11 0.01 II 
RF1,5 0.1 li tres/kg/day 
RF1,6 0.018 II 
RFl, 7 to RFl,ll 0.0011 II 
vl 0.18 1i tres/kg 
v5 0.5 X 10-3 II 
N .. B. M1 to M11 , MT1 to MT11 , and v5 are the initial 
conditions of the differential equations (1.1) to 
(1.15). 
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1.5 The Computer Program CAMET 
The necessary computation required for the 
solution of the differential equations (1.1 to 1.15) 
is carried out with the computer program CAMET, 
written in FORTRAN by A. McKinnon, for the University 
of Canterbury IBM 360/44 computer. The memory re-
quirements of the complete program as it exists for 
the simulations in this thesis (including the plotting 
subroutine PLOTER in Appendix IV) are approximately 
22,000 thirty-two bit words. Current listings and/or 
card decks are available from Dr. w.s. Metcalf, 
Chemistry Dept., University of Canterbury, Private Bag, 
Christchurch 1, New Zealand. 
1.6 Numerical Methods 
The differential equations (1.1 to 1.15) of table 
1. 2 are solved numerically using a predictor-corrector 
method (Milne 1953, Ralston 1960). Briefly stated this 
involves the repeated solution of each equation at 
small steps in simulated time until the simulation is 
completed. 
The steps involved for the solution of a 
differential equation 
(1.41) . y = f(x,y, ••• ) 
(where y is the first derivative of y with respect 
to time) at the (n + l)th step are-
(a) the prediction of Yn+l using 
. 
( 1. 42) Yn+l = Yn-1 + 2hYn 
(where h is the step length in time and yn is 
the derivative of y at the nth step). 
(b) the calculation of yn+l from the differential 
equation (1.41) using the value of Yn+l from the 
preceeding step. 
(c) the correction for Yn+l using the formula 
(1.43) Yn+l = Yn + h/2 (yn+l + Yn). 
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As the method is not exact the error is periodically 
estimated for each variable, and depending on its magnitude 
the step length h is lengthened or shortened if necessary. 
McKinnon has since improved upon the integxation algorithm 
by the addition of a Runge Kutta starting procedure and the 
use of the integration routine itself to perform 
interpolations between previously computed points, when 
.step length reductions are required. 
Simultaneously, at each step, the cumulative totals of 
a number of model variables (the integrated totals since 
the beginning of the simulation at t = 0) are calculated. 
Variables summed include urinary and faecal calcium, dietary 
intake and total absorption for each gut compartment. 
A simple trapezoidal summing is used 
= s + n 
R + R { n+l n ) h 
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th 
where sn, S(n+l) are the calculated sums at the n 
. th 
and (n+l} steps Rn, R{n+l} are the variable rates 
th at the nth and (n+l} steps. h is the step length 
as before. Though simple, the method is adequate in 
practice. 
1.7 Model Inputs and Outpu~ 
The use of subroutine OPTION developed by 
McKinnon allows any parameter to be changed before a 
simulation. Unless a parameter is altered in this way 
it is automatically set equal to the va:ue assigned to 
it in table 2.2. Control parameters such as the length 
of the simulation and whether or not tracer calcium 
is to be included are also regulated with OPTION. 
The computer program allows the simulated input of 
either tracer or stable calcium by two different routes. 
Oral input (Rdiet' RTdiet) introduces calcium into the 
stomach compartment, and intravenous input (R. f' RT. f) ~n ~n 
directly into the plasma compartment. The duration 
and magnitude of such inputs are specified by the user, 
otherwise they are set equal to zero. As a result of the 
present work simulated infusions of the hormones 
calcitonin (CT) and parathyroid hormone (PTH) are also 
permitted. 
20 
The principal model output takes the form of two 
graphs, plotted by the computer line printer, with four 
variables on each graph. Model variables to be plotted 
are chosen by the user and additional printed output can 
be specified if required. The program to plot the graphs 
reproduced in this volume was developed as part of the 
current work and a listing appears in Appendix IV. 
1.8 Results of Model Simulations. 
The model described above was used by Livesey to 
simulate a variety of experiments related to calcium 
metabolism. In the main the parameters were those of 
table 1.3 although for each simulation some alterations 
were made (Livesey 1970). Subsequently model predictions 
were compared with experimental data obtained independently. 
Simulation 1 
The four compartment model of figure 1.2 was tested by 
simulating the plasma, urinary and faecal dynamics of 
tracer calcium following an intravenous dose. The results 
were compared with those of Neer et al. (1967) - an excell-
ent fit being observed. However as the model parameters 
are derived from Neer's experimental data, this simulation 
was essentially a test of the numerical stability of the 
computation and of the accuracy of the fitted model 
parameters. 
Simulations lb & 2 
The intestinal absorption of a single oral dose of 
calcium and tracer calcium was simulated to examine 
the ability of the model to combine the intestinal and 
plasma dynamics of tracer calcium. Two runs were made 
with different initial quantities of carrier calcium 
in the stomach to predict the effects of 
different sized loads on the tracer dynamics. 
~he larger dose simulation (lb) was based on an 
experiment by Jaworski et al. (1963) and the 
smaller dose simulation (2) on data supplied 
by Caniggia et al. (1963). The results of 
these simulations are reproduced in table 1.4. 
The predicted maximum tracer specific activities 
are satisfactorily close, Simulation lb being 
within the experimental standard deviation 
although in Simulation 2 the result is somewhat 
high compared with the experiment. The predicted 
time at which the maximum concentratLon of tracer 
in the plasma occurs closely approximates that 
found in practice and,the deviations found in the 
total faecal tracer are also acceptably small. 
On the other hand, as was pointed out by Livesey, 
the delay of 10 minutes observed by Caniggia 
between the ingestion of the tracer and its 
appearance in the plasma was absent in the 
simulated output. After this the experimental 
data and the model predictions were in agreement. 
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Table 1. 4 Oral Tracer Calcium Simulations 
Reference No. of 
Subjects 
Stomach 
Calcium 
Dose 
(m.moles/kg) 
Faecal Excretion 
of Tracer (% of 
dose) and Collect-
ion Period 
Max. Plasma 
Specific 
Activity (% 
dose/litre) 
and Time 
Jaworski 11 0.11 62 ± 4 l. 73 ± 0.26 
et al. (6 days) (2-3 hours) 
( 196 3} 
Simulation 0.12 58 1.6 
lb (3 days) (2. 8 hours) 
Caniggia 5 0.035 33 ± 4 2.41 ± 0.15 
et al. .(3 days) ( l. 5 - 2 hours: 
Simulation 0.035 26 3.0 
2 (3 days) (2 .1 hours) 
Simulation 3 
The simulation of two simplified 3 meal days was carried 
out in this run. Three discrete doses of calcium (each of 
0.114 m.moles/kg corresponding in size to the typical calcium 
content of a meal) were ingested at approximately 8, 13 and 18 
hours on each simulated day. Simultaneously the dynamics of a 
single dose of tracer calcium in the plasma (given at t = 0) 
over the simulated period were followed. 
The circadian oscillation in the plasma calcium predict-
ed by the model was in agreement with the experimental data of 
Jubiz & Tyler (1969) who discovered a minimum in plasma calcium 
between 4 and 6 a.m. and a maximum at 8 p.m. A similar 
pattern with respect to urinary calcium (Briscoe & Ragan 
1966, Nordin et al. 1967) has been observed and this too was 
evident in the simulated output. 
The upper and lower limits of the endogenous 
calcium secretion into the. gut were calculated from the 
model simulation, using a method based on tracer 
experiments reported in the literature (Heaney & Skill-
man 1964). The rate calculated in this way (between 
0.0456 and 0.0809 m.moles/kg/day) using the simulated 
excretion data was much lower than the actual simulated 
intestinal secretion of calcium (0.19 m.moles/kg/day), 
confirming the discrepancy previously noted between 
estimates based on physiological considerations alone and 
calculations based on tracer experiments. The basic 
cause of this disagreement between methods, as pointed 
out by Livesey, is that the absorption of calcium is a 
function of the quantity of calcium in the gut. Hence 
it is not possible to speak of an invariant fraction of 
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the digestive juice calcium that is reabsorbed and recycled 
back to the blood stream. (Heaney & Skillman 1964) . 
Simulation 4 
Finally to check the parameters and the equations 
governing renal excretion a four hour calcium retention 
test (Nordin & Fraser 1954, Bhandarkar & Nordin 1962, 
Nordin & Smith 1965) was simulated. This test involves 
the infusion of calcium at the rate of 2.25 m.moles/kg/ 
day for four hours. The 24 hour urinary excretion 
simulated by the model was 0.154 m.moles/kg/day and by 
employing the method described by Nordin & Smith (1965) 
the calculated calcium retention was 56.3% of the infused 
dose (the experimental range is 44-66%, Bhandarkar 
& Nordin 1962) It is also worth noting that the four 
hour rise in plasma calcium concentration (0.72 m.moles/ 
litre) was close to the mean experimental value (0.80 
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± 0.14 m.moles/litre, Nordin & Fraser 1954}. 
Several of these simulations (or slightly 
modified versions} will be repeated in the following 
chapters with the new model equations and parameters 
of tables 2.1 and 2.2. In the course of discussion 
of these simulations, including comparisons between 
the output from CAMET and CAMET2, a more detailed 
account will be given. 
1. 9 Conclusions 
CAMET represents a substantial advance on the 
previous models in'that it can simulate to within 
normal physiological limits both oral and intravenous 
tracer dynamics. The models of the first two classes 
listed in table 1.1 accounted for either oral or 
intravenous tracer dynamics, but not both. CAMET 
has enabled the simulation of more complex and 
interesting experiments, not previously attempted, so 
throwing light on a number of aspects of overall 
calcium metabolism. 
The fact that hormonal control of calcium metabol-
ism (Chapter 3) was not included in the model is worth 
noting. Of course to some extent the averaged effects 
of the hormones are built into the parameters used 
in the model. But in general, inexplicable deviations 
have not occured in any simulation to suggest unsuspect-
ed hormone action. At the same time under conditions 
of stress hormonal effects are well documented 
(Chapter 3) • By the same token, hormonal control of 
renal excretion imp.:r:oves the characteristic dynamics 
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of some simulations and situations where the 
presence or absence of the hormone is crucial to 
the organism may also be demonstrated (Chapter 4) • 
Hence CAMET as it existed at the beginning 
of 1971 represented a fusion between the two main 
types of published compar'!::mental models, but 
remained undeveloped in respect to the active 
regulation of calcium metdbolism via the complex 
' ~ . 
system of hormonal feedbacks. The way in which 
this problem has been approached, while at the same 
time preserving and extending the capabilities of 
the model is outlined in the following chapters. 
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CHAPTER 2 
CAMET2 EQUATIONS AND PARAMETER VALUES 
2.1 The equations and parameters resulting from 
the work described in the following chapters are 
given in tables 2.1 and 2.2 respectively. In table 
2.1 where the equation has remained essentially 
unaltered from that in table 1.1, it is marked with 
an asterisk and i:q. table 2. 2 where parameter values 
between CAMET and CAMET2 are comparable the CAMET 
value (Livesey 1970) is also given. 
Throughout this thesis units are usually in 
terms of kilograms, 1itres, moles and days, except 
where hormones are involved and the more convention-
al nanogram units are used. Extensive quantities 
are normalized to unit body weight. A body weight 
of 65 kg is adopted if there is no evidence to the 
contrary. 
Table 2.1 Model Equa·tions 
Dif'fe·ren:tial Equati·ons 
Plasma and exchanging calcium 
- R - R . - R 
. gsec ur~n derm 
- RTgsec - RTurin - RTderm 
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11 11 
where Rabs = L: RI,l RTabs = E RTI,1 I=6 I=6 
11 11 
Rgsec = E Rl,I RT = E RTl,I I=5 gsec I=5 
. ( 2. 3) M2 = R1,2 - R2,1 
* . ( 2. 4) MT2 = RT1,2 + RT 3,2 - RT2,1 - RT2,3 
* . (2.5) MT3 = RT2,3 + RT4,3 - RT3,2 - RT3 4 , 
* . (2. 6) MT4 = RT3,4 - RT4,3 
Stomach 
*(2.7) . Ms = Rdiet + R1,5 - R5,6 
* . (2. B) MT5 = RTdiet + RT1,5 - RT5,6 
*<2.9} . vs = RFdiet + RF1,5 - RF5,6 
Intestine 
* . (2 .10) MI = R(I-1), I+ Rl,I - RI 1 (I+l)- RI ,1 6 <I ~ 10 ' 
*<2.11) . MTI = RT(I-1) ,I + RT1,I - RTI, (I+l) - RTI,l 6 ~I ~ 10 
* (2.12) . Mll = R10,11 + R1,11 - R - R feel 11,1 
* . ( 2. 13) MTll = RTlO ,11 + RT1,11 - RTfec1 - RT11,1 
Hormones 
. (2.14) Me = Rsc + R -cinf Rdc 
. ( 2.15) M = Rsp + Rpinf - Rdp p 
Bone 
. ( 2 .16) ~ca = R - R ace dec 
( 2. 17) ~coll = R -co ace Rcodec 
* 
* 
* 
* 
* 
* 
* 
(2.18) 
(2.19) 
(2.20) 
(2.21) 
(2. 23) 
(2.24) 
(2.25) 
(2.26) 
(2.27) 
(2.28) 
(2.29) 
* (2.30) 
* (2.31) 
* (2. 32) 
* (2.33) 
* (2.34) 
* (2.35) 
* (2.36) 
* (2. 37) 
* (2.38) 
~ Expressions and Volumes 
Plasma and Exchanging Calcium 
RTI,J = MTIKI,J ~~I~4, 
Stomach 
RF5,6 = FV ~ 5 
R5,6 = RF5 ,6c5 
RT5,6 = R5, 6SA5 
Rl,5 = K0 RG5 
RT1,5 = Rl,SSA 1 
Intestine 
RF1,6 = 3RF5,6 + Gl 
Rl,6 = Kc(G2RF1,6 + G3) 
R = K0 RGI 1,I 
.l'-J~4, 
RFI, (I+1) = RF (I-1),1(1 - AFI) + RF1,I 
RFfec1 = RF10,11 (l- AF11) + RF1,11 
VI = BI,1RFI,(I+l)/(BI,2 + RFI,(I+l)) 
V11 = B11,1RFfec1/(B11,2 + RFfec1) 
RI,(I+1) = RFI,(I+1)CI 
RTI, (I+1) = RI,(I+1)SAI 
RI,1 = EI,1CI/(EI,2 + CI) 
RTI,1 = RI,1SAI 
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I = J ± 1 
7::; I::>. 11 
6 .;; I ~ 10 
6 :!f I ~ 10 
6 ~ I ~ 10 
6 ~ I ~. 11 
6 ~I~ 11 
(2.39) 
( 2. 40) 
{2.41) 
( 2. 42) 
(2.43) 
(2. 44} 
(2.45) 
(2.46) 
(2.47} 
* (2.48) 
(2.49) 
(2.50) 
* ( 2. 51) 
RG1 and RF1 are constant rates - see table 2.2 
and Chapter 5. 
Hormones 
Rsc = o.o 
Rsc = A23(Cl - A22) 
Rdc = KdcMc 
Rsp = A25(A24 - Cl} 
R = o.o sp 
Rdp = Kd M p p 
Bone 
Rcoacc = A4 
Rcodec = Al/Kc 
Race = KcKossumcoll 
RTacc = Kacccl SAl 
Rdec = K R rp codec 
Urinary Excretion of Calcium 
RT . = R . SAl ur~n ur~n 
Dermal Excretion of Calcium 
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Concentration$ and Specific Activities 
* Ml/Vl (2.54) cl = 
* (2.55) CI = MI/VI 5 ~ I ~ 11 
(2.56) cc = Mc/Vc 
(2.57) c = M /V p p p 
(2.58) Kc = cl/Cl where '\ = 2.5 m.moles/li tre 
* (2. 59) SAI = 1 .;:: I ~ 11 
· Quantity of unmineralized Bone Collagen 
( 2. 61) 
Total 
MTtot 
Tracer Calcium 
= 
11 
E MTI 
I=l 
Calci urn Balance 
at t = o. 
'
2
•
62 ) ~al = sdiet + sinf - sfecl - surin - sderm 
(2 • 63 ) CTbal = STdiet + STinf + MTtot - STfecl - STurin 
- ST derm 
Unless a parameter is specifically stated to have 
a new value in the subsequent simulations then it will 
have the value assigned to it in table 2.2. The initial 
values of the. gut parameters which are listed (the quant-
ity of calcium in each intestinal compartment M5 to 
M11 and the stomach volume v5) are the eventual steady 
state values obtained by running the program with no oral 
inputs .. 
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Table 2.2 Model Parameters 
Parameter CAMET2 CAMET Units 
Differential' Egua:ti'on rni'ti'al Condi'tions 
Ml 0.45 0.45 m.molesjkg 
M2 0.52 0.52 II 
M3 1.23 1.23 II 
M4 0.87 0.87 II 
M5 0.28 X 10-3 0.01 II 
M6 0.11 X 10-2 0.8 X 10-3 II 
M7 0.65 
-3 0.1 10-2 II X 10 X 
M8 0.21 X 10-3 0.1 X 10-2 II 
Mg 0.10 X 10-3 0.6 X 10- 3 II 
MlO 0.64 X 10-
4 0.6 X 10-3 II 
Mll 0. 40 X 10-
4 0.6 X 10- 3 II 
MT1 to MTll o.o o.o II 
Me 7.1 ng/kg 
Mp 93.0 ng/kg 
Mbca 0.4242 moles/kg 
Mbcoll 21.23 g/kg 
v5 0.187 X 10-3 0.5 X 10-3 litres/kg 
Rate Constants 
Kl,2 28.9 28.9 day -1 
K2 1 25.2 25.2 II 
I 
K2,3 3.10 3.10 II 
K3,2 1.30 1.30 It 
K3,4 0.127 0.127 II 
K4 3 0.180 0.180 II , 
K 0.078 0.078 " ace 
Kd 0.0153 1itres/kg/day 
Kdc 41.7 o.o day- 1 
o.o II 
Kdp 36.1 
0.60 10-2 litres/kg/day Koss X 
Parameter CAMET2 CAMET 
Intestinal Fluid Secretion Rates 
RF1 , 5 0.041 0.1 
RFl,? 0.011 0.0011 
RF1 , 8 to RFl,ll 0.0024 0. 0011. 
Intestinal calcium Secretion Rates 
RG5 
RG 7 
RG 8 
RG9 to RG11 
0.062 
0.016 
0. 0036 
0.0036 
Duodenal Secretion Parameters 
-0.078 
0.83 
0.013 
Fluid Flow Constants 
AF6 to AFll 
8 6,1 to ~8,1 
B9 ,1 to Bll,l 
B6,2 to B8,2 
8 9,2 to 8 11,2 
F 
0.48 
0.004 
0.0025 
0.14 
0.12 
3.0 
Hormone Effect Constants 
o.sa x 10-2 
o.s8 x lo-2 
0.262 
0.405 
3.84 
0.847 
1.7 
0.07 
0.02 
0.02 
0.01 
0 .so. 
0.004 
0.0025 
0.14 
0.12 
4.5 
o.o 
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Units 
li tres/kg/day 
II 
11 
m.moles/kg/day 
11 
11 
" 
li tres/kg/day 
m.moles/litre 
m.moles/kg/day 
litres/kg 
" 
litres/kg/day 
II 
g/kg/day 
II 
litres/kg/day 
m.moles/kg/day 
ml/ng 
" 
m.moles/litre 
Parameter CAMET2 CAMET Units 
Hormone Effect ·cons·t:a:n:ts ( Ctd. ) 
A23 0.37 X 103 o.o ng litre 
. -1 
m.mol1:! kg-1 day-1 
A24 3.0 o.o m.molei:;/li tre 
A25 0.67 X 10
4 o.o ng litre '1 -1 m.mo e kg-1 day-l 
Intestinal ·A:bsorpt·ton Parameters 
E6,1 to E8,1 0.19 0.19 m.moles/kg/day 
Eg 1 to Ell,l 0.10 0.10 II , 
E6,2 to E8 ,2 2.2 2.2 m.moles/litre 
E9,2 to E11,2 5.0 5.0 
.II 
Volumes 
vl 0.18 0.18 litres/kg 
vc 71.0 o.o m 'l/kg 
vP 155.0 o.o II 
Calcium/Collagen Bone Ratios 
Kpr 50.0 g/mole 
Krp 0.02 mole/g 
Control Parameters 
0 tmin 0.1 X 10-
4 day 
E h' rr ~ 0.1 X 10-
5 
E 
rr1o 0.1 X 10-
6 
xdt 0.5 X 10-
5 
Model Inputs 
R . f c~n 
R • f p1n 
calcium and tracer in diet 
fluid in diet 
calcium and tracer infusion 
calcitonin infusion 
parathyroid hormone infusion 
All the above input rates are automatically set 
equal to zero unless altered by the programmer for 
a simulation involving one or more of these inputs. 
At this point it may be noted that the features 
of CAMET2, discussed in subsequent chapters, which 
distinguish it from CAMET are as follows -
Chapter 4 
(1) Introduction of the hormones calcitonin (also 
34 
known as thyrocalcitonin) and parathyroid hormone.· 
(2) Improved control of renal excretion - including 
the effects of calcitonin and parathyroid hormone. 
Chapter 5 
(3) Many CAMET intestinal parameters are changed to 
conform with better or more recent information. 
(4) Loss of calcium through the skin is introduced. 
(5) The inclusion of the additional calcium secretion 
into the gut in response to a meal. 
Chapter 6 
(6) Reduction in the number of exchangeable calcium 
compartments from 4 to 2 (fig. 6.1) while maintaining 
the number of exchangeable tracer compartments at 4. 
(7) Introduction of bone calcium and bone collagen as 
definite model entities. 
(8) The rates of bone calcium deposition and decretion 
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are made dependent on the corresponding collagen rates. 
Each simulation is summarized on a separate page 
for easy reference (see list of simulations) • The summary 
includes the simulation title, simulated inputs, para-
meter changes (if any) and the principal numerical results. 
Graphs belonging to the simulation are headed by the 
simulation title. 
CHAPTER 3. 
HORMONAL CONTROL OF CALCIUM HOMEOSTASIS. 
3.1 Three substances, calcitonin (CT), parathyroid 
hormone (PTH) and vitamin D, together play a central 
role in calcium metabolism. In fact, in the absence 
of either PTH or vitamin D calcium metabolism becomes 
deranged and death may· follow. In this chapter 
current knowledge about these substances is reviewed, 
and numerical data of relevance is reduced to tabular 
form. The equations and parameters used in Chapter 4 
are based on this information. Although vitamin D 
is not yet included in the model (little is known 
about the dynamics of vitamin D metabolites) more 
recent experimental work is covered for completeness. 
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It is by now well established that the injection 
of PTH causes a delayed and relatively slow rise in 
plasma calcium, which takes from 18 to 24 hours to 
reach a peak and is accompanied by a fall in phosphate 
concentration. CT, on the other hand, causes a rapid 
and transient fall in plasma calcium over a period of 
a few hours. Its effects are particularly marked in 
young animals or in diseases where bone turnover is 
known to be elevated. The mode of precise control 
of calcium concentration within the body can be 
explained in terms of the antagonistic effects of CT 
and PTH. Both hormones, together with vitamin D 
work through a complex, integrated system of control 
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and feedback loops involving a number of target organs. 
The main control pathways are shown in figure 3.1 and 
the specific actions of the hormones are discussed in 
sections 3.6 to 3.8. 
3. 2 The Thyroid a:nd Pa:ra:thyro'id Glands 
Before the beginning of this century the parathyroid 
. glands had been located anatomically and the drastic 
effect of their removal observed (section 4.5). 
Some time later the first extraction of PTH was 
accomplished (Collip 1925) • It was only as recently 
as 1961 however, that the discovery of the hypocalcaemic 
hormone, calcitonin was announced (Copp et al. 1961). 
This followed the classical experiments of Sanderson 
et al. (1960) where it was shown that dogs whose thyroid 
and parathyroid glands had been removed (an operation 
termed a thyroparathyroidectomy) were less able to cope 
with either hypocalcaemic or hypercalcaemic stress than 
were control dogs. The lack of control in hypocalcaemia 
was correctly attributed to the absence of PTH, but no 
convincing explanation could be made of the impaired 
control in hypercalcaemia compared with dogs possessing 
intact glands. Since then work on CT has proceeded at 
a very rapid rate. At the present time as much, if not 
more, is known about the chemistry and dynamics of CT 
than about PTH. 
It is now generally accepted (Bussolati & Pearse 
1967, Copp 1969) that CT is secreted by specialized 
c1 
Thyroid 
C cells 
Parathyroid 
gland 
destruction 
of 
calcitonin 
Rdc 
space of 
calcitonin 
Vitamin 0 
c1 
Rdiet 
c1 
RFcJiet 
Bone 
(decretion) 
Kidney 
Bone 
(accretion) 
Rinf 
c1 
Race 
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cells called C cells or parafollicular cells which 
originate embryologically in the last branchial 
(ultimobranchial) cleft (Pearse & Carvalhiera 1967). 
Immunofluorescent techniques have demonstrated a 
localized concentration of CT within these cells 
(Bussolati & Pearse 196 7) • In vertebrates (other than 
mammals) these cells form a distinct ultimobranchial 
. gland from which CT may be extracted (O'Dor et al 
1969a). During mammalian embryonic development the 
C cells become dispersed and are mainly incorporated 
into the thyroid. In man these cells are also located 
in the thymus and the parathyroid glands (Galante et 
al. 1966). The embedded C cells are distinct 
morphologically, histochemically and ~mbryonically 
from the s.urrounding tissue. The relative contribution 
of the C cells at different locations to the total 
amount of hormone secreted is uncertain. However very 
low or undetectable levels of CT in the peripheral 
plasma are found in the absence of the thyroid gland. 
in both man (Melvin et al. 1971) and the pig (Cooper 
et al. 1971) • This suggests that the thyroid is the 
dominant source of CT in both these species. 
PTH is secreted by the parathyroid chief cells 
situated within the parathyroid glands. In man, two 
pairs of glands exist (weighing about 0.1 g in all) 
in close association with the thyroid (Fourman & 
Royer 1968). 
3.3 Hormone Chemistry 
In the short time since the discovery of CT 
its chemical structure, including the amino acid 
sequence has been determined. Separate groups 
40 
using a variety of approaches (Bell et al. 1968, 
Potts et al. 1968b)first resolved the structure of 
purified CT extracted from the pig thyroid. All of 
the calcitonins so far chemically analysed - includ-
ing porcine, bovine, human and salmon CT ~ have cer-
tain structural characteristics in common~ They are 
single chain polypeptides . characterized by a 1-7 
intrachain disulphide bridge, forming a 23 membered 
ring at the N terminus. 
s-------------------------1 H2N-Cys.Gly.Asn.Leu.Ser.Thr. 1 2 3 4 5 6 7 • Met. Leu. Gly. 8 9 10 
Thr.Tyr.Thr.Gln.Asp.Phe.Asn.Lys.Phe.His.Thr.Phe. 
11 12 13 14 15 16 17 18 19 20 21 22 
0 
Pro.Gln.Thr.Ala.Leu.Gly.Val.Gly.Ala.Pro NH 
23 24 25 26 27 28 29 30 31 32 2 
Figure 3.2 Amino Acid Sequence of Human Calcitonin 
Apart from two amino acids in human calcitonin 
(fig. 3.2), the residues in this ring are identical 
in all four calcitonins. Leucine at position 9, 
glycine at position 28 and a prolinamide carboxyl 
terminal are also common features. However, with 
the exception of the bovine and porcine hormones 
which differ at only three locations, the different 
types of CT vary considerably in the composition 
and sequence of amino acid residues within the two 
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extremes of the molecule. This is reflected in immune-
logical differences (section 3.4). Human, porcine and 
salmon calcitonin have all been synthesized with full 
biological potency. Relative to the mammalian calciton-
ins which have similar biological activities, salmon CT 
has a very high potency (table 3.1). The precise bio-
chemical role of the molecule in relation to its hypo-
calcaemic effect remains obscure (section 3.9) • 
Table 3.1 . Physical Properties of Calcitonin 
Type 
Bovine 
Human 
Porcine 
Salmon 
' . ' . . . . . . . . ' . . . . 
Molecular* No of 
Weight amino 
3634 
3418 
3604 
3427 
32 
32 
32 
32 
Biological** 
Potency 
Reference 
200 
309 
270 
3500 
Brewer & Ronan (1969) 
Dietrich & Rittel (197~ 
Tashjian & Voelkel 
( 19 70) 
Bell et al. (1968) 
Gutteman et al. (1969), 
Niall et al. (1969), 
O,Dor et al¥ (1969b) 
* calculated from amino acid composition. Similar values 
have been determined from gel filtration elution times 
(O'Dor et al. 1969a). 
** as determined by biological assay on rats (section 3.4) 
Parathyroid hormone is a protein hormone consisting 
of a straight chain polypeptide, like CT, but is almost 
three times as large. So far only the absolute amino acid 
sequence of bovine PTH has been determined (Brewer 
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and Ronan 1970). It consists of 84 amino acid residues, 
is strongly positive due to an excess of basic amino 
acids, particularly lysine and arginine, but contains 
no cystine. From the initial determination of the 
empirical formula of human PTH it would appear that it 
contains two additional amino acid residues and that sig-
nificant differences occur in the proportions of some 
residues (O'Riordan et al. 1971). Overall however, the 
amino acid composition of the two hormones is similar. In 
fact the physical properties such as the molecular weight 
( N 9600 determined by ultracentrifugation) and the 
charge properties of the three types of PTH studied so 
far (bovine, human and porcine) are almost identical. 
They are however immunologically distinguj.shable 
(O'Riordan et al. 1969, Woodhead & O'Riordan 1971). 
In contrast to earlier views (Potts et al. 1965) it 
appears that the biologically active portion of the mole-
cule is within the 34 amino acid chain at the amino term-
inal of the peptide. This fragment has been synthes-
ized (Potts et al. 1971) and tested for biological effects. 
The synthetic peptide had an equal or greater biological 
activity than the natural hormone fragment but was only 
a quarter to one third as effective as the complete 
native hormone. It was suggested that the remaining 
carboxyl terminal chain (residues 35 to 84) of the complete 
molecule protects the hormone from metabolic degradation, 
although as yet this idea remains unproven. 
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Essentially pure bovine PTH has a biological 
potency of greater than 3000 u.s.P. units/mg (Brewer 
& Ronan 1970). The corresponding value for human 
PTH, estimated from rather impure extracts is 
approximately 2500 u.s.P. units/mg (Addison et al. 
1971). 
3.4 Hormone Assay Procedures and Units of Measurement 
CT and PTH have been estimated almost exclusively 
by bioassay until comparatively recently. However with 
the availability of the pure hormones, radioimmunoassay 
techniques of much greater sensitivity have been devel-
oped. Irnrnunoassays make use of the ability of animal 
immunity mechanisms to recognise foreisn substances 
(antigens) and to eliminate them by developing specific 
proteins (antibodies) which chemically bind the antigen. 
Antibodies are developed against the hormone to be 
measured and by determining the degree of binding in an 
incubation mixture of antibody-hormone the quantity 
of hormone in an unknown sample can be calculated from 
a predetermined standard curve. In radioimmunoassays 
a small quantity of labelled hormone is added to the 
incubation medium to measure the extent to which the 
measured hormone binds to the antibody. Radioirnrnuno-
assays developed for CT and PTH are being increasingly 
employed both clinically and experimentally - permitt-
ing the study of their roles in disease states, their 
distribution and rates of disappearance from the blood 
and the factors controlling their production. In the 
mean time however, data for man has accumulated 
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expressed in terms of the biologic or immunologic 
equivalent of the hormone from cows, pigs and other 
species. Such results are valuable from a qualitative 
point of view but cannot te used to derive reliable 
model parameters, particularly as clear chemical and 
immunological differences are known to exist between ex-
tracts from different animals. The difficulty is com-
pounded by the use of many different assay techniques. 
Wherever possible in choosing model parameters emphasis 
has been placed on experimental results expressed in 
gravimetric terms and involving a minimum number of im-
plicit interspecies comparisons (Chapter 4). 
Calcitonin 
The earliest of the bioassays for CT (Hirsch et al. 
1964) is based on the fall in plasma calcium one hour 
after the injection of the sample into a rat under care-
fully standardized conditions. This assay has since 
been improved (Cooper et al. 1967) and other similar 
assay procedures described (Kumar et al. 1965, Copp & 
Kuczerpa 1968, Gudmundsson et al. 1969). Sufficient 
sensitivity to measure the concentration of CT in normal 
human plasma has been achieved but only after extraction 
and concentration of the plasma protein fraction. The 
usual CT unit of measurement in biologic assays is the 
MRC (Medical Research Council) unit where 1/100 of an 
MRC unit is defined as the quantity of a standard porcine 
thyroid extract required to produce a fall of 
0.25 m.moles/litre (1 mg/100 ml) in the plasma calcium 
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concentration of a lSOg rat (Research Standard A for 
Thyroid Calcitonin, Medical Research Council Communicat-
ion, February 1966). Currently standard B of a much 
higher potency is available. Synthetic human calcitonin 
has a biological activity close to 300 MRC units/mg 
(Tashjian & Voelkel 1970). 
Since 1968 when the first radioimmunoassay for 
porcine CT was developed (Deftos et al. l968)v at least 
three radioimmunoassays have been reported for the 
measurement of CT in human plasma. Two of these (Clark 
et al. 1969, Deftos & Potts 1970) could not detect the 
hormone in normal plasma, but could measure elevated 
levels in patients with cancer of the thyroid. A much 
more sensitive and specific assay (Tashjian et al. 1970) 
which is not disturbed by the presence of CT from other 
species or the presence of other polypeptide hormones 
(including human PTH) has shown concentrations of CT in 
the range 0.02 to 0.40 ng/mt (in 58 normal subjects). 
Very high values, up to 540 ng/mL, were measured in 32 
patients with thyroid carcinomas. This assay was based on 
the production of guinea pig antibodies to human CT and 
the use of labelled synthetic human CT as the tracer. 
Parathyroid Hormone 
The biological potency of PTH is generally expressed 
in USP units. One USP unit is defined as 1/100 of the 
amount of hormone or extract which will raise the serum 
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calcium concentration of mature male dogs by 
0.25 m.moles/litre (1 mg/100 mZ) within 16-18 hours 
(Collip & Clark 1925). This assay has since been replaced 
by others; with rats as the assay animal (Munson 196~ and 
an in vitro technique (Zanelli et al. 1969). 
The first radioimmunoassay for PTH was developed for 
bovine PTH (Berson et al. 1963) , where the assay tracer 
was I 131 labelled bovine PTH. In fact a great deal of 
the existing knowledge about PTH and its characteristic 
dynamics has resulted from·the use of this assay, or 
modifications of it (Potts et al. 1968a). The assay has 
been extended to measure the PTH of other species but the 
results for human PTH have generally been disappointing. 
With few exceptions most attempts to apply this assay to 
man have been unable, or only just able, to measure PTH in 
normal human serum, although high blood levels of PTH have 
been detected in hyperparathyroidism (Berson & Yalow 
1966, Melick & Martin 1968, Reiss & Canterbury 1969). 
One of the reasons for this finding is that the extent of 
the cross reaction between the bovine PTH antibodies and 
human PTH is relatively small and difficult to determine 
(O'Riordan et al. 1969). In preliminary studies it has 
also been found that a PTH precursor, some twenty amino 
acids larger than the secreted hormone, is synthesized by 
the parathyroid chief cells (Sherwood et al. 1970, Kemper 
et al. 1972), and that this 'proparathyroid hormone' is not 
only chemically but also immunologically distinct from the 
secreted hormone (Habener et al. 1971). Hence the hetero-
geneous nature of parathyroid gland extracts (to which 
the assay antibodies are developed} complicates the 
interpretation of assay results - particularly when applied 
to other species. 
To overcome the low sensitivity of the usual bovine 
assay procedures for human PTH several different approach-
es to the problem have been published recently. Arnaud 
et al. (1971} described a radioimmunoassay with a lower 
limit of detection estimated at 0.1 to 0.2 ng/ml which 
was capable of measuring the PTH concentration in 94% of 
normal persons. The radioimmunoassay employed antiserum 
to porcine PTH and the measured human hormone competed 
with bovine PTH (which was also the tracer) for the anti-
serum binding sites. An even more sensitive procedure 
(Addison et al. 1971) employs labelled bcvine PTli anti-
bodies (rather than labelled PTH). After incubation the 
antibody - PTH complexes are separated and counted. This 
method overcomes some difficulties in the conventional 
assay where iodination of tne PTH tends to damage the 
hormone, and where the labelled hormone is somewhat un-
stable. Quantities as small as 5 pg of bovine PTH and 
8 pg of human PTH could be detected and the mean serum 
concentration in 30 normal persons was 0.56 ng/ml with 
a range of 0.1 to 1.8 ng/ml. 
In table 3.2 published values for the concentrations 
of CT and PTH in human plasma are collected. Where CT 
values, measured by bioassay, are given in MRC units the 
corresponding value in ng/ml is also given in parentheses 
- assuming 300 MRC units to one milligram of hormone. 
The hormone concentrations adopted in the model are 
0.1 ng/ml for CT and 0.6 ng/ml for PTH (at a plasma cal-
cium of 2.5 m.moles/litre). 
Table 3. 2 Human Plasma Concentration1! of Calcitonin 
and Parathyroid Hormone 
Number and 
status of· 
subjects 
Calcitonin 
1 normal 
1 normal 
normals 
6 with 
thyroid 
tumours 
10 normals 
* ** Method Concentration Reference 
B 
R 
B 
0.6 m MRC u/ml 
(2ngjml) 
0.12 m MRC u/ml 
(0. 4ng/ml) 
< 2ng/ml 
15-320 ng/ml 
Sturtridge & Kumar 
( 196 8) 
Clark et al. (1969) 
0.17-0.49 m MRC Gudmundsson et al. 
u/ml (1969) 
(0.5 - 1.5 ng/ml) 
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58 normals 
18 with 
thyroid 
tumours 
R 0.02- 0.4 ng/mZ Tashjian et al.(l970) 
1-540 ng/mZ 
5 with 
thyroid 
tumours 
R 
Parathyroid Hormone 
normals 
normals 
10 with 
primary 
hyperpara-
thyroidism 
normals 
R 
R 
R 
0.3-lOOng/mZ 
0.25-2ng/ml 
*** 10 - 60 
294 ( 190-390) 
unde te ctab le 
< 0. 25ng/ml 
Deftos et al. (1971) 
0 'Riordan et al. 
(1969) 
Reiss & Canterbury 
(1969} 
Buckle (1970) 
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** Number and Method Concentration Reference 
status of 
subjects 
20 with 2.4 (O.l-5.4)ng/ml 
chronic 
renal 
failure 
34 with R 8.4±1.1 ng/ml O'Riordan et al. 
chronic ( 19 70) 
renal 
failure 
30 normals R 0. 56 (0 .1-1. 8) ng/ml Addison et al. 
(1971) 
1 hyper- 15 ng/ml 
parathyroid 
1 hyper- 9.5 ng/ml 
parathyroid 
B represents bioassay, R radioimmunoassay 
** where possible means and ranges are given 
*** arbitrary units in terms of bovine PTH equivalents 
3.5 Hormone Secretion and Disappearance 
Studies with a range of peptide hormones have 
emphasized the rapid rate of turnover of these hormones 
in the blood. Calcitonin and parathyroid hormone are no 
exception to this observation - their rates of secretion 
are rapidly responsive to physiological demands and once 
secretion is abolished they disappear with a half-life 
measured in minutes. 
The rates of secretion of both CT and PTH are direct-
ly controlled by the ambient calcium concentration. 
so 
Other substances may influence the rates of secretion 
but the calcium concentration is the principal factor 
in the ·fast acting hormonal feed back loops by which 
extracellular calcium is regulated. Earlier physiologic-
al experiments which had indicated this control (such as 
the inverse relationship between the parathyroid gland 
size and the dietary calcium) have been confirmed, not 
only by the use of biologic and radioimmunoassays, but 
also by in vitro biochemical studies. The uptake of 
labelled amino acids from the culture medium of parathyroid 
glands and the appearance of labelled, biologically 
active, peptide is inversely proportional to the concent-
ration of calcium in the incubation medium (Hamilton & 
Cohn 1969, Au et al. 19 70) • By radioimmunoassay Sherwood 
et al. (1968) were able to show a highly significant 
inverse re.lationship between the plasma concentration of 
PTH and the calcaemia over a range of 1 m.mole/litre to 
3 m.moles/litre in the cow. In general, infusions of the 
chelating agent ethylene diamine tetraacetic acid (EDTA) 
leading to a decrease in plasma calcium in turn lea~to 
a marked rise in the level of circulating hormone, 
detectable within 3-5 minutes from the beginning of the 
infusion, while sustained hypercalcaemia as a result of 
calcium chloride infusion resulted in a complete disappear-
ance of measurable PTH. Analogous results have been 
reported for humans (Buckle 1970, Arnaud et al. 1971), 
but because of the difficulties of measurement the results 
are neither as precise nor extensive as for bovine PTH. 
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However Arnaud et al. (1971) showed a significant 
negative correlation between serum calcium and circul-
ating PTH in normals; elevated values in hyperparathyroid-
ism despite high blood calcium, and undetectable levels 
in patients with hypoparathyroidism. 
The suggestion that the phosphate ion is able to 
effect the rate of secretion of PTH (Clark 1968) lacks 
convincing experimental support. The increased PTH 
secretion associated with phosphate infusions or diets 
rich in phosphate is believed to be secondary to the 
association of ionized calcium with phosphate ions 
(Sherwood et al. 1968, Reiss et al. 1970). However it is 
quite clear that plasma magnesium able to exert an 
effect on PTH secretion in a similar manner to calcium, 
although in vivo the gland appears to be more sensitive 
to small changes in calcium than in magnesium (Buckle 
et al. 196S, Targovnik et al. 1971). Another Group II 
metal ion, strontium, may also be active in this process -
but under normal circumstances it would not be expected 
to play a significant physiological role (Care & Bates 
1970). CT secretion rate is proportional to the con-
centration of calcium in blood. 
The secretion of CT from surgically isolated pig 
thyroids in vivo into the effluent venous blood was 
directly proportional to the concentration of calcium 
in the perfused blood (Care et al. 1968, Cooper et al. 
1971) over a range of about 1.5 m.moles/litre to 
4 m.moles/litre. Maximal CT concentrations of up to 
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2000 - 3000 ngjml were measured when the thyroid was 
perfused with hyper~caemic blood (Cooper et al. 1971). 
Both hyper- and hypocalcaemic challenge were rapidly 
meet (within minutes) by alterations in the secretion of 
CT into the blood stream. Marked hypermagnesia has also 
been shown to elevate CT secretion from the perfused pig 
thyroid (Li ttledike & Arnaud 1971) and it was noted that 
equimolar concentrations of calcium and magnesium stimulat-
ed the release of comparable quantities of CT. 
The ability of calcium to stimulate the secretion of 
CT in experimental animals also extends to humans 
(Tashjian et al. 1970) including those with high endogen-
ous CT levels due to medullary thyorid carcinomas (Deftos 
et al. 1971, Melvin et al. 1971). Althouch patients 
suffering from chronic renal failure tend to have high 
PTH concentrations (O'Riordan et al. 1970), their plasma CT 
and calcium are within the normal limits (Chittal et al. 
1971). In 17 such patients a strong positive correlation 
was found between plasma calcium and CT concentrations, 
and the data from two hypocalcaemic subjects suggested 
that CT secretion could be completely suppressed somewhere 
below 2 m.moles/litre of plasma calcium. 
In addition.to the calcium and magnesium cations the 
C cells are sensitive to molecules that are capable of 
activating an adenyl cyclase system. In brief, the addit-
ion of dibutyryl cyclic-3' ,5'-adenosine monophosphate 
raises the output of CT from the perfused pig thyroid; 
the details are reviewed elsewhere (Care & Bates 1970). 
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Glucagon, a hormone involved in carbohydrate metabolism, 
has been demonstrated to increase CT secretion in anim-
als (Care, Bates & Gitelman 1970, Cooper et al. 1971) 
while in man the response is variable (Melvin et al. 1970, 
Tashjian et al. 1970, Deftos et al. 1971). The effect of 
glucagon appears to be exerted through the activation of the 
adenyl cyclase system. In addition it has recently been 
discovered that several polypeptide hormones involved in 
digestion, including pancreozymin and gastrin, together 
with other peptides possessing the same c terminal 
tetrapeptide, increased CT release in the pig (Care et al. 
1971). The importance to be attached to this discovery is 
uncertain since the hormone concentrations employed were 
somewhat above physiological values. However, if con-
firmed it raises the interesting possibility of the thyroid 
anticipating a dietary calcium load before it is actually 
transferred to the blood from the gut. 
From a survey of the literature it is evident that 
under some circumstances the relation between the plasma 
calcium and the secretion rates of CT and PTH breaks down. 
Deviations occur when there is a sudden change in the plasma 
calcium. Under conditions of rapidly decreasing calcium 
the production of PTH (Sherwood et al. 1968), and under 
conditions of increasing calcium or magnesium the product-
ion of CT (Littledike & Arnaud 1971) is biphasic, consist-
ing of a higher than expected secretion rate at first, 
followed by a return to the predicted linear relationship. 
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In patients suffering from chronic hypocalcaemia 
resulting from malabsorption of calcium or renal disease 
the PTH gland hypertrophies and exceptionally high 
concentrations of the circulating hormone have been 
recorded (Arnaud et al. 1971). A further example of PTH 
. gland overactivity has been found .associated with thyroid 
tumours and high CT concentrations (Melvin et al. 1971) , 
but it is not known whether subtle changes in calcium 
concentration or a more direct link between the tumour 
and the PTH gland is involved. 
CT secreting cells differ from their PTH counterparts 
in that they contain large stores of hormone relative to 
the normal secretion rate. It has been estimated that the 
pig thyroid contains sufficient CT to maintain the normal 
secretion rate for about eleven days with no further 
synthesis (Care & Bates 1970). However chronic hyper-
calcaemia such as that produced by a consistently high 
calcium diet (Gittes et al., 1968) or an excess of 
vitamin D (Frankel & Yasumura 1970, Frankel & Yasumura 
1971) is able to significantly reduce the quantity of 
CT stared within the thyroid. 
The biochemical mechanisms by which CT and PTH are 
released into the blood are little more than conjecture 
at present. But the basis of present theories is that 
changes in plasma ionized calcium change the rate of re-
lease of stored CT while effecting the actual synthesis 
rate of PTH (Care & Bates 1970). 
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Once secreted, CT and PTH are rapidly metabolized, 
with the result that both hormones have short half lives. 
Such a rapid removal reflects uptake by target organs and 
degradation in the blood stream. When the results of 
t . t k f 131 lt' f . t . . t ~ssue up a eo I resu ~ng ·rom ~n ravenous ~nJeC.-
ion of either [r131 ]cT or [r131 ]PTH were compared, the 
major distinction between the two hormones was the re-
latively higher liver uptake of CT and the higher uptake 
of [r131 ]PTH by the kidney. Accumulation of radioactivity 
in skeletal muscle and, to a lesser extent, in bone were 
also recorded (de Luise et al. 1970). As there is no 
known CT effect on the liver it was suggested that this 
was its major. site of degradation in vivo. The rate of 
plasma inactivation of CT {n vitro has been measured on a 
number of occasions and found to be significant (Tashjian 
& Munson 1965, West et al. 1969). Porcine CT in human 
plasma disappears in a biphasic manner, rapidly at first 
and then more slowly. The slower component has a half-
life of 3.8 hours (Riggs et al. 1971). On the other 
hand loss of activity of synthetic human CT incubated in 
human plasma is small - disappearing with a half life 
of 1.84 days (Ardaillou et al. 1970). CT from the 
sheep, cow and pig which are structurally very similar 
are more rapidly degraded than human CT and much more 
rapidly than salmon calcitonin which is especially 
resistant to inactivation (Habener et al. 1972). 
56 
After the initial cleavage of proparathyroid hormone 
to produce PTH within the gland (section 3.4) there 
appears to be further splitting of the chain into small-
er fragments once the hormone is released into the 
blood (Sherwood et al. 1970, Habener et al. 1971). It 
is possible that one of these fragments is the biologic-
ally active molecule, but then the second cleavage may 
simply represent the first stage of the catabolism and 
degradation of PTH. 
In vivo, the disappearance from the plasma of CT 
and PTH have been investigated by a number of workers, 
but data derived from these studies is somewhat at 
variance. The single half life found by some workers 
for CT and PTH implies a first order rat~ of disappearance, 
but recently others using more advanced techniques have 
described a much more complex situation for CT, in which 
the disappearance of CT cannot be described by a single 
exponential (Ardaillou et al. 1970, Riggs et al. 1971) • 
Analysis of the experimental data leads to multiexponent-
ial equations (with two or three terms) in much the same 
way that tracer calcium is described (Chapter 1) • Com-
parable studies of PTH in vivo have not been made. In 
table 3.3 the half lives of CT and PTH reported in the 
literature, together with volumes of distribution are 
summarized. 
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Table 3. 3 · The Half 'Lives and Volumes of Distribution 
of Calcitonin and Parathyroid Hormone • 
. ' .. ' ' 
Number 
and 
Species 
Method* and 
Type of Cal-
citonin used 
Half 
Life 
* Volume of 
Distribution 
Reference 
Calcitonin 
Man (1) endogenous 
CT (B) 
(minutes) (% body wt) 
15 Cunliffe et 
al.," ( 196 8) 
Rabbit (5) porcine CT (R} 5-15 Deftos et al. 
( 196 8) 
Pig ( 1) 
Pig (2) 
Man ( 10} 
Man ( 10) 
uraemic 
subjects 
Man (5) 
labelled 
porcine CT 
infused 
porcine CT 
labelled 
human CT 
II 
labelled 
porcine CT 
Parathyroid Hormone 
Rat (6} labelled 
Cow (1) 
Cow (3} 
bovine PTH 
bovine PTH 
endogenous 
PTH (R) 
Man (8 endogenous 
hyper- PTH (R) 
parathyroids 
Man (7) labelled 
Man (5 
nephrect-
omized) 
bovine PTH 
" 
Man ( 3 chronic 11 
renal failure) 
Man (2 
uraemic 
subjects) 
* 
bovine 
PTH (R) 
( 1) 5 
(2) 37 
(1) 2-3 
(2) 33-37. 
( 1) 2.8 
(2) 11.5 
(3) 317.8 
( 1) 4.5 
(2) 22.5 
( 3} 1564.3 
9 West et al. 
(1969) 
7.07±0.04 Ardaillou et 
al. (1970) 
9.17±0.d6 
(1) 2.4±0.3 21.4±2.0 
(2) 40.9±6.2 
Riggs et al. 
( 19 71) 
22.3 36.4 
18 30 
10 - 15 
Melick 
et al. (1965) 
She:rwood et 
al. ( 196 8) 
19.8(11.4-28.8) Buckle (1969) 
27.6 15.5 Melick & 
Martin (1969) 
35.8 
40.8 
( 1) 5 
(2) 60 
13.6 
12.6 
10-20 litres O'Riordan et 
al. (1970) 
Clearance of hormone measured by bioassay (B) or 
radioimmunoassay (R). **where more than one exponential com-
ponent in the diSappearance curve was reported the corresp-
ing half lives are given as (1) ,(2) or (3). 
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3.6 Physiological Effects of Calcitonin (CT) 
By virtue of its ability to secrete CT the 
thyroid is able to control or blunt hypercalcaemic 
stress, whether caused by calcium infusion (Ibbert-
son et al. 1967, Kennedy & Talmage 1971), parathyroid 
hormone injection (Sorensen 1970) or, in the rat, 
even a normal dietary calcium load (Gray & Munson 
1969). 
Bone 
As the appearance of hypocalcaemia after the 
administration of CT was observed in nephrectomized 
animals (Gudmundsson et al. 1966) and after the re-
moval of the intestinal tract (Aliapoulious et al. 
1965) it was suspected that CT must act, at least in 
part, on the bone. It is now generally agreed that 
CT acts by inhibiting bone resorption and by 
inhibiting the action of PTH on bone resorption 
(section 3.7) although the presence of PTH is not 
essential (Gudmundssonet al. 1966, Bell & Stern 1970). 
The following lines of evidence support this content-
ion. 
[A] In bone tissue culture systemsthe morphological 
and biochemical consequences of the addition of 
various substates may easily be determined; however 
interpretation of the results is sometimes difficult 
because of doubt about the degree of correspondence 
between the physiological and culture system environ-
ments. While there'is some disagreement between 
investigators with various tissue culture systems 
(Goldhaber et al. 1968), the main features observed 
when CT is added to the culture medium are a reduced 
number of osteoclasts (multinucleated bone resorption 
cells) and a reduced rate of release of hydroxyproline 
(an amino acid component of the collagen matrix of bone 
tissue) and of ca45 that had previously been incorporated 
into the bone (Raisz et al. 1967, Flanagan & Nichols 
1969). 
(B] The specific activity of ca45 injected into the 
plasma remains higher in animals given exogeneous CT, 
than in controls. However the characteristic absolute 
rate of disappearance remains essentially unaltered. 
This is interpreted to mean (in the absenca of any CT 
action on the gut) decreased resorption of stable cal-
cium from the bone (Hirsch 1967, O'Riordan & Aurbach 
1968, Caniggia et al. 1969). 
(C) The major component of the inorganic matrix of bone 
is the protein collagen (Chapter 6) and this protein is 
almost the sole source of the amino acid hydroxyproline. 
Hydroxyproline is not directly involved in collagen syn-
thesis but arises from the hydroxylation of proline 
incorporated into the procollagen polypeptide (Grant & 
Prockop 1972). Hence the plasma level and the rate of 
urinary excretion of hydroxyproline serves as an indic-
ator of the rate of collagen catabolism. It should be 
remembered however that collagen is not confined to bone 
but is a general connective protein distributed through-
out the body, and that loss of polypeptide chains in 
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[D] 
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collagen synthesis may also contribute to hydroxyproline 
excretion (Flanagan & Nichols 1969) • 
The excretion of hydroxyproline drops sharply in 
animals given calcitonin by injection. The rise that is 
observed when PTH is injected can be negated, at least 
initially, by the simultaneous injection of CT (Pechet 
et al. 1967, Rasmussen & Feinblatt 1971). 
In thyroparathyroidectomized rats repeated doses 
of CT result in a decrease in the number of osteoclasts 
and an increase in the quantity of bone compared with 
control animals (Foster, Doyle et al. 1966). When 
similar experiments are carried out in animals with 
intact parathyroids no significant ~ifferences are ob-
served, presumably due to increased parathyroid activ-
ity as a result of the continual bouts of CT induced 
hypocalcaemia (Chiroff & Jowsey 1970). 
(E] In man, only in patients with diseases involving 
increased bone turnover does CT substantially reduce 
plasma calcium levels (Foster, Joplin et al. 1966, 
Bijvoet et al. 1968, Martin & Melick 1969). This phen-
omenon is most strikingly illustrated in Paget's disease 
which is characterized by intensive bone remodelling 
activity. 
Another possibility that must be considered is an 
effect of CT on bone formation. Flanagan & Nichols 
(1969) found that CT had a small inhibitory effect on 
bone collagen synthesis, but it seems likely that CT 
does not play a significant role in this respect. 
The removal of the ultimobranchial glands from young 
chickens had no significant effect on serum calcium 
or phosphorus or on the X-rays and microradiographs 
of the skeleton, over a period of 14 weeks compared 
with controls (Brown et al. 1969). 
Intestine 
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Attempts to demonstrate a correlation between CT 
administration and changes in the movement of calcium 
from the gut lumen to the blood or in the opposite 
direction have failed (Krawitt 1967, Cramer et al. 
1969). The possibility remains open however that di-
gestive hormones may influence CT secretion (section 
3. 5) • 
Kidney 
On the basis of the evidence at the time it was 
written the appropriate equation in CAMET2 requires 
an increased renal excretion of calcium when serum CT 
is increased. However there is considerable controv-
ersy over the effects of CT on the renal excretion 
of electrolytes,for a number of reasons. Firstly, 
there are probably genuine species differences in the 
reaction to CT - which are exaggerated by the wide 
range of dose levels, different types of CT used and 
the differing forms of administration. But also im-
portant (in this respect) is the general observation 
that where urine collections of sufficient frequency 
have been made (Bijvoet et al. 1968, Haas et al. 1971) 
the effects of CT on renal excretion of calcium 
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(and other electrolytes) are transient and fall 
away rapidly after an injection or the cessation of a 
CT infusion. In the case of calcium the renal effects 
of CT become masked by the induced hypocalcaemia and 
the ensuing stimulation of PTH secretion - combining 
to actually reduce urinary calcium below that of con-
trols. This is particularly so in young animals where 
the propensity of CT to lower plasma calcium is marked. 
Hence measurements made over extended periods may 
not only fail to record i:he initial peak in excretion 
but actually find either a r~drlced level or a statist-
ically insignificant change. 
'' Aldred et al. (1970) demortstrated increased 
sodium, calcium and phosphate with lesrer, but signif-
icant, increases in urinary potassium and creatinine 
and reduced magnesium excretion in rats when salmon 
CT was injected subcutaneously. Porcine CT was able 
to increase sodium and potassium excretion, although 
larger doses were required. Both forms of CT produced 
hypocalcaemia and hypophosphatemia. Cramer et al. 
(1969) also observed increased phosphate and reduced 
magnesium clearance in the dog, and others have noted 
the phosphaturia (excess phosphate in the urine) 
subsequent to CT administration (Hirsch et al. 1964, 
Kenny & Heiskell 1965, Milhaud & Moukhtar 1966, Robin-
son et al. 1966, Rasmussen et al. 1967). The fact 
that increased phosphate clearance occurs in animals 
lacking parathyroid glands rules out the possibility 
of PTH producing this effect (section 3.7). However 
part of it may simply be associated with the fall 
in plasma calcium (resulting from CT administration) 
as Rasmussen et al. ( 196 7) found that the phosphaturia 
could be reproduced simply by lowering the calcium 
levels in parathyroidectomized animals with EDTA. 
CT has been found to decrease (Pechet et al. 
1967, Rasmussen et al. 1967) and to increase (Milhaud 
& Job 1966, Aldred et al. 1970) urinary calcium in 
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animals. The increased calcium excretion in rats treated 
repeatedly with CT over a period of three days by Milhaud 
& Job (1966) was not statistically significant but was 
achieved in the face of significantly lowered plasma cal-
cium. In young rats, which are particularly susceptible 
to the calcium lowering properties of CT, Williams et 
al. (1972) showed that only large doses of salmon CT 
could counteract the hypocalcaemia to produce an increase 
in calcium excretion - smaller CT doses were associated 
with decreased values. Yet in the dog Clark & Kenny (1969) 
and Pak et al. (1970) could find no direct effect of CT 
on renal function; the increased phosphate excretion that 
was observed could be abolished by parathyroidectomy and 
was attributed to secondary hyperparathyroidism as a 
consequence of the decrease in serum calcium. 
In man there seems to be general consensus that 
CT reduces tubular reabsorption of calcium and phos-
phate (Robinson et al. 1966, Ardaillou et al. 1967, 
Bijvoet et al. 1968, Martin & Melick 1969, Singer et 
al. 1969, Haas et al. 1971); a result that is not 
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dependent': oll the parathyroid gland as it has been 
observed in hypoparathyroid patients (Ardaillou et al. 
1967, Haas et al. 1971). The small complicating hypo-
calcaemic effect of CT in adult man, compared to the 
smaller mammals, is probably the main reason for this 
consensus. It should be taken into consideration however 
that the dose levels involved in most of these studies 
were very high in comparison to physiological levels -
up to several orders of magnitude greater. 
The overall place of CT in calcium metabolism and 
the possible significance of its effect on the kidney, 
two factors that are not well understood are considered 
in section 4.4 and section 4.7. 
3.7 Physiological Effects of Parathyroid Horrn.one (PTH) 
It is known that the administration of PTH to a 
parathyroidectomized animal produces a characteristic 
sequence of events: an immediate increase (within 
minutes) in the excretion of phosphate by the kidney, 
a decrease in the calcium excretion and a simultaneous 
fall in the concentration of phosphorus in the plasma. 
There follows a gradual rise in plasma calcium which may 
not appear for some hours and which is accompanied 
by a progressive increase in the excretion of calcium 
in the urine. Once established, hypercalcaemia and 
hypercalciuria persist and their magnitudes are related 
to the dose of the administered hormone. 
Bone 
It has become clear that the action of PTH on the 
bone is basically a cellular process, taking the form 
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of increased osteoclastic bone resorption. PTH has 
no effect on dead bone (as estimated by the release of 
C 45 . t. lt t ) d ' . t t . a ~n ~ssue cu ure sys ems nor oes ~ opera e ~n 
the absence of oxygen or glucose (Tenenhouse et al. 1966) • 
Osteolytic bone resorption has been consistently demon-
strated in tissue culture after the addition of PTH 
to the medium (Raisz 1965, Tenenhouse et al. 1966, Gold-
haber et al. 1968). Tenenhouse et al. (1966) showed 
that hormone concentrations of J.o- 8 moles/litre (com-
pared with 10-lO moles/litre in vivo) gave rise to a 
discernable increase in calcium mobilization. From both 
morphological and biochemical considerations PTH leads 
to the removal of both the collagen matrix as well as 
the bone mineral, although the exact sequence of events 
is uncertain (Mecca et al. 1963, Stern et al. 1970). 
Collagen degradation is reflected in the increased 
presence of collagenase enzymes and in the renal ex-
cretion of hydroxyproline (Harris & Sjoerdsma 1966v 
Latiner 1966, Pechet et al. 1967). 
Actinomycin D, a potent inhibitor of RNA synthesis 
does not prevent the PTH stimulated release of calcium 
during the first 6 hours but suppresses it subsequently 
(Rasmussen et al. 1964, Raisz & Niemann 1967). It was 
suggested that the initial effect of PTH is to stimul-
ate resorption by the existing osteoclasts and the 
later actinomycin D-sensitive phase of calcium resorpt-
ion was due to the development and differentiation of 
new osteoclasts from their cellular precursors. 
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However this view has been questioned by Bingham et al. 
(1969). It was concluded on the basis of autoradio-
graphic studies, which enabled a detailed study of the 
metabolism of different rabbit bone cell populations, 
that no significant increase in osteoclast numbers occurred 
until 17 hours after the PTH injection - reaching a maxi-
mum between 22· and 26 hours. In contrast plasma calcium 
was rising after 3 hours. From the first few hours the 
biochemical activity of the existing cells was increased 
significantly. The first measurement, 1~ hours after in-
jection of PTH,revealed an increase in nuclear RNA 
synthesis. Cytoplasmic RNA reached its maximum some 7-12 
hours after the beginning of the experiment and the 
increase in protein synthesis was roughly correlated with 
its appearance. Both were still elevated at 24 hours. 
In the main, RNA synthesis in osteoblasts (collagen 
synthesizing cells) was depressed compared with controls. 
This depression of RNA synthesis was of the order of 50% 
and occurred not only in the osteoblasts but also in 
their cellular precursors the preosteoblasts. Thus the 
hormone had an effect not only on the two types of 
mature cells but also on their cellular precursors - an 
effect that persisted long after the initial injection. 
On the basis of this experiment it was proposed that the 
rise in plasma calcium was mainly due to the increased 
activity of the existing osteoclasts on bone dissolution. 
The rise in their number was a secondary effect and not 
responsible for the initial rise in plasma calcium. 
The relationship of PTH to bone formation is not 
well understood. Apart from the observations of Bing-
ham et al. (1969) there have been a few reports of re-
duced hydroxyproline incorporation into collagen in the 
short term after the administration of PTH in vitro 
(Goldhaber et al. 196 8, Flanagan & Nichols 1969) • Pro-
longed exposure to high levels of PTH. as in hyperpara-
thyroidism results in increased bone formation as well 
as increased bone resorption (Frost 1969). 
Vitamin D is now known to be important in PTH 
mediated bone resorption and this is considered in 
section 3. 8. 
Intestine 
Of all the sites at which PTH is known to be in-
volved least is known about its effect on the movement 
of calcium into the body from the gut. There is no 
doubt that vitamin D is the principal factor in the 
active process that occurs in the transfer of calcium 
across the intestinal membranes (section 3.8) but PTH, 
directly or indirectly, has a significant supplementary 
effect. 
Clinically this relationship has been suspected 
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for some time, mainly because of the lower than expected 
faecal calcium in patients with hyperparathyroidism 
(Albright et al. 1932, Lafferty & Pearson 1963}. 
Where balance and isotopic absorption studies have been 
carried out on patients suffering from hypoparathyroid-
ism or hyperparathyroidism (conditions resulting from a 
deficiency or an excess of PTH respectively} calcium 
absorption has deviated significantly from the normal 
range. Although the numbers involved in such tests 
were small,hypoparathyroids tend to have low calcium 
absorption while hyperparathyroids have high absorption 
despite the elevated serosal calcium concentration 
(Jaworski et al. 1963, Heaney & Skillman 1964, Spenser 
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et al. 1968, Birge et al. 1969). In addition Jaworski 
et al. (1963) observed a gradual decline in the absorpt-
ion by one hyperparathyroid patient after removal of a 
parathyroid tumour. Six normal persons administered a 
twice daily dose of PTH increased their absorption 
. 47 
of Ca (measured by an external radioisotope counting 
technique) in a carrier dose of 4.5 m.moles of stable 
calcium by approximately 21 ± 7% (Wills et al. 1970) • 
In vit~o Rasmussen (1959) demonstrated that the 
property of an isolated rat intestinal sac to develop 
and to maintain a calcium concentration gradient across 
its walls was reduced after the rat had been parathyroid-
ectomized. PTH action on the gut has also been further 
corroborated by Cramer (1963). The significantly re-
duced absorption of calcium from dog jejunal fistulas 
as a result of thyroparathyroidectomy (p < .001) could 
be restored by the administration of PTH extract to the 
animal. 
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Kidney 
Under normal circumstances calcium is excreted 
by the kidney after over 97% of the filtered diffusible 
calcium is reabsorbed from the kidney nephrons (Nordin 
et al. 1967). PTH can alter the extent to which the cal-
cium is reabsorbed resulting in large changes in the 
actual amount excreted in the urine. In 1929 Albright 
& Ellesworth reported that the administration of para-
thyroid extract to a hypoparathyroid patient at first 
resulted in a decreased calcium excretion subsequently 
followed by a rise. The significance of the initial 
effect was not appreciated until the 1950's when Talmage 
and his colleagues demonstrated in rats and mice that 
parathyroidectomy elicited a marked rise in urinary 
calcium, despite falling plasma calcium, and a correspond-
ing fall in phosphate excretion. The converse was true 
when parathyroid extract was administered (Talmage & 
Kraintz 1954, Talmage et al. 1955). A unilateral de-
crease in calcium clearance (that is in urinary calcium 
excretion) and an increase in phosphate clearance results 
from the addition of PTH to the blood supply of one of 
the two kidneys, compared with the clearance of the control 
kidney (Lavender et al. 1961, Eisenberg 1968). 
Earlier indirect data suggested that PTH might have 
the same effect on human calcium and phosphate excretion. 
In circumstances where stimulation of PTH secretion was 
thought likely, urinary excretion of calcium was low and 
when PTH secretion was depressed calcium excretion rose. 
However as the plasma calcium concentration also changes, 
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an action of PTH on the kidney could not be unequivocally 
demonstrated one way or the other. Kleeman et al. (1961) 
first demonstrated that PTH has the same effect in the dog 
and man as in rats and mice. Although his experiments 
were carried out with plasma calcium in a state of flux 
as a result of calcium infusions or removal of parathyroid 
glands it was concluded that at any given filtered load of 
calcium the. greater the level of PTH the lower was the 
renal excretion of calcium. Soon afterwards the same 
result was observed in dogs where the calcium loads on 
the kidney were carefully controlled throughout the 
experiment (Widrow & Levinsky 1962). 
In general the administration of PTH leads to a 
rapid increase in the renal clearance of sr.di urn, potassi urn, 
phosphate and bicarbonate and a decreased clearance of 
hydrogen, ammonium, calcium and magnesium ions (Hellman 
et al. 1965, Haas et al. 1971). From the work of Haas 
et al. (1971) it is clear that alterations in kidney 
ion transport are closely linked to the current PTH status 
of the subject. At the cessation of PTH infusions the 
disturbed clearance of all measured ions changed quickly 
towards control values. 
There is little evidence to suggest that PTH acts 
by altering the glomerular filtration rate (Haas et al. 
1971) and, unlike in the bone, inhibitors of RNA and 
protein synthesis do not alter the action of this hormone 
on renal excretion. The primary effect of the hormone on 
the kidney is uncertain and it is not known whether it 
acts specifically on one ion such as the calcium or phos-
phate ion or whether it influences the handling of all ions -
for example by altering membrance permeability. 
The interrelationships between the calcium load, 
parathyroid hormone, calcitonin and renal excretion of 
calcium are discussed more fully in the next chapter. 
3.8 Physiological Effects of Vitamin D 
In the last few years there has been a rapid accum-
mulation of knowledge relating to vitamin D chemistry 
and action. In vivo vitamin D has been shown to be con-
verted to a number of metabolites, only some of which are 
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believed to be biologically active (Norman et al. 1964, 
DeLuca 1967). 25-hydroxycholecalciferol (25-HCC) and 
25-hydroxyergocalciferol have been isolated and are 
considered to be important biologically active derivatives 
of vitamins n3 and D2 respectively (Blunt & DeLuca 1970). 
More recently attention has been focussed on an even 
more potent biological derivative of vitamin D: 
1,25-dihydroxycholecalciferol (1,25-DHCC) (Holick et al. 
1971). At least part of the 10 to 12 hour delay that 
occurs before the administration of vitamin n3 has any 
effect on intestinal transport (DeLuca 1967} is due to 
the conversion of the vitamin into its active metabolites 
probably in the liver and in the kidney. 
As the action of vitamin D on both the bone and the 
intestine can be blocked by the prior addition of actin-
omycin D and other inhibitors of RNA and protein synthesis 
(Norman 1965, Zull et al. 1966}, the vitamin is thought 
to ultimately involve protein synthesis. However the 
action of 1,25-DHCC on the intestine, unlike that of 
25-HCC, is not blocked, by actinomycin D (Tanaka et al. 
1971). 
72 
Bone 
Vitamin D has a primary effect on bone tissue that 
is distinct from its action at the gut wall. In some 
way the rate of bone resorption is dependent on vitamin 
D; it is also possible that the vitamin is required in 
bone deposition. 
The nature of vitamin D action on bone has been 
studied in vitro. It has not been convincingly demonstrat-
ed that unaltered vitamin o2 or o3 are able to alter 
significantly the rate of bone resorption in tissue 
culture. In contrast, 25-HCC induces a rapid and marked 
increase in the quantity of calcium released into the 
culture medium (Raisz 1965, Raisz & Trummel 1970). In-
creases in hydroxyproline excretion have b~en recorded 
(Pechet et al. 1967) indicating an increased rate of 
bone resorption following vitamin D therapy in vivo. 
However Mautalen (1970) found no significant change 
in this parameter. 
In vitamin D deficiency hypocalcaemia may occur 
and bone resorption is impaired despite consequential 
hyperparathyroidism. It is now thought that vitamin D 
is important to PTH mediated resorption, but there is 
disagreement over the extent to which vitamin D is required. 
Some investigators (Harrison & Harrison 1964, Rasmussen 
& Fleinblatt 1971) have found that PTH cannot mobilize 
significant quantities of bone in the absence of vitamin 
D, while others claim that vitamin D, while having a 
synergistic effect on the action of PTH, is not essential 
to PTH stimulated bone reso~rption (Raisz & Trummel 1970). 
Hypercalcaemia, hypercalciuria and changes in bone 
morphology resulting in increased porosity occur when 
pharmacological doses of vitamin D are administered 
(Danowski 1962, Chen & Bosmannl965). The increase in serum 
calcium can be demonstrated in rats existing on a diet 
lacking, or extremely low in calcium (Carlsson & Lindquist 
1955) ; a fact which precludes the alternative explanation 
that stimulated intestinal absorption alone accounts for 
the change. The rationale behind the administration of 
huge doses of vitamin D in hypoparathyroidism, where serum 
calcium has dropped to a low level (section 4.5), is based 
on these effects. 
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The question of whether or not vitamin D has a direct 
effect on either bone collagen synthesis or on the subsequent 
mineral deposition is still largely unanswered. Canas et 
al. (1969) showed an increase in the rate of uptake of 
labelled proline into bone matrix 12 hours after vitamin D 
deficient rats received a dose of the vitamin, even though 
serum calcium had not been restored to normal. An increase 
in the rate of bone formation within 4 hours of the commence-
ment of a vitamin D perfusion of a dog forelimb in vivo was 
reported by Nguyen & Jowsey (1970a). However both these 
reported observations may be secondary to some other vitamin 
action. 
It is generally thought that bone mineral crystallization 
is only indirectly dependent on vitamin D. In rickets the serum 
calcium is usually in or close to the normal range although 
phosphate concentration is low (Fourman & Royer 1968). The 
calcification that occurs in rickets after vitamin D 
therapy is usually ascribed to the ability of the vitamin 
to change the concentrations of the plasma ions back 
to normal levels (DeLuca 1967). However the position 
is probably more complex than this physiochemical explan-
ation. Osteoid tissue of rachitic bone will not calcify 
in vitPo and bone tissue in rickets is biochemically 
abnormal (Fourman & Royer 1968). 
Kidney 
There is no evidence to su~gest that vitamin D in 
physiological quantities has any effect on the renal ex-
cretion of electrolytes. Pharmacological quantities may 
exert some influence - particularly in decreasing tubular 
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reabsorption of phosphate (Ney et al. 1968}. This finding 
does not of course rule out the possibility of more pro-
found effects by the newly discovered vitamin D metabolites. 
Intestine 
It has long been known that there exists a mechanism 
on the intestine for the adaption of total calcium 
absorption to the requirements of the body and that this 
process involves vitamin D (Nicolaysen & Eeg-Laysen 1953, 
Malm 1958). The ability of vitamin D to facilitate calcium 
transport across the gut wall has often been demonstrated 
by a variety of methods. For instance Avioli et al. (1965} 
were able to show significantly increased ca47 absorption 
47 
and decreased Ca faecal excretion in patients after 
vitamin D therapy. Compared with the unaltered vitamin, 
25-HCC acts on the gut much faster and in much smaller 
quantities (Olson & DeLuca 1969) while 1,25-DHCC is 
approximately 1000 times as potent as 25-HCC (Boyle et al. 
19 7 2) • 
Transport of at least part of the absorbed calcium 
across the intestinal membranes is now generally agreed 
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to be an active or energy consuming process, the evidence 
for which is summarized elsewhere (Schachter 1970, 
Wasserman & Kallfelz 1970}. Recently, in this connect-
ion, Wasserman and his colleagues have isolated a specific 
protein from intestinal tissues - the calcium binding 
protein (CaBP). The protein has been obtained in high 
purity and some of its properties have been determined. 
Its molecular weight is in the range 25000 to 28000 and 
it binds one calcium ion per protein molecule. The 
CaBP has been implicated in the absorption of calcium as 
it is absent from the tissues of rachitic animals and 
appears only after administration of vi tar.J.n D (Wasser-
man & Taylor 1966). Furthermore the rate of absorption 
of calcium across the intestinal membranes is highly 
correlated (correlation coefficient of 0.99) with the 
CaBP content of the duodenal mucosa (Wasserman & Taylor 
1968). Thus it was shown that animals adapted to a low 
calcium diet by absorbing calcium more efficiently than 
animals on a normal diet, and that the former group had 
more CaBP than the normally fed animals. Although 
absolute evidence for the role of this protein has not 
yet been demonstrated, up to the present all the data 
suggests that it is involved in calcium absorption. 
3. 9 Biochemical Basis of Hormonal Action 
It is beyond the scope of this review to consider 
in any detail the present position with regard to the 
biochemical mechanisms of CT, PTH and vitamin D. 
However it should be mentioned that subsequent to the 
introduction of PTH into an organism two changes 
are rapidly induced. 
[A] A. greatly increased adenyl cyclase activity 
(Chase et al. 1969). 
[B.] A reduction in extracellular calcium concentration 
(Parsons et al. 1971). 
The reduction in plasma calcium in the dog, following 
the intravenous injection of 20 USP units of PTR, was max-
imal at 15 minutes and of the order of 0.1 m.moles/litre 
(0.4 mg/100 mt) (Parsons et al. 1971). Since this was not 
a dilution effect caused by fluid transfer and since it is 
known that certain calcium-sensitive enzymes are inhibited 
during this phase of PTH action (Rasmussen & Tenenhouse 
1968), an intracellular increase of calcium is thought to 
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be a primary action of the hormone. Analysis of the changes 
in the absolute quantity of introduced tracer calcium and 
its specific activity provides further support for this 
point of view (Parsons et al. 1971). Because of the well 
known sensitivity of a large number of cellular enzymes to 
ionic calcium it is reasonable to suggest that the 
alterations in bone cell metabolism for example (section 
3.7) follow from the increased cytoplasmic calcium. 
Both the PTH mediated increase in adenyl cyclase 
activity and the reduction in extracellular calcium 
are unaffected by simultaneous treatment with CT 
(Robinson et al. 1972). It has been suggested that CT 
by shifting calcium from the cell has a similar but opposite 
effect to PTH, although direct evidence on this point 
is lacking. Again while little is known about the 
primary effects of vitamin D it has been demonstrated 
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in isolated mitochrondria systems that vitamin D is able 
to alter membrane permeability to calcium (Wasserman 
& Kallfelz 1970). 
In fact all three hormones may have dual functions -
I 
the ability to alter membrane permeability in the short 
term, and to stimulate or depreps the production of 
macromolecules within the cells which ultimately initiate 
the longer term effects discussed in section 3.6 to 3.8. 
CHAPTER 4 
CALCITONIN, PARATHYROID HORMONE AND RENAL 
EXCRETION OF CALCIUM 
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4.1 The equations and parameters controlling calciton-
in and parathyroid hormone secretion and their subseq-
uent disappearance together with the interaction of 
these hormones with the kidney are introduced in th,is 
chapter. It is evident from the preceding chapter 
that definitive data on many aspects of endocrinologic-
al control in man is at best sketchy. Hence the 
approach adopted has been to take model parameters 
from the experiments judged to most closely approxim-
ate normal human physiology (if in fac·;. there is a 
choice) and then to test the model against independent 
experimental data derived from widely differing and 
ptrongly perturbed states of calcium metabolism 
(Simulations 1 to 5) • Although the method is empiric-
al some interesting points are illustrated, some 
~nexpected results obtained, and some clinical 
experiments are suggested. 
4.2 Calcit9nin and Parathyroid Hormone 
Linear equations to represent the relationship 
between the hormone secretion rates and blood calcium 
concentration are suggested by the experimental 
evidence of section 3.5. Equations of this type 
have been proposed in the past (Copp 1969, Livesey 
1970) and are employed in CAMET2 (equations 2.40 and 
2.42). Not taken into account are the small delays 
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in the secretion of the hormones in response to 
physiological demands nor are changes in gland size and 
output as a result of chronic changes in blood calcium 
levels (section 3.5). However since the delay is of the 
order of minutes and since the model simulations are 
carried out over a period of a few days or less neither 
omission is likely to have a material effect on model 
predictions. 
It is evident in domestic animals and, from more 
limited data, in man (Arnaud et al. 1971, Chittal et 
al. 1971) that both CT and PTH secretion are suppressed 
over certain ranges of blood calcium. In CAMET2 the 
simulated CT secretion ceases at and below a calcium 
concentration of 1.7 m.moles/litre (A22 ) -obtained by 
extrapolation of the results of Tashjian et al. (1970) 
where the increases in CT concentration, consequent 
upon calcium infusions, were measured. The limited 
results of Chittal et al. (1971) are not inconsistent 
with this value. As no corresponding data is currently 
available for PTH in man, the suppression of PTH 
secretion found in cows (Ramberg et al. 1967, Sherwood 
et al. 1~68) at a calcium concentration of 3.0 m.moles/ 
litre (A24 > and above is adopted for man also. 
An arbitrary but representative concentration of 
0.1 ng/mt (at a plasma calcium concentration of 
2.5 m.moles/litre) is taken for the purposes of the 
model since only the range (0.02 - 0.4 ng/mZ) in human CT 
concentration has been reported (Tashjian et al. 
1970, Melvin et al. 1971). The corresponding CAMET2 
value for the PTH concentration is 0.6 ng/ml selected 
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to be close to the mean experimental value of 0.56 ng/mZ 
in 30 normal subjects reported by Addison et al. (1971). 
Both hormones are represented in the model by single 
pools where the rate of disappearance is proportional to 
the quantity of hormone in the pool (equations 2.41 
and 2.44). In such a oase of first order kinetics 
the decay rate of the hormones is described by a single 
exponential term. 
As was noted in Chapter 3 however, recent experiments 
with CT have shown that its disappearance can only be 
described by a more co~plex function, such as a series 
of exponentials (Ardaillou et al. 1970, Riggs et al. 1971). 
No doubt these results reflect the rates of uptake by 
different target organf:i and perhaps degradation in the 
plasma. However at pr~sent little would be gained, in 
return for the additional computation required, to re-
produce these observations (by employing a multicornpart-
mental model for example) when virtually nothing is 
known about the utilization and catabolism of CT. A 
further source of error inherent in this representation 
is that the hormonal mixing time is not taken into account 
- but as this is of the order of 10 minutes (Melick 
et al. 1965) the error is probably negligible. 
Given the concentration of CT and its volume 
of distribution (Ardaillou et al. 1970) the quantity of 
CT per unit body weight Me may be calculated. Hence by 
substituting this value into equation (2. 41} 
the first order rate constant Kdc may be obtained where 
Rdc' the rate of removal of CT, was given by Ardaillou 
et al. 19 70 as the metabqlic clearance rate (that is the 
distripution volume of blood that is irreversibly cleared 
of CT per unit time). Finally the parameter A23 in equat-
ion (2.40) can be derived from the steady state equation 
where the rate of secretion of CT is set equal to its 
rate of catabolism. 
Similarly for the PTH parameters, except that Kdp 
was calculated directly from the half life estimate of 
27.6 minutes of Melick & Martin (1969). 
The various model hormonal parameters and the 
references from which they were derived are· collected 
in table 4.1 and in addition the hormone secretion rates 
are plotted against the plasma calcium concentration 
in figure 4.1 according to the equations of CAMET2. 
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Table 4.1 CAMET2 . Hormonal Parameters 
Parameter CT 
Concentration (ng/m"l) 0.1 
(c1 = 2.Sm.moles/litre) 
half life (minutes) 23.9** 
calcium concentration ~ 1.. 7** 
range over which hor-
mone secretion is 
suppressed (m.moles/ 
litre) 
volume of distribution 71 
(mz./kg) 
PTH 
0.6 
27.6 
;::3.0 
155 
secretion rates*** 296 3350 
cl = 2.5 m.moles/litre 
(ng/kg/day) 
References* 
Tashjian et al. (1970) 
Addison et al. (1971) 
Ardaillou et ~1. (1970) 
Melick & Mart;in ( 1969) 
Tashjian et a~. (1970) 
Sherwood et a!. (1968) 
Ardaillou et ~1. (1970) 
Melick & Martin (1969) 
* first reference of each pair is associated with the CT 
value and the second with the PTH value 
**calculated from the experimental results of the listed 
reference 
***calculated from model equations 
The CAMET2 values for the normal rates of secretion 
of CT and PTH are of the same order of magnitude as those 
reported for the pig normalized to unit body weight (Care 
& Bates 1970). The high rate of secretion of PTH re!ative 
to CT has also been noted - Care & Bates estimated that PTH 
secretion in the pig on a molar basis was 10 times that of 
CT. 
4.3 Renal Calcium Excretion 
According to Copp et al. (1960a) about 10 grams 
of ultrafiltrable calqium are filtered every day 
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by the renal glomeruli. Since in most people, the 
total daily kidney excretion of calcium is of the 
order of 100-300 mg, over 97% of filtered calcium is 
reabsorbed by the renal tubules. Of the reabsorbed 
calcium in rats and hamsters approximately 67% is 
reabsorbed in the proximal convolution, 20 - 25% 
in the loop of Henle and 10% in the distal convolut-
ion (Lassiter et al. 1963). Since a small change 
in the renal reabsorption efficiency is sufficient 
to bring about large changes in the amount of 
calcium finally excreted,control at ~his point 
provides a sensitive and, as will be seen, a vital 
means by which overall calcium homeostasis is 
maintained. 
The list of substances that are able, directly 
or indirectly, to effept the rate of renal calcium 
excretion is both long and varied. It includes other 
electrolytes such as sodium (Wills et al. 1969, 
Davis & Murdaugh 1970) and phosphate (Hulley et al. 
1969); a number of hormones the ·most important of 
which is PTH, together with other less well established 
factors such as age anq s.ex. 
The magnitude of urinary calcium excretion is also de-
pendent on the filtered load of calcium (the product of 
the ultrafiltrable calcium concentration and the 
. glomerular filtration rate). Hence a change in either 
of these factors may bring about a change in urinary 
calcium excretion. However comprehensive reviews of 
most aspects of the renal handling of calcium have 
appeared elsewhere (Nordin et al. 1967, Epstein 1968). 
For the present only three factors that influence 
renal calcium excretion are incorporated into CAMET2 -
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the calcium load (or more strictly the calcium concentrat-
ion) and the hormones calcitonin and parathyroid hor-
mone. Their general relationship to the kidney is 
shown in figure 4.2. Although direct da~a relating 
the concentrations of tpese three substances to urinary 
calcium excretion is sparse (and in the case of the hor-
mones almost non-existent) much is known or can be 
safely inferred from the following experimental results 
or the following states of health and sickness. 
[A] Hypoparathyroidism: Th~ PTH concentration is zero or 
close to zero (Arnaud et al. 1971) and the CT concentrat-
ion associated with the low plasma calcium levels, 
usual in this disorder, may also be assumed to be zero 
(section 3.5). Nevertheless, it should be noted that 
Tashjian et al. (1970) could not correlate serum CT 
levels with either ahronia hypocalcaemia or ahronia 
hypercalcaemia and in fact CT concentrations were usually 
in the normal range. Renal calcium excretion is small 
+v 
thyroid 
plasma 
calcium 
para-
thyroid 
CT + ~- PTH .___._---;:iii~~::- kidney ~------
w 
urinary Ca 
Figure 4.2 The control of renal 
calcium excretion 
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in untreated hypoparathyroids. In a group of 6 such 
patients a mean serum calcium concentration of 
1.60 ± 0.27 m.moles/litre was accompanied by a mean 
urinary calcium excretion (normali~ed to unit body 
weight) of 0.014 ± 0.006 m.moles/kg/day (Lamberg 
et al. 1960) • 
[B] Calcitonin Infusion There is some data available 
on the increase in calcium excretion in man during 
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CT infusions. For the purposes of the model the 
experimental data o~ Ardaillou et al. (1967) was select-
ed, despite the small number of subjects (4) , for two 
reasons. First, the dose (2 MRC units infused over one 
hour) was small in comparison with most other experi-
ments; secondly, relatively small urinary collection 
periods (~ hour intervals) were employed. By the end 
of the infusion the rate of urinary calcium excretion 
had approximately doubled and was associated with a 
small drop in plasma calcium ( N 0.125 m.moles/litre). 
The CT and PTH conc~ntrations associated with this 
experiment were predicted using the model equations. 
By infusing CT into young cows it hasbeen found that 
there is no direct stimulus to PTH secretion by the 
infused CT and that any increase in PTH concentration 
may be predicted with confidence from the magnitude 
of CT-induced hypocalcaemia (Reitz et al. 1971). 
However it should be emphasized at this point 
that the assumptions involved in applying Ardaillou's 
data to the model allow only a crude model approximation 
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of CT effects on the kidney which, as it has turned 
out, may be underestimated (section 4.4). For example 
since an infusion of 2 MRC units per hour represents 
about nine times the no+mal physiological secretion 
rate, saturation of the renal CT mechanism may well have 
occurred. Certainly much larger doses of up to 4 MRC 
units per kilogram body weight have not produced 
correspondingly larger effects (Martin & Melick 1969, 
Singer et al. 19.69, Brown et al. 1970). 
[C] Normal Daily Calcium Excretion : The ranges and means 
of the normal daily calcium excretion in the urine for 
statistically large samples of the population are known 
(Nordin et al. 1967). In one study reported by Nordin 
et al. the mean daily renal calcium excretion in 88 
females was 4.6 ± 2.1 m.moles and in 104 males 
6.2 ± 3.1 m.moles. The average urinary excretion of 
these two groups (5.4 m.moles/day) is adopted in CAMET2. 
[D) Calcium Infusion PTH secretion is suppressed 
(Arnaud et al. 1971) and the approximate changes in CT 
concentration are known (Tashjian et al. 1970) when the 
calcium concentration is elevated. During calcium 
infusions in 5 normal people, renal calcium excretion, 
measured over 20 - 25 minute intervals by Levitt et al. 
(1958), reached 0.67 ± 0.14 m.moles/kg/day associated 
with a calcium concentration of 3.6 ± 0.4 m.moles/litre. 
The mean experimental data from each of these 
situations (listed below in table 4.2} was used to solve 
equation (2.50) for the empirical constants A6 to A9 
[A] 
[B] 
[C] 
[D] 
inclusive. In practice there is a close temporal relation-
ship between hormonal concentrations and renal electrolyte 
excretion (sections 3.6 and 3.7) so the instantaneous nature 
of equation (2.50) seems unlikely to cause any major errors 
in the simulations discussed in the present work. From a· 
physiological point of view however the equations is un-
satisfactory since it predicts negative urinary excretion 
rates at low calcium concentrations ( < 1.55 m.moles/litre) 
or at high CT concentrations ( > 1.18 ng/mZ). On the other 
hand, in no CAMET2 simulation so far carried out are these 
concentrations reached, or even approached, and in fact they 
rarely occur in nature. 
Table 4. 2 Data Fitted to Renal Calcium Excretion Equation 
Plasma CT* PTH* Urinary References 
Calcium Cone. Cone. Ca*** 
Cone. {ng/mZ) (ng/mZ) Excretion 
(m.moles/ (m.moles/kg/ 
litre) day} 
89 
1.60** o.o o.o lL014 Lamberg et al. ( 1960) 
2.37 
2.50 
3.60 
* 
** 
*** 
0.78 0.75 0.17 Ardaillou et al. ( 196 7) 
0.10 0.60 0.083 Nordin et al. 
0.24 0.0 0.67 Levitt et al. 
hormone concentrations not given experimentally 
but calculated from model equations 
(1967) 
( 1958) 
mean serum calcium value of 6 untreated hypoparathyroid 
patients (page 332 Lamberg et al. 1960}. Subjects with 
serum calcium concentrations over 2 m.moles/litre 
excluded. 
experimental results normalized to unit body weight 
assuming a mean mass of 65 kg. 
In a situation where the determination of these 
hormonal and renal parameters would have been very 
difficult even 2 years ago it is evident that the 
next few years will yield better data, particularly 
pertaining to man, from which more reliable model 
constants could be derived. For the moment however, 
with the few exceptions noted in the following text, 
the present values appear to approximate satisfactorily 
the position as it is currently understood. 
4.4 Calcium Infusions 
One of the aims of the calcium metabolism project is 
to simulate as many routine diagnostic tests as possible -
at first for normals but extending to abnormal responses 
as the model is developed. By this means a comparison 
may be made between experimental data obtained under stand-
ard conditions and the predictions of the model. Event-
ually such a process need not be limited to a one way 
comparison - the clinical test itself could be examined 
in the light of the predictions of a well developed model. 
In the present work three non-tracer tests described by 
Nordin & Smith (1965) are simulated. The first two (the 
calcium and EDTA infusion tests} are included in this 
chapter and the calcium deprivation test may be found in 
Chapter 7. As well as these tests the calcium balance is 
routinely calculated by CAMET2 (equation 2.62) and is 
. given for all simulations. 
The basic clinical procedure of the calcium infusion 
test is to measure urinary and serum calcium over the 
duration of a 4 hour ipfusion of 15mg of calcium per kilo-
gram body weight (Nordin & Fraser 1954}. 
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Osteomalacia, a disorder in adults characterized by large 
amounts of \mdermineralized bone matrix, can be detected 
by this test as additional calcium is retained in the body 
(presumably in the skeleton) which results in lower serum 
calcium and urinary excretion (Nordin & Fraser 1956) • The 
test procedure is reproduced in Simulation 1 except that 
for simplicity the dietary intake of calcium is omitted. 
However as the experimental subjects of Nordin & Fraser 
(1954) were on a low calcium diet the difference is un-
likely to substantially influence the outcome. The princip-
al numerical results and the plotted output of particular 
interest are given on the following pages. 
In table 4.3 mean increases in plasma calcium con-
centration (from pre-infusion control values) with stand-
ard deviations measured in 14 experimental subjects 
(Nordin & Fraser 1954) are compared with the CAMET2 values. 
Table 4.3 Calcium Infusion Test : Plasma Calcium 
Time Changes in Plasma Calcium (m. moles/litre) 
(hours) 
Nordin & Fraser (1954) CAMET2 
4 0. 80 ± 0.14 0. 89 
8 0.55 ± 0.06 0.52 
12 0. 35 
24 0.25 ± 0.15 0.08 
Apart from the higher experimental value at 24 hours 
(which may have been due to the dietary intake) the 
simulated increments in plasma calcium are within one 
standard deviation of the experimental means. The 
SIMULATION 1 CALCIUM INFUSION I 
Source Program : 72150 No. : 72162-2 
A simulated infusion (R. f) of 15mg of calcium per 
kilogram body weight over 4 J.n hours from t = 0 was carried 
out· to test model predictions against the results of the 
clinical test. The associatedperturbation of hormonal 
concentrations are also demonstrated. 
References: Nordin & Fraser (1954), Nordin & Smith (1965) 
Arnaud et al. (1971} 
.Simulated Time: 1 day 
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Model Inputs: Calcium Infusion* 
(m.moles/kg/day) 
Time 
(days) 
2.25 
0.00 
Results: [A] Parameters during simulation 
cl Rurin cc 
(m.moles/li tre) (m.molesjkg/day} (ng/ml} 
2.50 
3.39*** 
2.58 
0.0827 
0.569*** 
0.105 
0.10 
0.20 
0.11 
[B] Accumulated Totals (m.moles/kg) 
sacc 
0.60 
0.01 
0.48 
s . 
ur1.n 
o.o 
0.16 7 
0.0 
0.1675** 
1.00 
0.0609 0.130 0.102 0.0024 0.376 0.269 1.00 
* Rinf equals 2. 25 m.moles/kg/day from t = 0 until 
t = 0.167 days when it is set automatically to zero. 
** Since CAMET2 only saves values for plotting and printing at 
discrete intervals the values saved at the time closest to 
t = 0.167 are given. 
*** Maximum value. 
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increased CT concentration (figure 4.4) is in line with 
that recorded experimentally after a calcium infusion 
of the same magnitude (Tashjian et al. 1970). Yet, given 
that the simulated rise in plasma calcium was similar 
to that found by Tashjian, this was to be expected since 
the CT secretion parameters are partly derived from 
Tashjian's report (section 4.2). Ca+cium infusions in 
the cow (Potts et al. 1968a) and in man (Arnaud et al. 
1971) have resulted in PTH response curves approximating 
that plotted in figure 4.4. However in the cow the decay 
in PTH concentration is faster than predicted by the 
model - Arnaud's results for man do not permit a close 
comparison owing to the insensitivity of his assay at 
low hormone concentrations. 
One measure of the sharply increased urinary 
excretion of cal~ium associated with the infusion (fig-
ure 4. 3) is the percentage of the infused dose excreted 
in any time interval (after correction for the basal 
level by subtracting. the urinary calcium collected over 
the same period of a control day). For the purposes of 
the model the •control day' is the fasting simulation 
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of Chapter 7 (Simulation 9). The values calculated in this 
way, including the six consecutive 4 hour intervals 
following the commencement of the infusion, are given 
together with the experimental data from 21 normal sub-
jects (Nordin & Fraser 1956) in table 4.4. 
Table 4.4 Calcium Inf'Usion Test Urinary Calcium 
Collection 
Period* 
{hours) 
Urinary Calcium Excretion (% of infused dose) 
0-4 
s-a 
9-12 
l3-16 
17-20 
21-24 
0-12 
0-24 
Nordin & Fraser (1956)** 
15 
17 
10 
5 
4 
41 ± 7 
* calcium infusion over 0 - 4 hours. 
CAMET2 
10.4 
18~9 
12.3 
6.5 
4.0 
2.9 
41.6 
55.0 
** first 5 values taken from graphed results to the nearest 
whole number; no statistical information supplied. 
As a final check on the simulated results the calcium 
retention - calculated by the method of Nordin & Smith (1965) 
which takes into account the rise in plasma calcium and the 
urinary excretion over the four hour infusion period - was 
53%. Bhanqarkar & Nordin {1962) reported a range of 44-66% 
with a mean of 53.3% in 19 normal subjects. 
Hence, with perhaps the exception of the urinary ex-
cretion of calcium in the first 4 hours (table 4.4), the 
model and the biological results agree well in all r~spects. 
The lower initial urinary calcium could be the result of 
many factors (including a faster than predicted suppression 
of PTH secretion) • 
The most significant physiological control in hyper-
calcaemia not taken into account is the action of CT in 
depressing bone resorption (section 3.6). However the form 
of the equations controlling calcium deposition and removal 
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from the bone (equations 2.45 to 2.49) allow for changes 
in these rates that are respectively directly proportional 
and inversely proportional to the calcium concentration. 
Since both the plasma calcium and urinary calcium per-
turbations were successfully simulated it appears that these 
equations mimic to a sufficient extent the events at the 
bone with respect to the transfer of calcium. A net uptake 
of 0.028 m.moles/kg by the bone was predicted by the model 
over the 24 hour simulation. Certainly it seems unlikely 
that CT could have a drastically greater inhibitory effect 
than this figure indicates (such as a complete blockage of 
calcium resorption for any length of time) without becoming 
evident in the experimental results. In view of the small 
net skeletal uptake the use of the term • skeletal -retention 1 
as a synonym for 'calcium retention• (Finlay et al. 1956, 
Nordin & Smith 1965) in the calcium retention test described 
earlier is misleading as it implies a much larger uptake 
by the skeleton than must actually occur in only 4 hours. 
The distribution of calcium to the soft tissues is probably 
. greater than allowed for in the calculation of the calcium 
retention. 
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Of some interest is the shoulder in the curve describing 
the simulated renal calcium excretion at t = 8 hours (figure 
4.3). This is caused by the reintroduction of PTH into 
the simulated system as the plasma calcium falls below 
3.0 m.moles/litre; more experimental values than presently 
available would be required to con rm the presence of such 
a response in vivo. 
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The results of this simulation support the widely 
accepted finding that greatly increased urinary calcium 
excretion is the princ~pal response to hypercalcaemia 
stress (McCance & Widdowson 1939, Baylor et al. 1950). 
Over the simulated day the renal loss of calcium was 
0.27 m.molesjkg, the faecal loss was two orders of 
magnitude lower at 0.24 x lo-2 m.moles/kg and dermal 
losses were 0.044 m.moles/kg. Clearly intestinal 
excretion under fasting conditions, even allowing for 
model approximations, is i~significant compared with the 
totai excretion by all other routes. 
Since the function of CT appears to be confined to 
damping hypercalcaemia stress it seemed pertinent to 
repeat the calcium infusion test of Simulation 1, but 
without CT (Simulation 2). This is readily achieved 
mathematically by sett~ng the quantity of CT (M0 ) and 
its rate of secretion (Rsc) to zero. For the purposes 
of comparison the computed plasma calcium concentrations 
and the urinary excretion rates from Simulations 1 and 2 
are plotted together in figures 4.6 and 4.7. 
The main features to be observed are: 
(A] A small divergence in the plasma calcium values 
- reaching a maximum of 0.06 m.moles/litre at 9 hours and 
slowly declining thereafter to 0.04 m.moles/litre at 
the end of the simulated day. 
[B] A more striking difference in the rate of urinary 
calcium excretion which disappears after 9 hours at which 
point in time the total simulated renal calcium excretion 
was 0.155 m.molesjkg in Simulation 1 and 0.135 m.moles/ 
kg in Simulation 2. 
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SIMULATION 2 CALCIUM INFUSION II 
Source Program 72150 No : 72162,...3 
The calcium infusion of Simulation 1 was repeated but with 
the quantity of CT and its secretion rate set equal to zero 1 
thereby altering the simulated renal excretion of calcium. The 
results of the two simulations are compared with each other and 
with clinical trials in hypothyroid patients. 
References: Ibbertson et al. (1967} 1 O'Brien & Mcintosh (1967) 
Simulated Time: 1 day 
Parameter Changes: 
Model Inputs: 
A23 set to 0.0* 
Me set to 0.0 
Calcium Infusion 
(m.moles/kg/day) 
2.25 
o.oo 
Results: [A] Parameters during Simulation 
Cl Rurin Cc 
(m.moles/litre) (m.moles/kg/day) (ng/mZ) 
2.50 
3.41** 
2.62 
0. 0 75 7 
0.472** 
0.105 
0.0 
o.o 
0.0 
(B] Accumulated Totals (m.moles/kg) 
0.0785 
s 
ace 
0.131 0.100 0.0025 0.376 
0.60 
0.01 
0.44 
s . 
urJ.n 
0.251 
Time 
(days) 
0.0 
0.167 
o.o 
0 .16 75 
1.00 
1.00 
* Setting A23 to zero has the effect of making the secretion 
rate of CT (R6 c) equal to zero (equation 2.40). 
** Maximum value. 
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Similar in vivo experiments have been performed 
with normal and hypothyro~d patients (Ibbertson et al. 
1967, O'Briep & Mcintosh 1967, Pharmakiotis et al. 1971). 
A feature common to the results of both Ibbertson et al. 
(1967) and o•Brien & Mcintosh (1967) was the rapid diverg-
ence within a few hours o! the plasma calcium levels 
between the hypothyroid and the control. groups. Subsequently 
the rate of decrease in plasma calcium was similar in the 
two groups. In the case of Ibbertson et al. (1967) whose 
experimental procedure (a calcium infusion of 12 mg per 
~ilogram body weight over three hours) most closely 
approaches the CAMET2 simulations a maximum difference in 
the calcaemia of 0.23 m.moles/litre was recorded between 
6 and 7 hours decreasing to 0.15 m.moles/litre at the end 
of 24 hours. After the first 5 hours this difference 
was significant at the 0.05 level or better. 
The reason for the divergence of the simulated calcium 
levels (figure 4.6) is the higher renal excretion of calcium 
in Simulation 1 which includes an effect of CT on the kidney. 
The sudden convergence of the plotted urinary calcium 
curves in figure 4.7 is caused by the reintroduction of 
PTH into the simulated system as the plasma calcium drops 
below 3.0 m.moles/litre (figure 4.4). 
Whereas the pattern of events with respect to the 
serum calcium concentrations observed in the CAMET2 simul-
ations bears a resemblance to the experimental situation 
the magnitude of the effects observed in nature is much 
. greater than the computed quantity. However, since the 
CAMET2 parameters for CT were fixed upon, a report on 
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the renal effects of a CT infusion at an almost 
physiological rate has been found (Ardaillou et al. 1969). 
The results of this experiment indicate that the effects 
of CT on the kidney reabsorption of calcium may be under-
estimated in the model by a factor of 2 or 3. If such 
an effect were confirmed Ibbertson's experiment could be 
simulated with the same qualitative aspects relating to 
the serum calcium levels already discussed but with 
better quantitative agreement. 
The question of whether CT action on the kidney or CT 
action on the bone is of prime importance in the reaction to 
hypercalcaemic stress is of some interest. Present day 
estimates of the normal bone resorption rate are less 
than 10 m.moles of calcium per day (section 6.2). In view 
of this it seems impossible to explain the aifference 
in the serum calcium level between hypothyroid and normal 
subjects, that occurs in the first few hours of a calcium 
infusion, solely on the basis of a CT mediated reduction 
in bone resorption. Even in the improbable eventuality 
of a complete suppression of bone resorption during this 
time it is necessary to examine alternative effects of 
CT in the control of hypercalcaemia. Cochran et al. 
(1970) were able to reduce the high plasma calcium levels 
of 4 hyperparathyroid patients to the normal range by 
the slow administration of pharmacological doses of CT 
(4 MRC units per kilogram body weight). Significantly, 
the reduced plasma calcium concentration was substantially 
accounted for by the increased renal excretion in all 
4 patients. 
(A] 
(B] 
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Taking the simulated results as a whole together 
with the experimental data two conclusions are tentatively 
drawn: 
CT action on the kidney may be more important than 
is currently recognized in·meeting hypercalcaemic 
challenges, except (as suggested by Cochran et al. 1970) 
where bone turnover is elevated. Depressed bone re-
sorption probably plays a subsidiary role in subjects 
free from bone disorders. 
The action of CT on the kidney is only fully expressed 
in the absenae of PTH. -This view is consistent with 
the well known impotence of endogenous CT to control the 
development of hypercalcaemia in hyperparathyroidism. 
Considering the direct qnatagonism of CT and PTH on cal-
cium tubular resorption {Chapter 3), this is not an un-
xeasonable suggestion. It also follows that experiments 
involving the administration of CT to subjects with normal 
levels of blood calcium {and by implication normal levels 
of PTH) might not fully demonstrate the renal effects of 
a hormone whose physiological function is to control 
hypercalcaemia. Some caution must be exercised however 
when considering species other than man. There are good 
. grounds for believing that in a variety of animals 
bone resorption may be a rather more important aspect of 
the homeostatic control of calcium metabolism than it 
is in man. 
If in fact these suggestions have any physiological 
significance they could pe readily checked out. For 
example similar experimep.ts to those of Ibbertson et al. 
(1967}, but with the addition of frequent collections and 
measurements of urinary calcium over the experimental 
period should show significant differences between hypo-
thyroids and normal subjects. 
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In passing it is evident that Simulation 2, as far 
as it goes, meets one important physiological criterion . 
of hypothyroidism - a lack of noticeable effect on the 
blood calcium due to CT deficiency. The 8% drop in renal 
calcium excretion at t = 0 in Simulation 2 compared with 
Simulation 1 would normally cause a negligible shift in 
the calcium concentration of the plasma. 
4.5 The Effect of the Removal of the Parathyroid Glands 
Historically the discovery of the PTH glands was 
preceded by the observation that the remo·.ral of the 
thyroid was often accompanied by the onset of tetany 
(in severe cases characterized by physical convoltions). 
Later it was found that the removal of the parathyroid 
. glands alone could produce this effect but it was not until 
early in this century that the link between tetany and 
subnormal serum calcium concentration was discovered 
(Fourman & Royer 1968). Since then the experiment has 
been carried out many times, invariably resulting in the 
development of hypocalcaemia and a drastically reduced 
renal phosphate excretion. In 414 determinations of 
the plasma calcium in 96 normal fasted dogs Copp (1960) 
found that the average serum calcium concentration was 
2.47 ± 0.14 m.moles/litre (9.89 ± 0.54/100 ml) while the 
corresponding value from 196 determinations in 27 
parathyroidectomized dogs was 1.46 ± 0.29 m.moles/litre 
(5.84 ± 1.15 mg/100 ml). In man a drop in the level 
of calcium to between 1.5 and 2.0 m.moles/litre is 
usual (Lamberg et al. 1960, Danowski· 1962). 
The effect of the operation on renal 
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excretion of calcium in the rat was first demonstrated 
by Talmage and his colleagues (Talmage & Kraintz 1954, 
Talmage et al. 1955) and in the mouse by Buchanan e·t al. 
(1959). In all cases it was found that urinary calcium 
excretion rose sharply at first, simultaneously with 
declining plasma calcium levels, only falling later as 
the calcium concentration became progressively lower. 
In other animals including the dog (Kleeman et al. 1961) 
and the hamster (Biddulph et al. 1970) the same phenomenon 
has been observed. The calciuria following parathyroidect-
omy in the hamster is particularly acute. Ten times the 
quantity of calcium was excreted in the 7 hours following 
parathyroidectomy compared with controls. The fall in 
extracellular calcium was more than accounted for by this 
loss (Biddulph et al. 1970, Biddulph 1972). 
Obviously experimental data for man immediately 
following total parathyroidectomy is rare although some 
exists for hyperparathyroid patients after the removal 
of parathyroid tumours (Canary et al. 1962). The high 
concentration of peripheral PTH drops rapidly after the 
operation (Buckle 1969) and Canary et al. (1962) measured 
a fall in plasma calcium from high to normal levels in 
about a day. This was accompanied by sharply reduced 
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renal phosphate excretion and a rising level of extra-
cellular phosphate. One patient who was accidently totally . 
parathyroidectomized suffered a fall in the calcium con-
centration from 3.0 m.moles/litre to 1.8 m.moles/litre 
over the 48 hours following the operation. Unfortunately 
as the renal handling of calcium was not considered as a 
contributory factor either to the original high calcium 
levels or in the events subsequent to the operation the 
urinary calcium was not measured. 
Parathyroidectomy can be simulated with CAMET2 by 
setting the rate of secretion of PTH to zero (Simulation 3). 
The consequences are seen in figure 4.8 and 4.9. In less 
than 4 hours the PTH concentration declines to a negligible 
value. This is associated with a threefolu rise in the 
rate of urinary calcium excretion which thereafter fall~ 
with the calcium concentration. However even at 48 hours 
the rate of excretion ro.077 m.moles/kg/day) is only 
slightly lower than at t = 0 (0.083 m.moles/kg/day). 
Normally a similar drop in calcium concentration for any 
other reason causes a very sharp reduction in urinary 
calcium excretion (Simulation 4) • 
Naturally the model simulation is a simplification 
of the complex physiological changes that must occur with 
the loss of the parathyroid glands. The changes in bone 
and intestinal metabolism are not considered; neither are 
the direct effects of the hypocalcaemia (including the 
renal excretion of other electrolytes and the glomerular 
filtration rate (Kaufman & DiScala 1971)). In 
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SIMULATION 3 PARATHYROIDECTOMY 
Source Program : 72150 No : 72162-4 
The physiological consequences of the removal of the 
parathyroid glands were simulated by CAMET2. The rate of 
secretion o£ PTH was set equal to zero with considerable 
impact on both simulated renal calcium excretion and the 
serum calcium level. 
References: Canary et al. (1962}, Biddulph et al. {1970) 
Simulated Time : 2 days 
Parameter Changes : A25 set to 0.0* 
Results : [A] Parameters during Simulation 
cl R . ur~n cP 
{m.moles/li tre} (m.moles/kg/day} (ng/mZ) 
2.50 0. 082 7 0.60 
2.42 0.243** 0.01 
2.02 0.127 o .. o 
1.90 0 .. 0958 0.0 
1.84 0. 0770 0.0 
[B] Accumulated Totals (m.moles/kg} 
~al 
-0.344 0.198 
8de+m 
0.283 0.0633 
s . 
ur~n 
0.0033 0.278 
Time 
(days} 
o.o 
0.126 
1.00 
1.50 
2.00 
2.00 
* Setting A25 to zero has the effect of suppressing PTH 
secretion (Rsp) (equation 2. 42). 
** Maximum value 
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hypoparathyroids bope remodelling is depressed as 
assessed by microradiography, tetracycline labelling and 
other direct methods of estimating bone turnover rate 
(Jowsey 1968, Frost 1969, Nguyen & Jowsey 1970b). While 
the immediate consequence of the withdrawal of PTH is 
to depress bone resorption, in the long term the rate of 
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bone formation also appears to fall and the skeleton is 
restored to an approximate balance (Fourman & Royer 1968). 
The present model bone equations do not satisfy these 
observations. Since collagen resorption is inversely pro-
portional to the calcium concentration (equation 2.46) rather 
then linked to the PTH status the rate of resorption in 
Simulation 3 rises rather than falls. However the amount of 
unmineralized. collagen does increase in accordance with 
observation, qualitatively at least (Jowsey 1968). 
If stable levels of plasma calcium are maintained and 
if dermal losses of calcium are ignored, then a useful 
generalization to bear in mind is that renal . calcium ex-
cretion represents net bone resorption plus net intestinal 
absorption. This being so the intestinal absorption is low 
in the absence of PTH considering that the urinary excretion 
of calcium is generally below 2 m.moles/day in untreated 
hypoparathyroids (if the skeleton is in calcium balance). 
This is in accord with direct physiological evidence (section 
3. 7). On a simulated diet CAMET2 would fail to exhibit 
the low urinary calcium excretion characteristic of this 
complaint because the inflows into the plasma compartment 
would not be reduced as they are in nature. 
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Notwithstanding the simplified nature of this 
simulation, the reproduction of the major events with respect 
to calcium is evidence that PTH involvement in the tubular 
reabsorption of calcium is of primary importance in the main-
tenance of high blood calcium levels. Of the simulated net 
negative calcium balance (-0.34 m.moles/kg) over 80% was 
accounted for by the simulated urinary calcium (0.28 m.moles/ 
kg). The restoration of plasma calcium levels to normal 
is difficult for two reasons, firstly because of the relative-
ly large inflow of calcium required and secondly, of more 
importance, is the prompt excretion of calcium by the kidney 
that occurs in the absence of PTH. Only by large continuous 
infusions of calcium (up to 37.5 m.moles over 12 hours) was 
Eisenberg (1965) able to achieve and maintain a normal 
calcium concentration in hypoparathyroids in the face of 
greatly increased renal calcium excretion. In reality the 
fall of plasma calcium is further compounded by a lowered 
gut absorption but this is an effect subsidiary to the loss 
of calcium in the urine. 
4.6 EDTA Infusions 
The two simulations discussed in this section, both 
involving the simulated infusion of ethylenediamine -
tetraacetic acid (EDTA) , illustrate the strengths and 
weaknesses of the present model. 
The infusion of EDTA which complexes calcium and renders 
it physiolo~ically inactive is used to diagnose parathyroid 
insufficiency (Fourman & Royer 196 8) • Rapid excretion 
of the EDTA-calcium complex by the kidney follows (Levitt 
et al. 1958). Normally, in humans with intact parathyroids 
the fall in the concentration of ionized plasma calcium 
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resulting from an EDTA infusion is recovered within 12 
hours (Jones & Fourman 1963). In the presence of para-
thyroid insufficiency the ability to restore plasma cal-
cium is impaired: compared with controls the concentration 
of non-complexed calcium is still decidedly low even at 
24 hours (Jones & Fourman 1963). The simulated 2 hour 
decline in the calcium level (figure 4.10} was 0.61 m.moles/ 
litre - a ·value identical to the mean found by Jones & 
Fourman in 12 subjects with neither thyroid nor para-
thyroid disease. An experimental range of 0.48 to 0.75 
m.moles/litre was reported. However 4 hours from the 
beginning of the EDTA infusion the simulated and the 
experimental values begin to diverge. In the clinical 
trials serum calcium returned to the normal range (even 
slightly overshooting the preinfusion value) after 12 
hours. By com~arison the model results are quite different. 
Although a small rebound in the plasma calcium occurred 
(essentially completed in the hour after the infusion 
was stopped) a steady state value of 2.0 m.moles/litre 
was reached and maintained for the remainder of the 
simulation (figure 4.10). In fact this value represents 
the natural equilibrium calcium concentration of CAMET2 
(with no oral or intravenous calcium inputs) where the 
outflow of calcium (in the simulated renal, intestinal 
and dermal losses) equals the inflow from the bone: it 
has however no physiological significance. 
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SIMULATION 4 EDTA INFUSION 
source Program : 72150 No : 72162-1 
The infusion of ethylenediamine tetraacetic acid 
(EDTA) was simulated by a negative calcium infusion of the 
same magnitude but opposite sign to the rate at which cal-
cium is chelated by an EDTA infusion of 70 mg/kg over 2 hours. 
References : Copp (1960), Jones & Fourman (1963) 
Simulated Time 
Model Inputs 
Results [A] 
1 day 
Calcium Infusion 
(m.moles/kg/day) 
-2.27 
0.0 
Parameters during Simulatio~ 
Cl Rurin Cc Cp 
(m.moles/litre) (m.moles/kg/day) (ng/mZ} (ng/mZ) 
2.50 
1. 89* 
2.00 
0.0827 
0.0173 
0. 0217 
0.10 
0.042 
0.037 
0.60 
1.13 
1.20 
( B] Accumulated Totals (m.molesjkg) 
sderm 
-0.250 0 .. 0960 0.145 0. 030'9 
* minimum value 
s . 
ur1n 
0.0238 
Time 
(days) 
0.0 
0.0833 
0.0 
0.0842 
1. 00 
1.00 
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While the result in clearly abnormal by the criteria 
of Jones & Fourman (1963) it is strikingly reminiscent of 
the observations of Copp (1960) in a parathyroidectomized 
dog infused with EDTA. The small increase in non-complexed 
plasma calcium at the end of the infusion followed by a 
persistent plateau was also evident in Copp's experiment 
and similar results in the parathyroidectomized dog (Alex-
ander 1965) and the cow (Ramberg et al. 1967) have been 
noted. Of particular interest.was the demonstration by 
Alexander {1965) of the ability to reduce plasma calcium 
in the dog to progressively lower but stabie plateau values 
by sequential infusions of EDTA. 
To ensure that the lack of action of PTT! on the kidney, 
as in parathyroidectomized animals, does not materially 
alter the simulated EDTA-induced changes in plasma calcium 
concentration, Simulation 4 was repeated but with the addition 
of a simulated parathyroidectomy (as in the experiment of 
Copp 1960) immediately prior to the commencement of the 
EDTA infusion (Simulation 5). As can be seen from figure 4.11 
the changes in plasma calcium are similar to those in 
Simulation 4, but as the calcium level at the end of the 
EDTA infusion is now above the equilibrium point for 
hypoparathyroidism a slow decline in the calcium concentration 
occurs. As in the simulated parathyroidectomy (Simulation 3) 
this is the result of greatly enhanced renal excretion of 
calcium. In this connection it is noted that in the animal 
experiments that have been mentioned the plasma calcium was 
reduced very much more severely, to below the normal 
hypoparathyroid range, and in several cases a slow but steady 
rise was evident in the plateau concentration. 
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SIMULATION 5 EDTA INFUSION WITH PARATHYROIDECTOMY 
Source Program : . 72150 No : 72162-5 
To check that the simulated total removal of the para-
thyroids, as carried out by Copp (1960) prior to EDTA infusion, 
had no major effect on the results of Simulation 4 the rate 
of PTH secretion was set equal to zero and the simulated EDTA 
infusion commenced at 0.01 days. 
References: Copp (1960) 
Simulated Time: 1 day 
Parameter Changes: A25 set to 0.0 
Model Inputs: Calcium Infusion 
(m.molesjkg/day}. 
0.0 
-2.27 
o.o 
Results: [A] Parameters During Simulation 
Cl Rurin Cc Cp 
(m.moles/li tre) (m.moles/kg/day) (ng/mZ) (ng/ml) 
2.50 
2.50 
1.88 
1.84 
0. 0 82 7 
0.105 
0.0841 
0.0784 
0.10 
0.10 
0.04 
0.02 
0.60 
0.42 
0.02 
o.o 
[B] Accumulated Totals (m.moles/kg) 
sdec sderm s . ur~n 
-0.317 0.0921 0.151 0.0295 0.0969 
Time 
(days) 
0.0 
0.01 
0. 09 33 
0.0 
0~01 
0.0947 
1. 00 
1.00 
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Consideri~g that the subjects of Jones & Fourman 
(1963) were on a low calcium diet (4 m.moles/day) , 
intestinal absorption cannot account for the recovery in 
plasma calcium after EDTA infusion. Further to this, CT 
secretion is suppressed under conditions of hypocalcaemia and 
in animals the rise in serum calcium is abolished by previous 
parathyroidectomy. Hence the increase in serum calcium must 
come from greatly increased bone resorption. As approximately 
3 hours elapse before the effects of PTH on the bone are 
detectable in the blood (section 3.7) the good initial 
quantitative agreement between experiment and model prediction 
is not surprising. However the non-inclusion of the action of 
PTH on the bone is evidently a serious drawback to the present 
model. 
Finally, it is concluded on the basis o": all the simulat-
ions so far discussed that the idea of buffering of plasma 
calcium either by labile bone calcium reserves (McLean 1957, 
Ortner & von Endt 1971) or by a physiochemical equilibrium 
between bone crystal and serum calcium (Neuman & Neuman 1958, 
Nordin et al. 1965) need not be invoked to explain homeostatic 
control of calcium metabolism. The buffering that does occur 
would appear to be principally that of PTH mediated cellular 
resorption where both bone matrix and crystal are removed -
but only after a considerable delay following the initial 
stimulus. on the other hand there is some evidence to suggest 
the existence of a quantity of unmineralized calcium able to 
cushion, to a limited extent, perturbations in the calcium of the 
extracellular fluids. Since this question is of 
considerable importance to the modelling of calcium 
metabolism lt is further pursued in Chapter 6. 
4.7 The Place of the Kidn~y in Calcium Homeostasis 
As a further check on the validity of the model 
parameters and equations controlling renal calcium ex-
cretion, CAMET2 predictions are compared with the data of 
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Peacock et al. (1969) who investigated the urinary calcium 
excretion over a range of blood calcium concentrations 
(by the administration of either oral or intravenous cal-
cium loads). Each point on the CAMET2 theoretical curve 
(figure 4.12) represents the steady state rate of urinary 
I 
calcium excretion at the particular calcium concentration 
and the corresponding predicted hormone concentrations. In 
addition the renal calcium excretion was calculated and 
plotted over the range of calcium concentrations, first 
assuming that no PTH was present (Cp = 0.0) as in hypo-
parathyroidism, and secondly for a constant PTH concentrat-
ion of 1.2 ng/ml (continuous autonomous secretion). Super-
imposed on the graph are the experimental values of Peacock 
et al. (1969) for normals (with means and standard 
deviations indicated) together with some representative 
points from both hypo- and hyperparathyroid patients. 
However since the experimental values were originally 
expressed as mg of calcium per 100 rob of glomerular fil-
trate (thereby partially correcting for extraneous influences) 
a direct comparison with the model results is not possible. 
To meet this situation, the experimental value for urinary 
calcium excretion at 2.55 m.moles/litre plasma calcium 
was set equal to' the value predicted by CAMET2 and the 
remaining experimental points scaled accordingly. 
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The discrepancy arising between the experimental mean 
and the CAMET2 value at the calcium concentration of 
3.1 m.moles/litre is attributable to several causes, 
apart from possible inaccuracies in the model. Each 
experimental value of Peacock et al. (1969} represents 
the urinary calcium determined in a number of subjects 
whose blood calcium concentration extended over a small 
range about the mean plotted value. Hence while the 
CAMET2 equations predict a zero concentration of PTH 
at and above 3.0 m.moles/litre, PTH was probably 
present in at least some of the clinical subjects in 
the experimental sample - especially if measurements 
were made while the calcium concentration was increasing. 
It is noteworthy that the standard deviations around 
this range of plasma calcium concentration are especially 
large. 
It may be seen from the diagram that a steep rise 
in urinary calcium excretion occurs with even a modest. 
elevation in plasma calcium above 2.5 m.moles/litre -
as was demonstrated in the calcium infusion of 
Simulation 1 (figure 4.3). Below 3.0 m.moles/litre 
the rate of urinary calcium excretion in hypoparathyroids 
(where no PTH is present) is considerably greater than 
in normal subjects with the same calcium concentration. 
The dramatically increased rate of urinary excretion 
of calcium in the simulated parathyroidectomy (Simulat-
ion 3) represents the transition between the normal and 
the hypoparathyroid curves at a plasma calcium concentrat-
ion of 2.5 m.moles/litre. 
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A recommended treatment for hypoparathyroidism 
is the daily administration of large doses of vitamin D, 
often in combination with a high dietary intake of 
calcium (Fourman & Royer 1968). Usually this treatment 
is effective in partially restoring the calcium concentrat-
ion in blood, but only at the expense of much higher 
than normal urinary excretion. Whether or not a small 
vitamin D - mediated increase in the resorption efficiency 
of the renal tubules contributes to the rise in calcium 
levels is a debatable point. While it is no longer 
believed as was once thought (Litvak et al. 1958, 
Gordan et al. 1962) that pharmacological doses increase 
the renal excretion of calcium there is very little 
experimental data on which to base any a~sessment. The 
experiment of Bernstein et al. (1963) is often cited as 
evidence against such an effect but only three persons 
were involved in the experiment, one of whom showed some 
evidence of a lowered calcium loss in the urine as a 
result of vitamin D treatment. In another limited study 
Gran (196Ga) showed a much reduced calcium excretion in 
hypoparathyroid rachitic dogs once vitamin D was administ-
ered, and interestingly the calcium binding protein 
(section 3.8} has appeared in the kidney of rachitic 
chicks following the commencement of a vitamin D supple-
mented diet (Taylor & Wasserman 1967). Should it turn 
out that vitamin D and its metabolites have no €£feet, 
direct or indirect, on the tubular resorption of calcium 
and the present concept of renal responsibility for the 
low calcium level in hypoparathyroids is correct then 
vitamin D therapy in this disorder represents little 
more than treatment of the symptoms. 
The importance of the kidney control of calcium 
excretion is again evident in hyperparathyroidism. A 
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high level of endogenous PTH increases the efficiency of 
tubular reabsorption of calcium (figure 4.12) resulting in 
the development of a high calcium concentration in the blood 
and a rise in the renal calcium load until the point is 
reached where the calcium flow into the blood from the 
intestine and the bone again equals the outflow in the urine" 
The condition is aggravated by increased bone resorbtion 
and intestinal absorption of calcium (section 3.7) which 
is reflected in the higher urinary calcium excretion 
commonly observed in hyperparathyroidism (Sutton & Watson 
1969). While the well known increase in bone resorption 
associated with this disorder is a real e~fect it now 
appears that bone formation is also increased, although 
not to the same extent (Jowsey 1968, Frost 1969, Merz 
et al. 1971). This is in accordance with the observation 
that demineralization of bone in long-standing hyper-
parathyroidism is unusual (Gudmundsson & Woodhouse 1971). 
Overall then it appears that the widespread emphasis 
in the literature on bone, particularly PTH controlled 
bone resorption, as the most important factor in the control 
of calcium homeostasis and central to the development 
of hypoparathyroidism and hyperparathyroidism, is misplaced. 
B.E.C. Nordin and his colleagues have arrived, by experiment, 
at conclusions similar to those expressed above (Peacock 
et al. 1969 1 Cochran et al. 1970). Their conclusions are 
strongly supported by the present work. 
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To sumrnarize,the main conclusions of this chapter 
are: 
[A] The kidney represents the major organ in calcium 
[2] 
homeostasis and because of its ability to react quickly 
to changing conditions and to excrete large quantities 
of calcium (in relation to the flows from the bone and 
the intestine) is the major arbiter in determining 
the calcium concentration of the blood. So long as the 
calcium concentration is stable this represent$an 
equilibrium point at which the inflow equals the outflow. 
The PTH induced increase in the tubular resorption 
of calcium is essential to the maintenance of the plasma 
calcium concentration at around 2.5 m.moles/litre. The 
drop in the calcium level after parathyroid gland removal 
is largely attributable to the removal of this constraint 
on the renal excretion of calcium. 
[C.] The idea is advanced that CT action on the kidney 
may be important in the reaction to hypercalcaemic stress 
and that its action on the bone is of lesser importance 
in the presence of normal skeletal metabolism. 
[D.] While the modelling of bone by CAMET2 is only at a 
preliminary stage it would appear that bone plays a small 
role in controlling perturbations in calcium concentration. 
Yet whereas the kidney reacts quickly in excreting excess 
calcium or conserving existing calcium it cannot, by 
itself, restore a subnormal blood calcium level to the 
normal range. In this eventuality the action of PTH on the 
bone is essential to make up any deficiency in diet or 
absorption. 
Intestinal and Dermal Calcium Secretion 
5.1 Only two significant transfers of calcium 
around the body remained unaccounted for by CAMET: 
the calcium in the secretions that are emptied into 
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the alimentary canal in response to a meal and the cal-
cium in the sweat. In this chapter the literature on 
these flows is reviewed and new equations and parameters 
are introduced to account for them. The evidence for 
and against a relationship between the calcium concen-
tration in gut secretions and that in the blood is 
examined in section 5.5 and the model will be shown 
to predict (in accord with some physiological evidence) 
that a far larger proportion of the calcium secreted 
in response to a meal containing calcium appears in 
the faeces as 'endogenous faecal calcium' than of that 
secreted at other times. 
5.2 Dermal Excretion of Calcium 
Calcium is lost from the body in three ways; from 
the gut as endogenous faecal calcium, from the kidney, 
and through the skin. For persons in temperate climates 
the latter route is usually the least important, but 
is not negligible. Indeed, during heavy physical work 
or in extreme climatic conditions it may well be greater 
than the combined loss by other routes. Under such 
conditions estimates of over 1 litre per hour water 
loss in man (Lee 1964) and an instantaneous rate of 
calcium loss of up to 50 m.molesjday (Consolazio et al. 
1962) have been made. 
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The loss of water, with its dissolved electrolytes, 
occurs through the sweat glands as an active secretory 
process concerned with body temperature regulation. But 
apart from this a further loss occurs directly through 
the skin (insensible perspiration). From considerations 
of water balance alone, under temperate conditions and in 
the absence of visible sweating, the total dermal loss of 
water is approximately 1 litre per day - most of which is 
,_, "' believed to be insensible perspiration (Hernandez-Peon 
1960). Schwartz et al. (1964) estimated that the volume 
of sensible sweat in a controlled hospital environment, 
with minimal physical activity, as not greater than 300 
ml/day. The total water loss is considerably greater in 
tropical climates, reaching a range of 2.5 - 3.8 litres/ 
day in one study (Khogali et al. 1970). 
Reliable measurements of the total daily excretion 
of calcium through the skin are not yet available. Research 
I 
is hampered in that sweat production is unevenly distributed 
over the body (Weiner 1945) and that the concentration of 
calcium in sweat also appears to vary from one position 
to another (Johnson et al. 1969). In addition interpretat-
ion of the published experimental results is made more 
difficult by the fact that most experiments are carried out 
under conditions designed to.stimulate sweat production, 
but which are not typical of the normal environment. 
It has however been established that the calcium concentrat-
ion in sweat is inversely related to the rate of sweating 
(Mitchell & Hamilton 1949, Johnson et al. 1969). The 
results of such experiments are tabulated below. 
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Table 5.1 Dermal Calcium Losses 
Reference 
Mitchell 
& Hamil-
ton (1949) 
Johnston 
et al. 
(1950) 
Sweat Ca Cone. 
(m.moles/li tre) 
1.8 
(1.5-2.1) 
0.7 
(0.6-0.8) 
(0.34-1.00) 
Robinson & (0.25-2.0) 
Robinson 
( 1954) 
Altman 
(1961) 
Harden 
(1964) 
Consolazio 
et al. 
(1966) 
(1.25-2.50) 
1. 25 
(0.1-3.6) 
0.7±0.1 
2.0±0.4 
0.65±0.15 
0. 89 
0.66 
0.69 
1.07 
0 .83±0 .08 
Rate of Total Daily 
Sweating Ca Loss 
Experimental 
Method and 
Conditions (m Z/hour) (m.moles) 
91 3.7 
(62-146) (1.8-5.8) 
769 12.1 
(655-897) (8.7-15.4) 
308 
69±13 
115±15 
83±16 
353 
402 
297 
168 
232 4.6±0.4 
10 determinations 
with 4 subjects 
exposed for 7.5 
hours at 29oc. 
Relative Humid-
ity 50-52%* **· 
As above but 
38°C, 68-69% 
relative 
humidity. 
4 subjects at 
0 
. 36 c. 
Collected 
references 
83 determinations 
210 determinations 
14 control sub-
jects***· 
11 thyrotoxicosis 
patients 
6 treated 
thyrotoxicosis 
patients 
12 normal 
subjects* ** 
3.5 hours at 
38.50C 
7 hours at 38.5oc 
12 hours at 38.5°C 
12 hours (sleeping) 
33.1°c 
mean of 12 hour 
periods 
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Table 5.1 De.rmal Calci.um Loss.es .. 
Reference Sweat Ca Cone. Rate of Total Daily Experimental 
(m.moles/litre) Sweating Ca Loss Method and 
(ml/hour) (m.moles) Conditions 
Isaksson 3.0(0.5-9.1) 13 subjects, 
et al. 21 determin-
(1967) ations**** 
3.4(0.5-9.1) data from 13 
of the above 
determinat-
ions that 
were most 
complete. 
Rasmussen 2.0-3.0 estimate 
(1968) 
Johnson 0.45 603 arm sweat 
et al. 0.35 800 collected (1969) under con-
0.28 979 ditions of 
increasingly 
high thermal 
stress* 
*total calcium collected and measured 
**sweating rate determined from loss of body weight 
***thermally stimulated sweat collected over two hours and 
calcium concentration determined directly 
****patients with varying disorders including two with 
osteoporosis and one with osteomalacia. Calcium in sweat 
determined indirectly from sweat calcium to potassium 
ratio and the total potassium dermal loss derived from 
balance studies. Comfortable hospital environment. 
Measurements of the normal total loss of calcium through 
the skin range from 0.3m.moles per day in the elderly living 
in an air-conditioned metabolic ward (Gitelman & Lutwak 1963) 
to 9.1 m.moles per day in a patient on vitamin D therapy and 
a high calcium intake (Isaksson et al. 1967). Overall however, 
the results reported by Isaksson indicate a mean daily loss 
of the order of 2.5 m.moles (100 mg). 
Little data is available on alterations in sweat 
calcium consequent on alterations in calcium metabolism. 
Harden (1964) found the total calcium excretion and the 
concentration in sweat to be significantly higher in 
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thyrotoxicosis patients than in either controls or treated 
patients (table 5.1). He su~gested that this might be 
due to a decreased resorption of calcium in the sweat 
tubules as a result of hypoparathyroidism or alternatively 
to the increased load of calcium as a result of the high 
ultrafiltrable calcium in the plasma. A significant linear 
correlation was demonstrated between the concentration 
of sweat calcium and the urinary calcium/creatinine ratio 
( p <0.02). In its ability to reabsorb minerals the sweat 
tubule is similar to the kidney nephron (Dobson 1969, 
Schultz 1969) and both are known to be subject to a wide 
variety of neural, endocrine and pharmacological agents. 
On the basis of this limited evidence the equation 
used to represent dermal calcium loss in CAMET2 is 
R = K C derm derm 1' 
where Rderm = 2.5 m.moles/day at c1 = 2.5 m.moles/litre. 
Given that the volume of fluid lost every day through 
the skin is of the order of 1 litre, then a loss of 
2.5 m.moles of calcium per day means that the calcium is 
present in a concentration of 2.5 m.moles/litre. This is 
somewhat higher than the concentrations recorded in table 
5.1, and is also at variance with the reported absence 
of calcium from insensible sweat (Mitchel & Hamilton 1949). 
At these comparatively low rates of secretion the concen-
tration of calcium in the sweat does not appear to be 
known. However it should be noted that a mean loss of 2.5 
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m.moles per day which is assumed in CAMET2 could well 
be an overestimation for humans in sedentary occupations. 
The mean quantity of calcium lost through the skin 
under normal circumstances is a question of some practical 
importance to calcium balance techniques where this loss 
is usually ignored. It deserves further investigation. 
5.3 Intestinal Secretion of Calcium 
Under the following headings the physiology of each 
major intestinal flow with respect to calcium is summarized. 
The corresponding numerical data is shown in table 5.2. 
Saliva 
The secretion of saliva is continuous in the waking 
state averaging 0.5 ml/minute, but it may reach a stimulated 
maximal value of 4.7 ml/minute (Altman 1961). Saliva is 
a mixture of secretions principally from three major 
gland pairs: the submaxillary, parotid and the sublingual 
. glands. The. concentration of calcium in saliva, as well 
as differing between animal species, differs with the 
gland type and the rate of secretion of saliva. 
There is general agreement among the authors referred 
to in table 5.2 that the concentration of calcium in 
saliva is close to 1.5 m.moles/litre under basal conditions 
(that is secretion in the absence of any known stimulus). 
A fall in the concentration occurs to about 1 m.mole /litre 
with increasing saliva production (Schneyer & Schneyer 
1967). However part of this observed decrease is due 
to the changing relative contributions of the various glands 
to the total flow. The increasing proportion of parotid 
saliva, of a relatively low calcium concentration, means 
that the relationship observed between the flow rate 
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and the observed concentration is not necessarily true 
of any one component flow. As with the sweat glands, 
increased secretion of saliva is associated with increased 
sodium and chloride concentrations and a relatively 
stable potassium concentration. 
Total human saliva production is estimated to be 
around 750 mt/day (Schneyer & Schneyer 1967) calculated 
assuming 8 hours sleeping at 0.05 rot/minute, 2.5 hours 
eating at 2 rot/minute and the remainder of the day at 
0.5 rot/minute. In ruminants the quantity of calcium 
associated with the salivary flow is considerable on 
account of the copious production of saliva in these 
animals - one estimate puts the daily volume of saliva 
produced in sheep at over 10 litres (Storry 1961). 
Gastric Juice 
The relationships between gastric juice electrolytes 
and their various cellular origins are matters of in-
tense investigation and controversy among physiologists. 
Like saliva, gastric juice is a composite fluid made up 
from numerous secretions from different cell types 
reacting in different ways to pharmacological and 
physical stimuli. It differs in that the different 
cells are interspersed - making it impossible to collect 
separate cellular secretions for analysis. An added 
difficulty in man, where the conventional animal tech-
niques are out of the question, is the problem of 
contamination of the gastric juice with saliva or 
duodenal contents. Apart from saliva, the collection 
of all alimentary canal secretions is complicated by 
possible contamination with other fluids, and is 
a major source of the wide ranges in calcium concentration 
exhibited in table 5.2. 
The total output of hydrochloric acid, potassium and 
calcium increase proportionally but differently (although 
the concentrations of calcium and sodium decrease rapidly) 
as the secretion rate rises (Long 1961, Moore & Makhlouf 
1968). It is thought, partly on the basis of the inverse 
correlation between calcium and hydrogen ion concentrations 
observed as the output of the acid secreting (pariental) 
cells increases, that calcium is predominantly secreted 
by non-pariental cells in the stomach (Hunt & Wan 1967). 
The total non-fasting gastric fluid production is 
considerable, reaching 3 litres per day (Malm 1958). Basal 
secretion is continuous but decreases at night and with 
age (Long 1961). The concentration of calcium is 
1.5 m.moles/litre decreasing to about 0.6 m.moles/litre 
at high rates of production (Moore & Makhlouf 1968). 
Bile 
Bile differs from other gut secretions in the remark-
ably high calcium concentrations that can occur - up to 
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32 m.moles/litre (Diamond 1967). This does not reflect a 
high concentration of calcium in the bile continuously 
secreted by the liver, but is due to the resorption of water 
that takes place in the gall bladder (Wheeler 1967). 
Apart from its digestive function bile is an important 
excretory route for many degradation products of metabolism 
- including vitamin D metabolites (Avioli et al. 1967). 
It is concentrated in the gall bladder and under the stimulus 
of food is expelled into the duodenum (Hallenbeck 1967). 
In this way the requirements of continuous excretion 
of waste products and the periodic nature of digestion 
are reconciled. 
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The gall bladder concentrates up to half of the 
hepatic bile produced daily to within 10 - 20% of its 
original volume (Diamond 1967). The total hepatic 
production of bile is 1500 (1000 - 2000) mls in a day 
(Doubilet & Fishman 1961): the concentration of calcium 
in it is about 1.5 m.moles/litre (Altman 1961, Briscoe 
& Ragan 1965) • 
Pancreatic Juice 
The human pancreas secretes into the duodenum 
considerable quantities of alkaline juice in response to 
meals through a common outlet with the bile duct. This 
flow may reach up to 4.7 ml/minute (Janowitz 1967). 
The predominant ion is bicarbonate whose concentration 
increases to about 100 m.moles/litre in stimulated flows 
(Hansky 1967). From a direct intubation study involving 
20 normal persons Hansky reported that the concentration 
of calcium in pancreatic juice, under basal conditions, 
was 0.75 ± OJ20 m.moles/litre and 0.58 ± 0.13 at high 
rates of secretion. 
In dogs the calcium content of pancreatic juice does 
not appear to be secreted in the fluid containing the 
bicarbonate (Janowitz 1967) so its relatively low con-
centration may be a dilution effect. A low concentration 
of calcium in the presence of a high concentration of 
bicarbonate lessens the risk of calcium precipitation, 
although in hyperparathyroidism with concomitant hyper-
calcaemia calcium deposition in the pancreatic duct 
is sometimes observed (Hansky 1967) • 
Small Intestinal Wall Secretion 
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Of all the. gut secretions, least quantitative 
information is available on the activity of the intestinal 
glands lining the wall of the small intestine. This is 
partly due to the difficulty of obtaining access without 
resort to surgery and partly due to the simultaneous 
local absorption by the intestinal villi. 
In general most experiments with isolated gut 
loops have shown relatively small fluid secretion rates 
(Gregory 1962} , although in at least one such experiment 
the duodenal secretion of dogs was considerable even 
after the initial transient flow had ceased (Landor et 
al. 1955). Local mechanism stimulation is the only 
definitely accepted stimulus to such secretion although 
nervous control may also be involved (Gregory 1962). 
As far as can be judged from the available evidence 
the concentration of calcium in secretions produced by 
mechanical stimulation in the dog is about 1.5 m.moles/litre 
(de Beer et al. 1935). Altman (1961) cites a similar 
value for man although in this case contamination from 
above the collection point may have been significant. 
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Table 5.2 Flow Rates ·a·nd· Calcium Concentrations 
Reference 
Saliva 
Altman ( 1961) 
Schneyer & 
Schneyer (1967) 
Gastric Juice 
Malm (1958) 
Hunt (1959) 
Long (1961) 
Altman ( 1961) 
Moore & 
Makhlouf 
(1968) 
Bile 
Malm (1958) 
Altman (1961) 
Long (1961) 
Doubilet & 
Fishman 
(1961) 
Briscoe & 
Ragan (1965) 
Diamond 
(196 7) 
· of Intes·tinal Secretions 
State of 
S.e c.r.e.ti.on 
basal 
stimulated 
nocturnal 
basal 
stimulated 
daily 
ranges 
Calc~um 
Concentration* 
(m.moles/li tre) 
1. 5 ( 1. 3-2 • 4) 
1.5 
1.0 
(1.1-2.3) 
(0.4-3.8) 
1.6 
non-fasting** 
fasting** 
fasting 
nocturnal 
after meal 
fasting 
basal 
stimul-
ated*** 
gall bladder 
hepatic bile 
(0.2-2.4) 
1.8(1.0-2.4) 
1.5 (1.12-1. 79) 
0.6(0.49-0.66) 
(1.0-3.5) 
(2.5-3.5) 
(1.0-2.3) 
gall bladder 8.3(3.0-12.8) 
daily total 
**** 
gall bladder 
hepatic bile 
1.7(1.3-2.1) 
(25-32) 
6 
Flow 
Rate* 
(m l/minute} 
0.57(0.1-1.8) 
1.9 (0.4-4.8) 
0.05 
(0.33-0.5) 
2(1.5-5) 
(2000-3000)ml/day 
2500 II 
0.89 
0.59 
1.2(0 -2.9) 
0.8(0.2-1.7) 
1. 7(0.2-3.6) 
1. 0 ( 0. 7-9. 5) 
0. 6 ( 0. 3-0. 7) 
(3.5-4.2) 
(250-900)ml/day 
(2.6-15.0)ml/kg/ 
day 
1500(1000-2000) 
ml/day 
1002 ml/day 
( 1 subject) 
Reference 
Pancreatic 
Juice 
Malm (1958) 
Altman ( 1961) 
State of 
S.e.c.re.ti.on 
basal 
Doubilet & daily total 
Fishman (1961) 
Long (1961) 
Hansky (1967) 
Janowitz ( 196 7) 
fasted 
stimulated 
fasted 
non-fasting 
basal 
stimulated 
Intestinal Secretions 
Altman 90cm beyond 
( 19 61) 120cm II 
160cm II 
Calcium 
Concentration 
( m.moles/li tre) 
(1.1-1.6) 
(1.1-1.6) 
(0.1-3.6) 
(0.6-0.9) 
o. 75±0.20 
0.58±0.13 
1. 7±0. 3 
Flow 
Rate* 
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(m Z./minute) 
( 600-1770) m Z./day 
1.0(0.02-5.20) 
2500(1500-4000) 
mZ./day 
0.6(0.0-1.7) 
(17-20)mZ./ 
kg/day 
0.8 
3.0 
up to 4. 7 
pylorus 1.33(1.3-1.4) 
II 2.0 (1.3-3.2) 0.56 (0.18-1.05) 
II 1.9 (1.3-2.5) 0.37(0.28-0.47) 
Gregory 14 determinations 1.6(0.8-2.7) 
(1962) in 3 dogs 
* 
** 
*** 
**** 
means are given where possible with ranges in parentheses 
nocturnal values 
values for maximum rate of secretion 
total bile collected and measured from 3 subjects over a 
week,only one of whom had an intact gall bladder. 
5.4 CAMET2 Intestinal Parameters and Equations 
Equations 2.26 and 2.27 represent respectively 
the duodenal fluid (RF1 , 6) and calcium (R1 , 6> secret-
ions where the constants G1 , G2 and G3 were selected 
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to give physiological values to the secretions both 
before and during a meal. The use of a separate equation 
for the fluid flow RF1 , 6 replaces the representation of 
this flow in CAMET as a negative fluid absorption. 
For the sake of simplicity and in the absence of detailed 
data the duodenal fluid flow during the course of a 
simulated meal represents the fluid secretion over and 
above basal levels by alZ intestinal flows. As in 
CAMET this is achieved by making RF1 , 6 dependent on 
the rate of stomach emptying. The volume of stimulated 
intestinal juice secreted in response to a simulated 
.. 
meal is three times the meal volume (Borgstrom et al. 
1957). With equation 2.27 the calcium carried in this 
flow is now included in the model - with important 
consequen~es (section 5.6). 
The effect of a simulated meal on the total intestin-
al secretion of calcium and the concentration of calcium 
in the duodenal secretion (R1 , 6;RF1 , 6) is illustrated in 
figure 5.1. Although the total calcium secreted rises 
rapidly, the concentration of calcium falls in accordance 
with observation. 
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On the basis of the data in the preceding section, 
model parameters were chosen for the intestinal fluid 
flows RFl,I (I = 5, 11) and the associated calcium 
Rl,I (I= 5,11) (table 5.3). The rates of the intestinal 
secretions Rl,? to Rl,ll (as well as part of R1 , 6 ) were 
derived from the data of Wensel et al. (1969). They 
measured the movement of calcium across the intestinal 
wall in both directions over -different 50 em segments 
of the small intestine, using an intubation perfusion 
method. While the data is extremely variable and may not 
represent basal conditions the experiment is the most 
complete investigation of calcium absorption and secretion 
made to date in this region of the human gut. Intestinal 
wall secretions are assumed to be 1. 5 m. moles/litre in 
calcium (table 5.2) and on this assumption the fluid 
flow rates were calculated. The new values eliminate 
the unphysiologically high calcium concentrations in 
these secretions implied in CAMET. 
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Table 5. 3 CAMET2 Intestinal Secretions 
Compartment Calcium Flow* Fluid Flow* Ca 
and Secretions (m. moles/kg) (li tres/kg/ Concentration 
Represented day) day) (m.moles/litre) 
5 saliva 0.062 0.041 1.5 
gastric juice 
6 bile 0.050 0.045 1.1 
pancreatic juice 
intestinal wall 
7 intestinal wall 0. 016 0.011 1.5 
8 II II 0.0036 0.0024 1.5 
9 II II 0.0036 0.0024 1.5 
10 II II 0.0036 0.0024 1.5 
11 II II 0.0036 0.0024 1.5 
Totals 0 .. 14 0.11 1. 3** 
* basal secretion rate 
** mean concentration (m.moles/litre) 
The total basal secretion may be somewhat higher than is 
the case in nature as no account is taken of the lower nocturnal 
secretion (table 5.2), but this is of little consequence to model 
predictions as virtually all secreted calcium is reabsorbed 
during the almost"steady state conditions that exist between 
meals. 
In the course of the present work several anomalies 
relating to the modelling of intestinal calcium absorption have 
become apparent. While for the moment no attempt has been made 
to correct them, they are noted here for future reference. 
The simulated fasting flow of fluid from the distal ileum 
(RFfecl) is 0.36 mZ/minute -in agreement with experimental 
estimates of less than 1 ml/minute (Karr & Abbott 1935, 
Whalen et al. 1966). In nature however the flow is sporadic 
and subject to considerable variability in magnitude between 
subjects. Apparently, efficient absorption of both the 
fluid and the calcium secreted into the gut under resting 
conditions occurs in vivo. The basal salivary flow alone 
is of approximately the same size, and carries the same 
quantity of calcium (section 5.3), as physiological 
measurements of the distal ileal flow. The concentration 
of calcium in the simulated resting flow from the ileum 
is only 0.25 m.moles/litre or about l/6th of that found 
experimentally. Studies on the absorption of calcium 
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from solutions recycled through dog gut loops have 
indicated that calcium absorption does not occur when the 
calcium concentration of the intestinal contents falls 
below 0.50 - 0.75 m.moles/litre (Cramer & Dueck 1962). 
However, despite the low calcium concentrations in the 
intestinal compartments under basal conditions, over 98% 
resorption of the simulated intestinal juice calcium occurs 
as a consequence of the model equations. In view of the 
number of approximations involved in the intestinal model 
(Livesey 1970), the cause of this high absorption {which 
is also evident, but to a lesser extent, at high calcium 
concentrations) is not clear. 
The inconsistency in the fluid equations mentioned 
in Chapter 1 is apparent in figure 5.2 where the calcium 
concentration in compartment 7 and the total absorption 
of calcium from the gut are plotted over the course of 
a simulated meal. The instantaneous flow of fluid 
throughout the gut as the stomach empties, implied by 
equations 2.29 and 2.30, causes a transient drop in the 
concentration of calcium in compartments 6 to 11 which 
persists until the associated dietary calcium reaches 
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these compartments. 
As a consequence of the fixed plasma volume (V1} 
the inflow of calcium with the digestive juices in 
response to a meal causes a slight reduction in the plasma 
calcium concentration immediately following the simulated 
ingestion of a meal - before increased calcium absorption 
is adequate to compensate for this loss (figure 7.2). 
This is contrary to expectation as the calcium in the 
intestinal juices is less concentrated than it is in 
the plasma. 
Hence the fluid dynamics in both the intestinal 
and plasma compartments together with the equations 
controlling the absorption of calcium require further 
attention if some of the present simulations (Chapter 7) 
are to be improved and more complex situations reproduced. 
A basic source of difficulty in this regard is that 
CAMET2 is required to simulate the oral intake of calcium 
in two distinct forms: as a solution (common in clinical 
experiments such as tracer absorption studies) and as 
part of the normal dietary intake. The handling of solids 
and liquids by the digestive tract is different, especially 
by the stomach (Hunt & Pathak 1960, Toyama & Blickman 
1971). How this affects calcium absorption is not certain, 
but it is probably important. 
5.5 The Plasma Calcium Concentration and Digestive Juice 
Calcium. 
Two conflicting schools of thought exist on the 
relationship between the concentration of calcium in the 
serum and that appearing in digestive juices. 
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The evidence advanced against any change in the calcium 
content of digestive juices is twofold. Firstly there is 
the data of Cramer (1963) on the perfusion of distilled 
water through isolated intestinal loops of a dog. The 
amount of calcium recovered from the perfused fluid was 
constant over a range of 1.5 to 3.75 m.moles/litre of plasma 
calcium. Secondly, the lack of an increase in faecal 
calcium after repeated daily intravenous infusions of 
. calcium (McCance & Widdowson 1939, Baylor et al. 1950) has 
been cited as support for this point of view. This type of 
evidence is not convincing however, as the hypercalcaemia 
associated with infusions is transient and would not be 
expected to increase faecal calcium to a significant extent, 
especially as the endogenous calcium forms only a small 
part of the total (Heaney & Skillman 1964). The experiment 
of Baylor et al. (1950), involving the twice daily intra-
venous administration of calcium totalling 550 mg, was 
simulated to check this point (for one three meal day only). 
The rate of secretion of calcium into the intestinal 
compartments was allowed to vary with the plasma calcium 
concentration. In table 5.4 the results of this simulation 
together with those of Simulation 11, involving no 
infusions, are given. 
Table 5. 4 
Simulation 
6 
11 
The Effect of Infused Calcium on 
Faecal Excretion 
Total Intestinal 
Secretion 
(m.moles/kg) 
0.216 
0.198 
Total Faecal 
Calcium 
(m.moles/kg) 
0.141 
0.133 
147 
SIMULATION 6 THREE MEAL DAY WITH CALCIUM INFUSIONS 
Source Program : 72150 No : 72167-2 
A three meal day with two separate calcium infusions 
totalling 0.21 m.moles/kg was simulated to examine the 
effects on the total faecal excretion of calcium. The 
relatively small increase in the parameter, while illustrat-
ing the lack of influence that intestinal secretions have 
in controlling calcium levels, also shows that increased 
intestinal secretion may occur during hypercalcaemia with-
out being detected experimentally. 
References : Baylor et al. (1950) 
Simulated Time : 1 day 
Model Inputs [A] Fluid and calcium oral inputs as in 
Simulation 11. 
[B] Calcium Infusion (m.moles/kg/day) 
Results [A] Parameters during simulation 
cl 
(m.moles/li tre) 
2.50 
3. 01* 
2 .. 76 
Rf~cl Rgs~c Rurin 
lm. mo.l.es /.Kg /day) 
0.0021 
0.184 
0.0023 
0.143 
0.492 
0.158 
0. 0827 
0.251 
0.178 
0.0 
2.54 
o.o 
2.54 
o .. o 
[B] Accumulated Totals (m.moles/kg) 
sf· 1 s s. f s . ec gsec ln urln 
0.118 0.141 0.216 0 .. 209 0.159 
*Maximum plasma calcium concentration 
Time 
(days) 
o.o 
0.375 
0.416 
0.542 
.0.583 
o.o 
0.58 
1.00 
1.00 
The original point made by Baylor that the gut did 
not represent a significant route for the excretion of 
calcium from the plasma is supported by these results. 
However, considering the small number of subjects (3), 
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the variability exhibited between the experimental control 
periods, and the small increase (6%) in the faecal calcium 
as a result of the simulated infusions, the experiment 
cannot be said to reveal, one way or the other, whether 
additional calcium is secreted into the gut during hyper-
calcaemia. 
A dependence of the calcium in intestinal juices on 
plasma calcium has been directly demonstrated in animals 
(Gran 1960b). In hyperparathyroid humans with hyper-
calcaemia a significantly elevated calcium concentration 
in the basal gastric secretion has been observed, although 
no significant difference could be detected in stimulated 
secretion compared with normal controls (Christiansen 
& Aagaad 1971). Hansky (1967) also measured almost double 
(1.33 m.moles/litre) the mean normal calcium concentration 
(0.75 ± 0.2 m.moles/litre) in two patients with hyper-
calcaemia associated with hyperparathyroidism. However 
the position is more complex than a simple change in the 
calcium concentration as it appears that the volume of 
gastric secretions (and perhaps other secretions) is 
related to the calcaemia (Murphy et al. 1966, Hotz et al. 
1971). In man both the volume and the acid output of 
gastric secretion increases with increased plasma calcium. 
For instance, Murphy et al. (1966) measured an increase 
from 1.6 ± 1.1 m.molesjhour to 10.0 ± 6.8 m.molesjhour 
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in the basal gastric acid secretion of 8 subjects following 
a calcium infusion. 
Gran (1960b) calculated the total excretion of calcium 
into the intestinal tract of rats using the data from 
balance and tracer experiments. Although the equations 
he used were approximate, the calcium excretion depended 
linearly on the concentration of ionized calcium in the 
plasma. Using similar methods Toverud (1964) observed 
the same phenomenon in rats whose blood calcium was first 
lowered by parathyroidectomy and then raised by parathyroid 
hormone injections. 
Thus apart from the experience of Cramer (1963), using 
intestinal fistulas under conditions differing considerably 
from the normal, the evidence su9gests that there is a 
connection between the gut calcium secretions and the 
calcium concentration of the plasma. If the calcium in 
this fluid is simply the result of bulk transfer of plasma 
water together with its ultrafiltrable calcium from one 
side of a membrane to another then this is a reasonable 
conclusion. It is still true if there is a greater 
resistance to the flow of calcium than to water. 
It is assumed here that the linear relationship ob-
served by Gran (1960b) for ionized calcium also holds 
for the total calcium (C1). Accordingly, in equations 
2.24, 2.27 and 2.28 the rate of calcium secretion into 
the gut compartments is multiplied by a factor of c1;c1 , 
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where c1 equals 2.5 m.moles/litre. Considering the 
available physiological evidence it is doubtful that this 
is more than a rough approximation. Furthermore ionized 
calcium is not a simple function of the total calcium. 
The ultrafiltrable calcium, with respect to a cellophane 
. membrane, does however form a remarkably constant 60% 
(56 - 62%) of the total serum calcium (p <<0.001) over 
a range in serum calcium of 1.25 to 3.25 m.moles/litre 
(5 to 13 mg/100 mZ) at constant body temperature and 
pH (Robertson & Peacock 1968). Ionized calcium comprised 
82.7 ± 2.9 % of the ultrafiltrable calcium. 
Except perhaps where the simulated blood calcium 
is markedly outside the normal range, as in some disease. 
states, this addition makes a negligible difference to 
the model dynamics. In disease, particularly where PTH 
is involved, other effects on calcium absorption complicate 
the interpretation of changes in the quantity of endogenous 
faecal calcium (section 3.7). Alterations in the quantity 
of secreted intestinal calcium is also a factor to be 
taken into consideration in tracer experiments where the 
calcium absorption is being measured-as the results are 
sensitive to such changes (section 7.3). 
5.6 Endogenous Faecal Calcium 
The endogenous faecal calcium is derived from the 
various digestive secretions - after much of the secreted 
calcium is reabsorbed and recycled back to the body. Until 
the advent of tracer calcium investigations the endogenous 
fraction of the total faecal calcium was impossible to 
determine (except in the special case of fasting) because 
it is indistinguishable from the unabsorbed dietary calcium. 
In order to calculate the simulated endogenous 
faecal calcium, a three meal day (as in Simulation 11) 
was simulated but MT1 (the quantity of tracer in the 
plasma compartment) was set equal to 1.0 x lo-3 
m.moles/kg and the appropriate differential equation 
(2.2) was altered to keep MT1 constant throughout the 
simulation. By this means the interpretation of the 
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results is made much easier, since the specific activity 
in the plasma compartment (SA1) only fluctuates ±3% 
as the quantity of stable calcium alters in response to 
the simulated calcium intake. Hence the quantity of 
endogenous faecal calcium (Se) is calculated as 
= ( 1) 
where M1 represents the quantity of calcium in compartment 
1 and STfecl the total amount of faecal tracer over the 
simulated day. In Simulation 7 Se was 0.036 m.moles/kg 
or 92 mg on the basis of a 65 kg mass. 
The intestinal tracer excretion, plotted in figure 
5.3 is concentrated at the simulated meal times and is 
associated with the unabsorbed fraction of the dietary 
calcium. As the model does not include the colon, 
neither the mixing of the intestinal contents nor the 
transit delay of a few days that occurs in the large 
intestine are simulated. Although the rate of excretion 
into the gut of calcium (and hence tracer calcium) 
increases by approximately fourfold during a simulated 
meal (figure 5.1) this only accounts for a small part 
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Source Program: 72150 No : 72203-1 
The dynamics of urinary and faecal tracer excreted 
from the body during a simulated three meal day are demon-
strated. The manner in which calcium is handled by the 
kidney and the gut gives rise to errors in the conventional 
methods of calculating the total calcium secreted into the 
gut (S ) and, to a lesser extent, in calculating the 
endogeH~n~ faecal calcium (Se). 
Reference: Heaney & Skillman (1964) 
Simulated Time: 1 day 
Parameter Change: MT 1 set to 1.0 x 10-3 m.moles/kg* 
Equation Change: (2.2) MT1 = 0.0** 
Model Inputs: Fluid and Calcium oral inputs as for 
Simulation 11. 
Results: Accumulated Totals (m.moles/kg) 
(A] Stable Calcium 
Cbal sacc sfecl sgsec ssab 
0.001 0.115 0.127 0 .. 197 0.313 
[B] Tracer Calcium ( X 10 3) 
CTbal STacc STfecl ST STsab gsec 
0.661 0.433 0. 0 790 0.444 0.358 
s . 
ur1.n 
0. 0779 
ST . 
ur1.n 
0.175 
Time 
(days) 
1.00 
1. 00 
* Since the model is mathematically linear with respect 
to tracer calcium the numerical value of the 
** 
initial quantity of tracer calcium is arbitrary. 
This change has the effect of keeping MT1 constant (at 1.0 x lo-3 m.moles/kg) throughout the simulation. 
TRRCER EXCRETION I 
~ 2.~,o-7t 1 I I ' i I I I I I I I I I I i I I I I i I 1 rarow7 
~ z.ooxlo-7 ~ 4.1.AR"l u -(f) 
w 
__j 
0 
:L 
l.SOX10-7 s.CXJX!o-7 
a: w~1w7t (\ /\ /\ !.=lw7 w u CI a: I-
~ o.~~~J I \ I \ I \ t=l<r7 
::> 
o.o o.o 
0 4 8 1Z 16 zo Z4 
TIME IN HOURS 
figure 5.3 Urinary & faecal tracer excretion : Stable plasma specific activity 
.,., 
]) 
fTl 
0 ]) 
r 
-1 
:;o 
]) 
0 
fTl 
:;o 
3: 
0 
r 
fTl (j) 
" 0 ]) 
-< 
" A aJ 
L 
t 
....... 
'" CH 
154 
of the increased faecal tracer excretion that is 
observed. The simulated effect is however exaggerated 
to some extent by the abnormally high absorption 
parameters of the model, particularly evident at low 
calcium concentrations (section 5.4}. By comparison 
the rate of excretion of urinary tracer is much more 
uniform over the day (figure 5.3}. 
This pattern of tracer excretion is important in 
that it means that relations such as (1), where the 
average specific activity is used, or its equivalent 
= STf 1 /(ST . /S . } ec ur1n ur1n (2} 
(where ST . denotes the total urinary tracer excretion 
ur1n 
and S . the stable urinary calcium} commonly used to 
ur1n 
calculate the endogenous faecal tracer are not as exact 
as has been assumed. Consider a situation analogous 
to Simulation 7 except that the tracer calcium is not 
kept constant but allowed to decay, as in nature, by 
distribution and excretion ·(Simulation 8} • This produces 
a high specific activity in the urine over the first 8 
hours, but as virtually all tracer calcium excreted into 
the gut is reabsorbed in the absence of dietary intake, 
it is not until the first simulated meal that any 
appreciable tracer dose is delivered to the colon 
(figure 5.4). By this time however the plasma specific 
activity has declined appreciably (Simulation 15} • When 
the simulated excretion data of Simulation 8 was sub-
stituted into equation (2} a value of 0.029 m.moles/kg 
for the endogenous faecal tracer was obtained - or 19% 
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SIMULATION 8 TRACER EXCRETION II 
Source Program 72150 No 72219-1 
Simulation 7 was repeated but the initial dose of 
plasma tracer was allowed to change under the model equations. 
The stable calcium dynamics (and hence the quantity of 
endogenous faecal calcium) in the two runs were identical. 
Yet when conventional equations are applied to calculating 
the quantity of endogenous faecal calcium, using the simulated 
excretion data, a significant difference between the cal-
culated values from Simulations 7 and 8 is apparent. 
Reference: Heaney & Skillman (1964) 
Simulated Time: 1 day 
Parameter Change: MT1 set to 1.0 x lo-
3 m.moles/kg 
Model Inputs: Fluid and calcium oral inputs as in 
Simulation 11. 
Results: Accumulated Totals {m.moles/kg) 
(A] Stable Calcium 
~al sacc sfecl S sec ssab s urin g. 
0.001 0.115 0.127 0.197 0.313 0 .. 0779 
(B] Tracer Calcium (x 10 3) 
CTbal STacc STfecl STgsec STsab STurin 
0.914 0.115 0.0174 0.111 0.0931 0.0461 
Time 
(days) 
1.00 
1.00 
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less than the accurate value of 0.036 m.moles/kg 
from Simulation 7. Basically this discrepancy is 
caused by the strong bias of the endogenous faecal calcium 
to reflect the plasma specific activity during meals. 
Whether or not this observation is important experimentally 
would depend on the experimental regime, but under some 
circumstances it could conceivably cause appreciable 
errors. 
Livesey (1970) demonstrated that the method of 
Heaney & Skillman (1964) in calculating the total calcium 
secreted into the gut per day (S ) , using measurements gsec 
of the endogenous faecal calcium, seriously underestimated 
the actual quantity secreted. Without going into details 
(see Heaney & Skillman 1964, and Livesey 1970} it was 
assumed that, at the most, the fraction of endogenous cal-
cium secreted into the digestive tract that was reabsorbed 
was the same as that of the dietary calcium. Thus it was 
considered that S lay between the endogenous faecal gsec 
calcium corrected for this absorption, and the measured 
endogenous faecal calcium assuming that no absorption 
occurred. On this basis Heaney & Skillman (1964) calculated 
from 9 determinations in 7 normal subjects a range 
0.045 ~ s ~ 0.078 gsec m.moles/kg. 
When the excretion data of Simulation 7 was substituted 
into the same equations relatively good agreement was 
obtained. 
0.036 ~ sgsec ~ 0.092 m.moles/kg 
However, unlike the experiment in vivo~ the true value 
of Sgsec is known in the case of Simulation 7 and is 
equal to 0.20 m.moles/kg. This value is well outside 
the calculated range. As was pointed out by Livesey a 
cause of this disagreement is that the fraction of the 
dietary calcium absorbed by the gut is not constant as 
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was assumed, but is a function of many factors - including 
the intestinal content of calcium. Another source of 
error, related to the foregoing, is that the possibility of 
a greater fractional absorption of the secreted calcium 
than of the dietary calcium was not considered. From an 
examination of both intestinal physiology (section 5.4) 
and the CAMET2 results, it is clear that very efficient 
reabsorption of calcium occurs in the absence of dietary 
calcium. Physiologically this type of behaviour is seen 
in experiments such as that of DeGrazia et al. (1965) who 
found that by increasing the load of stable calcium carrier 
associated with an oral tracer dose from 10 to 200 mg, the 
absorption of the tracer fell from 80 to 26%. 
Essentially the method of Heaney & Skillman (1964) 
provides an approximate estimate of the amount of calcium 
emptied into the intestinal lumen during meals. 
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CALCIUM AND THE BONE 
6.1 In this chapter the processes by which calcium 
and its radioactive isotopes are deposited and removed 
from the skeleton are briefly examined. Equations 
are introduced to cover the_ growth and removal of both 
the mineral phase and the protein matrix of bone. 
Further transfer of calcium between the body fluids 
and bone mineral occurs by isoionic calcium exchange. 
Since processes that require an exact exchange cannot 
contribute to the regulation of plasma calcium most 
of the exchange processes in CAMET governing the 
dynamics of stable calcium are removed. They are 
retained for tracer calcium because exchange is 
effective in removing it from blood. 
6.2 Bone: Structure and Turnover 
Bone is comprised of two distinct but inter-
dependent phases - the inorganic bone mineral and the 
organic' matrix. The nature of these phases is dis-
cussed in this section; more detailed coverage may be 
found in the excellent reviews that have appeared 
recently on both the mineral (Eanes & Posner 1970) 
and the matrix of bone (Schiffmann et al. 1970, 
Grant & P.rockop 1972) • 
The major ions in human bone mineral, expressed 
as a percentage weight of the total dry fat-free bone, 
are calcium (22.5), phosphate (10.3), sodium (0.52), 
magnesium (0.26), carbonate (3.5), chloride (0.11) 
and fluoride (0.054) with lesser amounts of other 
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elements (Zipkin 1970). The crystallographic structure 
of bone mineral is not known. The measurements available 
are consistent with a structure similar to, although not 
identical with, the naturally occuring hydroxyapatite 
(Ca5 (Po4) 30H), whose unit cell is a right rhombic prism 
containing twice the stoichiometric number of atoms (Kay 
etal.l964). Certain features of bone mineral indicate 
that it differs from the natural or synthetic hydroxyapat-
ite and chief among these is the non-stoichiometric ratio 
of the constituent ions. The variation in the content of 
minor elements from one sample to the next is considerable, 
but even the calcium and phosphate contents fluctuate about 
the expected value. In part, this variability is believed 
to be caused by substitutions within the lattice (for 
example chloride and fluoride in the hydroxyl positions). 
Surface adsorption and crystal lattice defects have also 
been put forward as contributary causes. Bone crystals 
are extremely small. Recent X-ray diffraction studies have 
0 put the maximum dimension at about 100 A (Posner et al. 
1963). However, somewhat larger dimensions have been 
found using the electron microscope and it has been suggest-
ed that end-to-end fusion of the crystals would accommodate 
both results (Molnar 1959) • 
The presence of a separate non-crystalline or amor-
phous mineral phase, in proportions markedly affected by 
even mild preparative methods, further complicates the 
structure of bone mineral. Evidence for the existence of 
the amorphous mineral comes from X-ray diffraction, electron 
microscopy and studies of the precipitation and chemical 
properties of calcium phosphate minerals (Termine & 
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Posner 1967, Eanes & Posner 1970). The non-diffracting 
0 
amorphous granules range in diameter from 60 to 200 A 
(Molnar 1959) and their appearance in developing bone 
tissue, seen under the electron microscope as a fine film, 
precedes that of the hydroxyapatite. Unlike the hydroxyap-
atite they have no apparent structural relationship to 
the collagen matrix of bone. The subsequent development 
of the hydroxyapatite crystals is in part controlled by, 
and at ~he expense of, the amorphous phase (Quinaux & 
Richelle 1967, Termine & Posner 1967). Yet, even in 
mature bone tissue the amorphous mineral accounts for 
about 40% of the total inorganic content of bone (Harper 
& Posner 1966). 
The organic matrix of bone is primarily the protein 
macromolecule collagen. Generally it is quoted as 
forming 90 - 96% of the total organic fraction of bone 
but recently Dequeker & Merlevede (1971) could find only 
80% collagen in the dry organic matrix of human trabecular 
bone. The basic subunit of collagen is the tropocollagen 
molecule, which in turn consists of 3 polypeptide chains 
of about 1000 amino acid residues. The polypeptides, 
each of a molecular weight of about 95,000, are wound 
about each other in a helical structure for most of 
their length. By the formation of crosslinks between the 
0 
chains the tropocollagen molecule, 3000 A long and 
0 15 A in diameter, is formed (Grant & Prockop 1972). Two 
of the three chains are identical (the a1 chains) 
but the third differs in amino acid composition (a2 ). 
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Until recently it had been thought that all the collagen 
found within an animal was identical but chicken cartilage 
collagen has been found to differ from previously 
investigated chicken collagen in that it consists of three 
identical polypeptide chains of a new variety (a1 type II) 
(Miller & Matukas 1969). The collagen microfibrils are 
built up by the ordered arrangement of the tropocollagen 
molecules with their long axes parallel to that of the 
fibre. The whole structure is strengthened by an increasing 
degree of covalent bonding between the tropocollagen sub-
units. When viewed under the electron microscope, the 
alignment of certain charged regions of neighbouring 
tropocollagen molecules, lying parallel to one another in 
the microfibril, gives rise to a distinct banded periodicity 
0 
of 680 A. Significantly, the same distance separates the 
crystals in the early stages of nucleation and growth. 
Another interesting feature is the presence of 'holes' at 
the end of each tropocollagen molecule separating it from 
its immediate neighbours along the axis of the microfibril. 
0 . 
Each hole is 410 A long with the diameter of the tropo-
collagen molecule (Grant & Prockop 1972). 
There exist a number of theories to account for the 
deposition of bone mineral on the organic matrix but, as 
yet, none are wholly satisfactory. 
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lAJ Extracellular biological mechanisms are supposed 
to exist, which raise the calcium and phosphate 
concentrations to levels sufficient to cause spontan-
eous precipitation of bone mineral. 
(B] The presence of regular features in the collagen 
fibres and the apparent structural association between 
the collagen and the bone crystals has given rise to 
much speculation that the development of the bone 
mineral is controlled in some way by the collagen matrix, 
and even that the holes in the matrix represent 
nucleating sites (primary heterogeneous nucleation). 
The minimum ion product of calcium and phosphate 
( [ Ca] x [ Po4 ]) (where [PO 4] is the sum of inorganic 
phosphorus in its several forms) required for the 
spontaneous precipitation of hydroxyapatite in vitro 
is about 4(m.moles/litre) 2 ; under certain conditions 
and in the presence of foreign bodies this may be 
reduced to 2.8 (m.moles/litre) 2 - and still further in 
the presence of collagen (Fleisch 1964). The normal 
concentration of ionic calcium is about 1.3 m.moles/ 
litre and inorganic phosphate about 1 m.mole/litre. 
Once seeded the crystal growth can continue even in 
the presence of relatively low ion concentrations 
(Katz 1971). Thus while the idea of collagen nucleat-
ion takes into consideration the undersaturation of 
·body fluids in calcium and phosphate with respect 
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to crystal seeding, in order to account for histological 
changes observed in the matrix before calcification 
commences it has been proposed that nucleation follows 
the alteration or the removal of inhibiting ground 
substances. 
[C] There are theories which, while incorporating 
elements of· [A] and [B], propose that the amorphous bone 
salt is deposited before crystals form. The hydroxyapat-
ite is thought to develop by primary heterogeneous 
nucleation at specific sites on the collagen, perhaps 
followed by secondary nucleation (the self-seeding of 
crystals) but with the amorphous granules supplying mat-
erial for the developing, thermodynamically favoured, 
crystals. These theories are fully in accord with the 
observed appearance and subsequent decrease in the 
quantity of amorphous mineral in calcifying bone tissue 
(Quinaux & Richelle 1967, Termine & Posner 1967). 
However, since the concentrations of calcium and 
phosphate necessary to initiate spontaneous precipitation 
of amorphous granules are. greater than exist in biological 
fluids it is necessary to postulate some form of local-
ized concentration of ions. Indeed, in vitro, the 
amorphous calcium salts are more soluble than hydroxyapat-
ite - although at sufficie .. 1tly high ion concentrations 
the precipitation of the amorphous granules are 
kinetically favoured over the hydroxyapatite crystals. 
With increasing experimental support, the idea has been 
put forward (Eanes & Posner 1970, Lehninger 1970) that 
the bone cells are responsible for the creation of the 
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conditions under which amorphous salt precipitation 
occurs. Active transport of the ions to the mineraliz-
ation front or even the formation of amorphous granules 
'Within osteoblast mitochondria, in the first instance, 
with subsequent extracellular deposition have been 
su~gested as possible mechanisms. Certainly the osteo-
blasts are intimately associated with areas of osteoid 
tissue undergoing calcification (Arnott & Pautard 1967) 
and mitochondria have a remarkable capacity to concentrate 
calcium and phosphate from an external solution 
(Lehninger 1970, Wasserman & Kallfelz 1970). 
Notwithstanding the lack of knowledge of the 
processes involved in the deposition of mineral in bone 
there is a general consensus that elaboration of the 
collagen matrix takes place before the bone salts are 
precipitated. This observation forms the basis of the 
equations governing bone formation in the calcium meta-
bolism model. The rather unphysiological concept of 
an unmixed pool in CAMET (figure 1.1) is replaced in 
CAMET2 by two related pools: the bone calcium (~ca) 
and the bone collagen (~coll). Analysis of dry, 
fat-free human skeletons has shown that close to 
1/3 is organic and 2/3 is inorganic in nature (Trotter 
& Peterson 1955). A slightly smaller proportion of 
mineral (57.1%) has been reported by Zipkin (1970) 
as the mean of results taken framthe literature for 
individual bones. Ninety per cent approximately, of 
the organic fraction is collagen (Eastoe 1956) and 
22.5 (19.3 - 25.6)% of the total dry fat-free bone is 
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calcium (Zipkin 1970). The relative proportions of the 
two phases of bone change little with age. The organic 
content of trabecular bone per unit weight does not change 
with age or porosity (Dequeker & Merlevede 1971) but the 
quantity of mineral per unit weight of bone may however 
increase slightly with age, at the expense of water. Partly, 
this is brought about by the plugging of Haversian canals 
with amorphous salts (Arnold 1960, Jowsey 1960). In this 
respect osteoporotic bone, while of a lower density overall, 
is not significantly different from normal age-matched 
bone. Thus, with some experimental justification, the 
proportions of collagen and calcium in mature mineralized 
bone are considered constant in CAMET2 : given one the other 
may pe calculated using the proportionality constants Kpr 
and Krp derived from the above data. Further it is assumed 
in CAMET2, in order to greatly simplify the computation, 
that the bone collagen is either fully mineralized or not 
mineralized at all. Hence in the model the unmineralized 
collagen (U 11> is that part of the bone collagen pool mco · 
that is not calcified by the bone calcium 
Umcoll = ~coll - Kpr ~ca 
Of course in nature there exists a continuum in the degrees 
of osteon calcification, but the rapid initial mineral-
ization of newly synthesized collagen to about 75% of the 
maximum, and the slow turnover of adult bone results in a 
very small quantity of unmineralized collagen. At any one 
time only a few percent of all osteons in adult bone are in 
the process of formation (Jowsey 1960). 
16 7 
From an estimate based on tetracycline labelling 
experiments (Frost 1969) the rate of bone turnover is 
taken as 10% of the total skeleton per year. Rcoacc' 
the rate of bone collagen synthesis, is set equal to 
0.0058 g/kg/day and is constant throughout all the simul-
ations. The many factors that influence this rate 
(Rasmussen 1968) have still to be investigated and 
included in the model as it is developed to cover long 
term aspects of calcium metabolism. 
The rate of collagen resorption (Rcodec> is also 
set equal to 0.0058 g/kg/day (at a calcium concentration 
of 2.5 m.moles/litre) to give overall skeletal balance. 
It should be noted however that after the age of 40, or 
thereabouts, these rates become unbalanced in favour of 
bone resorption (Garnet al. 1967). Frost (1969) puts 
resorption at 10% of the skeleton per year and formation 
at 9.7% in the adult. Over long periods of time such an 
imbalance can result in the bone disorder osteoporosis -
or insufficient bone mass. In CAMET2 the rate of collagen 
resorption is made inversely proportional to the calcium 
concentration (equation 2.46) since it appears, on current 
evidence, to be sensitive to changes in the calcaemia -
probably through the relatively rapid action of CT 
(section 3.6). The much greater effect of PTH in increas-
ing bone resorption, emphasized by its absence in section 
4.6, remains to be incorporated. 
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The rate of bone collagen deposition and removal 
are made to control the corresponding calcium rates in the 
model. Thus formally, the rate of calcium decretion from 
the bone compartment is represented as following the re-
moval of the collagen matrix although, for all practical 
purposes, the simulated removal of both the matrix and 
the calcium is simultaneous. 
R = K R dec rp codec 
On this point the physiological evidence is in conflict: 
some investigators favour the view that the mineral is 
removed first since unmineralized collagen is more suscept-
ible to degradation by collagenase (Stern et al. 1970). 
Whatever the mechanism and the sequence of bone resorption 
there is much evidence to support a close relationship 
between the turnover of the two main components of the 
skeleton. Apart from the almost unchanging proportions 
of collagen and calcium in bone the biochemical studies of 
Firschein (1967) demonstrated that a direct relationship 
between the turnover of collagen and mineral exists under 
normal circumstances. Deductions about the turnover 
of one component may hence be made from a knowledge of 
the other. In passing it is noticeable that while there 
are pathological conditions such as rickets where collagen 
is laid down but not mineralized, there appears to be no 
documented instances of selective mineral removal from 
bone leaving the collagen matrix intact. 
The CAMET2 equation for the deposition of calcium 
in bone (R ) is 
ace 
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where 
Koss denotes a rate constant 
U the quantity of unmineralized collagen 
mcoll 
Thus the rate of deposition of calcium is made directly 
proportional to the quantity of unmineralized collagen. 
In vitro this is the case (Wadkins 1968) and might reason-
ably be expected in vivo. The rate of calcium accretion 
is also made directly dependent on the calcaemia. There 
is an impaired deposition of mineral in hypocalcaemia 
of whatever cause. However it is probable that in nature 
the relationship is not linear. In hyperparathyroidism, 
for example, the width of uncalcified osteoid tissue is 
larger than normally observed despite high serum calcium 
(Jowsey 1968). The phosphate concentration (which in 
hyperparathyroidism is usually low) is also important. 
In fact a linear relationship between the osteoid tissue 
width and the calcium-phosphorus product of the blood 
has been demonstrated (p < 0.001) (Jowsey 1968). Richelle 
et al. ( 1966) have proposed second order kinetics to 
describe the appearance of calcium in the collagen matrix. 
2 
cc (Ca - Ca) 
max 
where Ca is the mass of calcium per unit volume and Ca 
max 
the maximum level of bone calcification. Estimates of 
the time taken for collagen mineralization to the 75% 
level vary from a few hours to a week. The rate constant 
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Koss which controls this rate in CAMET2 (and also in-
cludes the proportionality constant Krp) was arbitarily 
selected to fall within this range - such that in the 
presence of stable plasma calcium a quantity of un-
mineralized collagen would be half-filled with mineral in 
2.31 days .. 
The differential equations (2.16) and (2.17) describe 
the changes in the quantities of bone calcium and bone 
collagen respectively. For a 65 kg mass the initial 
quantity of bone calcium amounts to 1103g and bone colla-
gen 1380g. These values were choosen to reflect typical 
calcium andcollagen contents of the adult skeleton 
(Trotter & Peterson 1955) and in a ratio such that 
skeletal balance at t = 0 is achieved. 
= Rdec = 0.116 m.moles/kg/day 
Rcoacc = Rcodec = 0.0058 g/kg/day 
The rate of calcium turnover is determined by the 
rate of collagen turnover and at 0.116 m.moles/kg/day 
is equivalent to 302 mg/day. Such a mineralization rate 
is close to the 250 mg/day predicted by Burkinshaw & 
Marshall (1971) from their calcium metabolism model 
comprised of a continuously expanding exchangable pool 
to account for exchange, but is only half the correspond-
ing rate in CAMET which included a considerable element 
of slow exchange. 
Naturally, the two bone pools alter negligibly over 
the course of the short term simulations described in 
the present work, but eventually it is hoped to extend 
the model to examine long term processes such as those 
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involved in the development of rickets and osteoporosis. 
It is evident that the bone still represents the most 
underdeveloped aspect of the present model. A comprehens-
ive model will need to incorporate the time delayed 
action of PTH in removing the calcium from the skeleton,and 
the factors that alter the rate of bone formation, and it must 
explicitly include the action of CT on bone resorption. 
Another aspect that requires consideration is the 
apparent semi-autonomous coupling of the bone formation 
and resorption rates that maintains a degree of skeletal 
homeostasis over long periods of time in the face of 
chronic stimulation of either formation or resorption. 
6.3 Calcium Exchange 
Some of the exchange properties of synthetic 
hydroxyapatite crystals in aqueous suspension have been 
examined (Neuman & Neuman 1958, Pak & Bartter 1967). It 
was found (Pak & Bartter 1967) that the uptake of 
ca
45 by suspended hydroxyapatite crystals could be 
described (as the fraction of the initial isotope dose 
remaining in solution) by 
ca45 = 0.240e-~t + 0.085e-0 • 177 t + 0.054e-0 • 0043 t 
soln,t 
+ 0 • 700e-0.000014t 
where the rate constants are expressed as the fractional 
change in radioactivity per minute. In like manner the 
release of ca45 into solution from prelabelled crystals 
(expressed as the fraction of the. original tracer 
remaining in the crystals) was 
45 
Cacryst,t = 0.400e-a1t + 0.076e-
0
•
126 t + 0.059e-0• 0059 t 
+ 0 _523e-0.000015t 
The exchange dynamics up to 65 hours were covered - but 
the rapidity of the initial uptake and release of radio-
calcium did not permit the determination of a1 . The 
isoionic nature and the reversibility of the exchange 
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(indicated by the numerical similarity of the above relat-
ions) were demonstrated. Evidence was also produced 
suggesting that the last exponential term described intra-
cystalline exchange, a process known to be slow; the re-
maining terms covering exchange in the hydration shell and 
on the surface of the hydroxyapatite. 
Similar responses (a fast initial uptake of radiocal-
cium followed by a much slower phase) are observed conseq-
uent to intravenous tracer administration in man (Simulat-
ion 15). However, ion exchange is more complex when the 
living organism is considered since the transport component 
of bone ion exchange is important. Only 5% of the cardiac 
output of 'blood passes through the skeleton and, in general, 
the crystal surfaces are much less accessible to the medium 
than synthetic hydroxyapatite suspended in solution. 
Rowland (1966) demonstrated, among other things, that the 
degree of exchange labelling of bone is strongly dependent 
on the proximity to vascular channels. Bone further than 
0 
about 2000 A from any vascular surface was lightly 
labelled; detectable by autoradiography only after 24 
hours or more. On the other hand, treuptake of isotope 
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by the exposed surfaces was rapid and isotope disappearance 
from these surfaces paralleled that in the blood. Heavy 
labelling of bone formation and bone resorption sites was 
also observed. Neuman et al. (1968) examined the kinetics 
of calcium exchange by recycling a ca45 solution through a 
column of hydroxyapatite crystals. From the results and 
from what is known about the skeletal blood flow it was 
estimated that to achieve full equilibration between blood 
and bone in man a period greater than 125 days would be 
required (in nature of course equilibration never occurs). 
In CAMET it was assumed that the movement of stable 
calcium could be described by a multicompartmental model 
based on tracer calcium dynamics. While this is true for 
the steady state the assumption is not well founded if 
perturbations to the plasma calcium occur, since it implies 
that calcium is free to redistribute itself throughout 
all 4 exchangable compartments. This is contrary to ex-
pectation however as much of the movement between the 
pools represents ion exchange, a process which, by definit-
ion, cannot effect a net transfer of calcium. Thus if any 
rates of transfer between compartments 1, 2, 3 and 4 
(figure 1.1) are strictly exchanges of calcium ions, then 
for any such rates RI,J = RJ,I but RTI,J I RTJ,I In the 
equations adopted now the following processes are taken 
to be strict exchanges 
but R1 , 2 is allowed to differ from R2 , 1 so permitting 
a net flow of stable calcium between pools 1 and 2. It 
seems safe to assume that the slow transfer of calcium 
to and from compartments 3 and 4 represents largely (and 
perhaps solely) ion exchange (Neer et al. 1967) .' The 
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addition of these constraints to the model has considerably 
improved its predictions where large perturbations to the 
plasma compartment calcium are simulated over periods of 
greater than 4 hours (Chapter 4). The compartmental 
structure of CAMET2 for stable calcium is shown in figure 
6 .1. 
6.4 Homeostasis of Plasma Calcium 
The apparent lack of a physiological equilibrium, 
noted in Chapter 4, between blood and bone calcium import-
ant to the.regulation of plasma calcium finds strong 
support in the perfusion experiments of Rodan et al. (1967). 
The blood circulation of the hind limb of anaesthetized 
dogs was isolated and pumped through an external loop. 
Calcium added to the circulation resulted in a stable, 
but elevated, concentration after initial distribution had 
occured. The rapid renal excretion of calcium that 
normally blunts hypercalcaemia stress (section 4.4) 
is not possible in the isolated limb and no local homeo-
stasis mechanisms with a half life of less than 20 hours 
could be detected. After ca47 was added to the hyper-
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calcaemic .limb the specific activity of the plasma 
(in counts/ml) decayed in the same manner as in a 
control limb. 
Support for the commonly held view that plasma 
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calcium is largely regulated by some form of physiochemical 
equilibrium between calcium in bone and calcium in blood 
rests largely on the in vitro properties of bone mineral 
(Nordin 1957, Neuman & Neuman 1958, MacGregor & Nordin 
1962, MacGregor & Brown 1965). For instance, Nordin 
{1957) showed that calf bone powder could maintain 
physiological calcium and phosphate concentrations when 
the pH of the solution was in the range 6.6 - 6.8. When 
this work was extended using human bone powder similar 
results were obtained (MacGregor & Nordin 1962). 
Although these results are interesting it has yet to be 
proved that such effects operate in living bone tissue 
either by the active regulation of the pH at bone surfaces 
or by a pa~sive equilibrium between blood and bone. 
It must, however, be recognized that there is a limit-
ed cushioning of perturbations in the calcium concentration 
of extracellular fluids which has not yet been explained. 
Perhaps evidence of this is most clearly seen in the 
fusion of EDTA to parathyroidectomized animals where a 
slow but limited upwards adjustment in the plasma calcium 
concentration occurs following the end of an EDTA 
infusion (section 4.6). The experiments of Rodan et al. 
(1967) showed that the same type of response was also 
obtained in the isolated limb as in the entire parathyroid~ 
ectomized animal. They concluded that the additional 
calcium mobilized from outside the extracellular space 
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amounted to about 1/1000 of that in the limb bone. 
It is assumed, without proof, that the second ex-
changable calcium pool of CAMET (figure 6.1) represents the 
calcium able to buffer changes in the extracellular fluids 
(largely contained in compartment 1). The anatomical origin 
of this labile calcium is uncertain. However Rodan et al. 
(1967) reported that as a result of EDTA administration to 
the perfused limb that the total calcium in the circulation 
rose by almost 50% (inclusive of EDTA-bound calcium) but 
the slow disappearance of ca47 (expressed as counts/ml) was 
unaltered. Such a result suggests that the calcium mobilized 
by the EDTA was not in equilibrium with the tracer injected 
some 2~ hours earlier. If this is the case, then the 
representation of this calcium in CAMET2 as a rapidly ex-
changeable pool may be misleading. One plausible explanation 
is that the additional calcium in the plasma represents some 
of the considerable quantity of calcium (amounting to 
3-4 g) associated with the soft tissues; including the 
walls of the blood vessels (Stoclet & Cohen 1966), bound to 
membranes (Gent et al. 1964) and associated with muscle 
tissue (Shanes 1963). By comparison the total calcium in 
the extracellular fluids, including the plasma calcium, 
amounts to little more than 1 g (Rich et al. 1961). In 
view of the very small concentration of ionic calcium in 
the cytoplasm of cells .. (on the basis of reports in the 
literature Rasmussen (1970) estimates between 10-2 and 
10-S m.moles/litre) this source can be ruled out. Only 
scattered evidence is available on the nature and extent 
of bound calcium in soft tissues but irt at least one 
investigation the binding of calcium to the erythrocyte 
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(red blood cell) membrane has been found to be a 
function of the calcium activity of the bathing medium 
(Gent et al. 1964). To determine the importance of 
this passive buffering in calcium homeostasis then 
considerably more information about the distribution, 
binding and transport of calcium in the various soft 
tissues of the body is essential. 
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CALCIUM TRANSPORT IN MAN 
7.1 The plasma calcium concentration is maintained 
at a remarkably constant level in the face of large, 
periodic inputs of calcium from the diet. This is 
brought about by the co-ordinated control of the trans-
port of calcium by the intestine, kidney and bone. 
While considerable progress has been made in the under-
standing of the nature of the control processes in cal-
cium metabolism (Chapter 3) , detailed knowledge about 
the fine regulation of the serum calcium is lacking. 
A number of CAMET2 simulations involving minimal 
perturbations to the plasma calcium are examined in 
this chapter. 
7. 2 The· Intake· of ca·lcium from the· Diet 
Simulation 9 is a one day fast. Plasma calcium 
and urinary excretion decline steadily (figure 7.1) 
As is found (Heaton & Hodgkinson 1963) the increased 
urinary calcium due to meals disappears, although in 
real life factors ndt yet included in the model 
(Chapter 4) produce fluctuations not found in Simulat-
ion 9. Presumably the serum calcium, which is also 
responsive to dietary intake (Carruthers et al. 1964, 
MacFadyen et al. 1965), falls also, thereby reducing 
the renal loss of calcium. 
However, in the experience of local investigators 
and from the scattered documented data that has been 
collected (Duncan et al. 1948, Scheck et al. 1966), 
prolonged fasting results in a gradual increase in 
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SIMULATION 9 FASTING 
Source Program : 72150 No : 72183 - 1 
The model was run for one day with no inputs of any 
sort. Plasma calcium fell by 9% and the rate of urinary 
calcium excretion by 42% compared with the initial values. 
Simulated Time: 1 day 
Results: (A] Parameters during simulation 
cl R . urJ.n cc cP 
(m.moles/li tre) (m.moles/kg/day) (ng/mZ.) (ng/mZ.) 
2.50 
2.37 
2.28 
-o .100 
0.0827 0 .. 10 0 .. 60 
0.0602 0.084 0.75 
0.0476 0.073 o. 86 
(B.] Accumulated Totals (m.mo1es/kg) 
sderm s . urJ.n 
0.111 0.122 0.0364 0.0019 0.0621 
Time 
(days) 
0.001 
o.so 
1.00 
1.00 
FASTING 
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Figure 7.1 Plasma Ca concentration and urinary Ca excretion during fasting ..... 
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urinary calcium to levels comparable with or in excess of 
control levels. The lowered serum pH developed by fasting 
subjects is probably responsible: metabolic acidosis has 
been implicated with increased urinary calcium (Duarte 
& Blande 1965, Nordin et al. 196 7) • A direct interrelat-
ionship between the renal transport mechanisms of the 
hydrogen and calcium ions is possible or, alternatively, 
it might be that the lowered pH produces this effect by 
inducing a shift in the partition of plasma calcium between 
its bound and unbound forms. The fraction of ultrafiltrable 
calcium increases significantly even with small decreases 
(0.25 pH units) in the pH (Robertson & Peacock 1968). This 
would reasonably be expected to produce an increase in the 
urinary excretion of calcium, an increase in PTH secretion 
and ultimately an increase in bone resorption - as must 
exist for the maintenance of the high rate of urinary 
calcium excretion during fasting. 
Generally speaking, the loss of calcium in the urine is 
relatively insensitive to the dietary intake of calcium 
··' (Knapp 1947, Peacock et al. 1967). At least 3 mechanisms 
are responsible - the saturable nature of the intestinal 
calcium transport, the ability of PTH to maintain the 
plasma calcium by increasing bone resorption when short 
falls in dietary intake occur and, over longer periods of 
time, the adaption of the gut to a lowered level of calcium 
intake by increased absorption efficiency. Nevertheless, 
if the dietary calcium is reduced severely enough a fall 
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in the urinary calcium can be induced. Restricting the 
intake of calcium to below 250 mg per day forms the basis of 
the calcium deprivation test (MacFadyen et aL 1965, Nordin 
& Smith 1965) used in determining whether or not hypercal-
ciuria is intestinal in origin. A low daily calcium diet of 
0.081 m.moles/kg (210 mg) was simulated for 2 'days (Simulat-
ion 10). The effects on serum and urinary calcium on the firs 
simulated day are compared to the results of Simulation 11 
(dietary calcium of 0.250 m.moles/kg) and the experimental 
results of MacFadyen et al. (1965) derived from 27 subjects. 
Table 7. 1 The· Effect of· a Low Calci urn: Diet on the Serum 
Normal 
Dietary 
Ca 
Low 
Dietary 
ca 
Difference 
between 
means 
'Con·ce·n·tra·ti·o:n· ·of· Cal'cium: and its Renal Excretion 
MacFadyen et al. ( 1965) CAMET2 
Plasma Ca* 
( mg/lOOml) 
9.46 ± 0.24 
9.29 ± 0.22 
0.17 
Urinary Ca 
(mg/day) 
Plasma Ca* 
(mg/lOOml) 
198.8 ± 110.7 9.87 
135.7 ± 71.7 9.60 
63.1 0.23 
Urinary Ca 
(mg/day) 
203.1 
158. 6** 
44.5 
Significance 
of p< 0.01 p < 0. 02 
difference 
*mean of plasma calcium concentrations at 9.30 a.m., 
12.30, 2.30, 4.30 p.m. 
** urinary calcium from 8 a.m. on day 1 to 8 a.m. on day 2 
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Source Program : 72150 No : 72167-3 
The calcium deprivation test described by Nordin & 
Smith (1965) was simulated to examine the effects of a low 
calcium diet on model predictions, especially the urinary 
calcium excretion. Three low calcium meals were simulated 
at the same times each day as in Simulation 11. 
References: MacFadyen et al. (1965), Nordin & Smith (1965) 
Simulated Time: 2 days 
Model Inputs*: Oral Calcium 
(m.moles/kg/day) 
0.0 
1.8 
o.o 
1.8 
o.o 
1.8 
o.o 
Oral Fluid 
( li tres/kg/day) 
0.0 
0.513 
0.0 
0.513 
0.0 
0.513 
0.0 
Results : [A} Parameters during Simulation 
cl 
(m.moles/li tre) 
2.50 
2.37 
2.31 
~al 
(m.moles/kg) 
o.o 
-0.0581 
-o .099 2 
R . 
urJ.n 
(m.moles/kg/day) 
0.0827 
0.0605 
0.0509 
[B] Accumulated Totals (m.moles/kg) 
5diet 
0.223 0.162 0.0681 0.379 
s . 
urJ.n 
0. 4 72 0.121 
*inputs repeated on second simulated day. 
Time 
(days) 
0.0 
0.333 
0.348 
0.541 
0.556 
0.750 
0. 765 
0.0 
1.0 
2.0 
2.0 
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It seems likely that little or no net absorption 
of calcium occurs on 200mg of calcium in the food, even 
after adaption to the regime occurs (Malm 1958). Although 
the experimental ranges are wide this reduction in dietary 
intake results in a small, but statistically significant 
fall in serum calcium and a fall ih the renal excretion 
of calcium. As in fasting the PTH interaction with the 
bone prevents a further drop in the serum calcium. A 
similar reduction in the plasma calcium was simulated by 
the model - resulting also in a reduction in the urinary 
calcium. Experimentally, a significant correlation 
(p < 0.005) was demonstrated between the change in the 
plasma calcium and the change in urinary excre.tion. Un-
like the fasting situation there was no tendency for the 
urinary calcium to rise over 9 days of low calcium intake 
in 11 subjects (MacFadyen et al. 1965). Potentially, a 
detailed study of the endocrinological and physiological 
changes resulting from the imposition of low calcium 
diets should yield considerable data on calcium homeo-
stasis in.health. Fasting appears to be a separate case. 
Next the model was used to simulate the consequences 
of 3 discrete oral calcium and fluid inputs, separated 
in time and of a suitable magnitude to represent the 
dietary ingestion of calcium in a 3 meal day, beginning 
at midnight (Simulation 11). The calcium content of each 
simulated meal (0.083 m.moles/kg) was chosen such that 
an approximate calcium balance was maintained over the 
simulated day (figure 7.4). The principal results are 
collected in table 7.2 in.both m.moles/kg and in mg 
assuming a 65 kg mass. 
SIMULATION 11 THREE MEAL DAY 
Source Program : 72150 No : 72167-1 
A simplified 3 meal day was simulated with three, 
22 minute long, calcium and fluid inputs-corresponding 
to meals at 8 a.m., 1 p.m. and 6 p.m. In the light of 
the considerable body of evidence that has accumulated 
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on the characteristics of normal human calcium metabolism 
the model predictions are considered. 
Simulated Time: 1 day 
Model Inputs: Oral Calcium 
(m.moles/kg/day) 
o.o 
5.5 
o.o 
5.5 
o.o 
5.5 
o.o 
Oral Fluid 
( li tres/kg/day) 
0.0 
0.513 
o.o 
0.513 
0.0 
0.513 
0.0 
Results: (A] Parameters during simulation 
cl R urin c c c p 
(m. moles/litre) (m.moles/kg/day) {ng/m'l) (ng/m'l) 
2.50 0. 0 827 0.10 0.60 
2. 39* 0.0636 0.088 0.71 
2.55** 0.0922 0.11 0.56 
2.50 0.0857 0.10 0. 5.8 
[B] Accumulated totals (m.moles/kg) 
5 acc sdiet sfecl s . ur~n 
0.115 0.117 0.250 0.133 0.198 0.315 0.0781 
*minimum plasma calcium 
**maximum plasma calcium 
Time 
(days) 
0.0 
0.333 
0.348 
0.541 
0.556 
0. 750 
0.765 
o.o 
0. 355 
0. 875 
1.00 
1.00 
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Table 7.2 Calcium Transfers in a Simulated Three Meal Day 
' Calcium Transfer m.moles/kg mg 
bone accretion 0.115 299 
bone decretion 0.117 305 
dermal loss 0.0379 98 
dietary intake 0.250 651 
faecal loss 0.133 346 
intestinal absorption 0.315 818 
intestinal secretion 0.198 515 
urinary loss 0.0781 203 
skeletal balance -0.0020 -6 
calcium balance +0. 0010 +3 
All the listed physiological parameters are acceptab 
in the light of values recorded in the literature for normal 
humans. However the net intestinal absorption of calcium is 
greater than would usually be found for a dietary intake 
of 651 mg/day. The linear regression of faecal calcium (y) 
on dietary calcium (x) derived by Malm (1958) for the calcium 
intake range from 39 to 1010 mg per day 
y = 0.594x + 64 mg 
predicts a faecal calcium of 451 mg compared with the simul-
ated 346 mg. On the other hand biological variation is 
considerable and such a result is not physiologically 
unreasonable (Malm 1958). Hyperabsorption is a consistent 
feature of all the model simulations involving intestinal 
absorption and should be corrected as soon as possible. The 
overall calcium balance of Simulation 11 respresents a 
considerable improvement over the -0.050 m.moles/kg 
predicted in the corresponding CAMET simulation where 
the simulated dietary intake (0.342 m.moles/kg) was sub-
stantially higher than in the present simulation. 
Regular daily cycles characterize many biological 
quantities, of which the serum calcium is one. The 
fluctuations are small (of the order of ± 3%) (Briscoe & 
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Ragan 1966, Jubiz & Tyler 1969) but nonetheless statistic-
. ally significant. In agreement with this data the model 
predicts a minimum plasma calcium of 2.39 m.moles/kg 
at 8 a.m. and a maximum plasma calcium of 2.55 m.moles/kg 
at 9 p.m. (figure 7.2). This circadian rhythm in the 
plasma calcium induces similar cycles in 3 other model 
parameters of interest : the serum concentrations of CT 
and PTH and the rate of renal calcium excretion (figures 
7.2 and 7.3). A circadian rhythm in the rate of urinary 
calcium excretion has been experimentally established. 
The highest loss is during the day (Heaton & Hodgkinson 
1963, Carruthers et al. 1964, Loutit 1965, Briscoe & 
Ragan 1966). ')~gain however, the rate of individual renal 
calcium exc~Eition is sp!:>ject to more erratic changes than 
,.!.r ~ ::· ~~ · : :·~,: .~· ~~ · .·' ~. .. 
produced by CAMET2 and a'~aton &-'H§dgkinson (1963) found 
'>i ' 
the peak in calcium ex¢tetion associated with breakfast, 
with a subsidiary rise in the. evening. 
Measured by bioassay, CT concentration rises during 
the day (Gudmundsson et al. 1969, Fraser & Wilson 1971) -
although in the latter case the rise was not statistically 
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significant. Contrary to model predictions (figure 7.3) 
Arnaud et al. (1971) have found a strong diurnal rhythm 
in PTH activity with the highest concentration at 
8 p.m. and a minimum at 8 a.m. On the surface this is a 
surprising result since the variation in the total calcium 
concentration would be expected to produce the opposite 
effect. Either there is some other important factor 
involved in the regulation of PTH secretion or the 
assumption that PTH secretion is linearly related to the 
total plasma calcium, at and near the normal concentration, 
is invalid. 
7. 3 Intestinal Ca'lc·ium Absorption 
Over the last 10 years many reports have appeared 
in the literature .concerning the absorption of radio-
,~'·· 
calcium from the intestine. The kinetics of the isotope 
appearance in the plasma and the maximum concentration 
attained have been used as indications of the absorption 
efficiency in health and in various disorders involving 
abnormal calcium absorption. The experimental procedures 
have differed markedly - for example in the magnitude 
and chemical form of the stable calcium carrier as well as 
the dietary regime of the subjects. All these factors 
influence the results. Livesey's calculations agreed 
with the experimental finding that the higher the load of 
stable calcium carrier the lower is the fraction of the 
tracer dose that is absorbed (DeGrazia et al. 1965, 
Nordin 1968). In Simulation 13 the effec.t of a meal 2 
hours after an oral tracer dose is examined. The initial 
conditions (300 mg of carrier calcium and 150 ml of fluid 
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in the stomach compartment) are those described by 
Jaworski et al. (1963) whose subjects were fasted over-
night before the dose of tracer and for 2 hours after it. 
The beginning of Simulation 13 corresponds to 10 a.m. 
with the first simulated meal at t = 0.083 days (2 hours). 
The meals were omitted in Simulation 12, but otherwise 
the two runs were identical. The results of these simulat-
ions with the data of Jaworski et al. (1963) are collected 
in table 7 .. '3 and the predicted plasma specific activities 
and the faecal excretion of tracer from each simulation 
are plotted together in figures 7.5 and 7.6. 
Table 7. 3 Effect df Simulated Meal Af·ter the Oral 
In<,;testidn of Trace·r Calci urn 
Simulation* Simulation* 
12 13 
Jaworski et al. 
(1963) ** 
Maximum 2.18 1. 96 1. 73 ± 0.26 
Plasma 
Tracer 
Concentration 
(% dose/litre) 
Increase in 0.11 0.09 0.18 ± 0.09 
Stable Calcium 
Concentration 
(m.moles/litre) 
Faecal Tracer 41.5 53.0 62.2 ± 4.1 
Excretion 
(% dose) 
Urinary Tracer 4.4 4.8 6.2 + 1.5 
Excretion 
(% dose) 
** 8 subjects, 11 determinations. Excreted tracer 
collected over 6 days. 
* 3 day simulation 
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Source Program : 72150 No : 72203-2 
The intestinal absorption of a single dose tracer 
calcium was simulated. Apart from the 300 mg of carrier 
calcium associated with the tracer dose no dietary calcium 
and no fluid intake was simulated. 
Reference: Jaworski et al. (1963) 
Simulated Time: 3 days 
Parameter Chan~es: M5 set to 0.115 m.moles/kg 
MT5 set to 1.0 X 1o-3 m.moles/kg 
F set to 4.5* 
v5 set to 0.0028 litres/kg 
Results: [A] Parameters during simulation 
cl MT1 Rabs 
(m.moles/kg) (% dose/litre) (m.molesjkg/day) 
2.50 0.0 0.14 
2.61** 2.18** 0.44 
2.35 0.83 0.13 
2.10 0.54 0.12 
[B] Accumulated Totals (m.moles/kg) 
cbal 8acc 8 fecl 8 gsec 8sab s . ur1n 
-0.326 0.325 0.0595 0.400 0.455 0.161 
CTbal ST 
· ace STfecl STgsec STsab ST**~ ur1n 
0.516 0.131 0.415 0.0965 0.681 0.044 
Time 
(days) 
o.o 
0.121 
1.02 
3.00 
3.00 
3.00 
*allows for faster stomach emptying of solutions (Livesey 
1970) 
**maximum value 
***all tracer totals X 10 3 • 
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Simulation 12 was repeated but with simulated dietary 
fluid and calcium intake over the three day period. The first 
meal input occurred at 0.083 days (2 hoqrs). 
Model Inputs*: Oral Calcium 
(m.moles/kg/day) 
0.0 
5.5 
o.o 
5.5 
o.o 
5.5 
0.0 
Oral Fluid 
(litres/kg/day) 
0.0 
0.513 
o.o 
0.513 
0.0 
0.513 
o.o 
Results: [A] Parameters during simulation 
cl 
(m. moles/litre) 
2.50 
2.59*** 
2.52 
2.47 
(% 
MT 1 
dose/litre) 
o.o 
1.96 *** 
0.6 7 
0.40 
Rabs 
(m.moles/kg/day) 
0.14 
0.54 
0.24 
0.34 
[ B] Accumulated Totals (m.moles/kg) 
cbal s sfecl s ssab s . ace gsec ur1.n 
-0.123 0.348 0.506 0. 610 0.964 0.256 
· CTbal S'T STfecl ST ST b ST**· ace gsec sa ur1..n 
0.402 o. 105 0.530 0.112 0.581 0.048 
*repeated on each simulated 
**all tracer totals x 103. 
day 
***maximum value 
Time 
(days) 
0.0 
0.083 
0. 09 8 
0. 291 
0. 306 
0. 875 
0. 890 
0.0 
0.087 
1.02 
3.00 
3.00 
3.00 
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The effect of the meal in Simulation 13 on the absorption of 
calcium is significant. While it cannot be certain that 
Jaworski's results were influenced in this way it would seem 
advisable to maintain fasting for 4 hours following the ad-
ministration of oral tracer. Interestingly Birge et al. (1969} 
found a reduction in the absorption of tracer calcium caused 
by a meal. given 2~ hours previously; the extent depending 
on the calcium content of the meal. An action of PTH in pro-
ducing this effect was sought but not found. It is possible 
that undigested food still in the intestinal lumen may have 
been partially responsible. 
CAMET2 was also used to simulate the oral intake of 
radiocalcium as described by Mautalen et al. (1969) under 
carefully standardized conditions (Simulation 14). The tracer 
dose was given in 125 ml of solution associated with 200 mg of 
carrier calcium as calcium chloride. Measurements of the 
plasma specific activity in 24 normal subjects were taken over 
the subsequent 48 hours and the results are compared with those 
of CAMET2 in table 7.4. The simulated rate of tracer 
absorption and its appearance in the plasma are plotted 
in figures 7.7 and 7.8. 
Table 7. 4 The API?earance of Orally Ingested 
Tracer Calcium in the Plasma 
Time Plasma Specific Activity 
(hours) (% dose/litre) 
CAMET2 Mau talen et al. 
1.0 1.63 1.55 ± 0.62 
1.5 2.23 1.97 ± 0. 75 
2.0 2.58 2.12 ± 0.75 
3.0 2.74 2.13 ± 0.62 
4.0 2.48 2.00 ± 0.58 
6.0 2. 05 1.69 ± 0.48 
24.0 0.97 0.96 ± 0.27 
48.0 0.73 0.71 ± 0.23 
(1969) 
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The intestinal absorption of a ca47 dose in solution with 
200 mg of stable calcium was simulated under the conditions 
described by Mautalen et al. (1969). No dietary intake was 
permitted for at least 4 hours. 
Reference: Mautalen et al. (1969) 
Simulated Time: 3 days 
Parameter Chans:es: M5 set to 0.0772 m.moles/kg 
MT5 set to 1 X 10-
3 
m.moles/kg 
F set to 4.5 
v5 set to 0.0021 litres/kg 
Model In)?uts *: Oral Calcium 
(m.moles/kg/day) 
Oral Fluid 
5.5** 
o .. o 
5 .. 5 
0 .. 0 
5.5 
0.0 
( li tres/kg/day) 
0.513** 
0.0 
0.513 
0.0 
0.513 
o.o 
Results: [A] Parameters during simulation. 
cl 
(m.moles/litre) 
2.50 
2.59 
2.42 
2.40 
*** MTl STurin 
(% dose/litre) (m.moles/kg) 
0.0 
2.76**** 
0.97 
0.60 
0.0 
0.0047 
0.0386 
0. 069.0 
[B] Accumulated Totals (m .. moles/kg)*** 
CT ST ST ST ST ST . bal ace feel gsec sab ur1n 
Time 
(days) 
0.0 
0 .. 015 
0.208 
0.223 
0.417 
0.432 
o.o 
0.111 
1.02 
3.00 
0.592 0.155 0.308 0.156 0.846 0.0690 3.00 
* repeated on each simulated day 
** initial simulated meal omitted on day 1 
*** X 103 
**** maximum value 
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All the predicted values are within one standard deviation 
of the experimental results, although only just so for 
the maximum values. 
Since the tracer calcium is removed from the plasma 
(by distribution and exchange) at a rate comparable to 
its entry, its specific activity in the plasma is a 
reflection of both the rate of absorption and the rate 
of removal. There exists therefore a considerable overlap 
in the maximum plasma specific activity ranges of 
different disease groups (Jaworski et al. 1963, Carson et 
al. 1970). To a degree this has been overcome by the use 
of double isotope studies (ca 45 and ca47 ) - one injected 
intravenously and the other given orally. Under the 
basic assumption that calcium entering the plasma from 
the intestine is handled in the· same way as that intro-
duced directly, the tracer absorption as a function of 
time may be computed using deconvolution techniques 
(Birge et al. 1969, Szymender et al. 1972). The absorpt-
ion curve generated by the present model (figure 7.7) is 
qualitatively similar to those computed by deconvolution 
- apart from the initial delay of 15 - 20 minutes 
(Birge et al. 1969) which is not predicted by CAMET2. It 
was found experimentally that only part of this delay 
was due to the stomach transit time. On the other hand 
when tracer was given in the middle of a meal the delay 
was not apparent (Szymender et al. 1972). Indeed, the 
maximum rate of absorption was, on average, 15. 6. ± 13.1 
minutes after administration - ranging as low as 4 minutes. 
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Currently the intestinal model is being reconstructed 
to give it a closer correspondence to physiological reality 
and to eliminate some of the present deficiences noted 
here and in section 5.4. 
7. 4 The Distribution and Excretion of Intravenous Calcium Tracer 
To ensure that the model is still able to reproduce 
the data of Neer et al. (1967) on which the exchangable 
pools are based (Chapter 1) an intravenous tracer simulat-
ion was carried out (Simulation 15). This simulation 
differs from Simulation 1 of Livesey (1970) in that the 
entire model was used and in that it included simulated 
meals. The inclusion of meals has become essential, as a 
result of the changes described in Chapter 5, for an 
acceptable loss of tracer via the intestine. The beginning 
of the simulation corresponds to the experimental injection 
time (2 hours after breakfast) and the total time simulated 
was 3 days. 
The decaying plasma tracer (MT1) computed by CAMET2 
(expressed as the per cent of the original dose in the plasma 
compartment) is tabulated below with the data generated by 
the model of Neer et al. (1967) based on the average 
measured variables of 10 subjects over 20 days. Considering 
that Neer's data includes a 5-10% scatter factor the 
simulated results are in good agreement. 
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SIMULATION 15 INTRAVENOUS CALCIUM TRACER 
Source Program : 72150 No : 72260-2 
The dynamics of a single intravenous injection of 
tracer calcium were simulated. The predictions are compared 
with the experimental results of Neer et al. (1967) to check 
that the ability of CAMET to reproduce this experiment has 
been conserved in the development of the present model. 
Reference: Neer et al. (1967) 
Simulated Time: 3 days 
Parameter Change: MT1 set to 1.0 x 10-
3 m.moles/kg 
Model In]2uts: Oral Calcium Oral Fluid Time 
(m.moles/kg/day} (li tres/kg/day) (days) 
0.0 0.0 0.0 
5.5 0.513 0.124 
0.0 o.o 0.139 
5.5 0.513 0.333 
0.0 o.o 0.348 
5.5 0.513 0. 916 
o.o 0.0 0.931 
Results: Accumulated Totals (m.moles/kg/day) 
[A] Stable Calcium 
~al sacc sfecl sgsec ssab s urin 
0. 0167 0. 34 7,.· 0.369 0.595 0.920 0.240 3.00 
[B] Tracer Calcium ( X 10 3) 
CTbal ST STfecl ST STsab ST urin ace gsec 
0. 828 0. 219 0.0390 0.224 0.181 0.0904 3.00 
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Table 7.5 The Specif·ic Activity of Plasma Tracer 
Following Intravenous Injection 
Time % Dose in Plasma Compartment 
(days) 
CAMET2 Ne.er et .al. (196 7) 
0.0014 95.9 96.07 
0.0028 92.3 96.46 
0.0035 90.5 87.75 
0.0056 85.4 86.45 
0.0077 81.1 83.07 
0.0105 76.0 70.33 
0.014 70.7 75.27 
0. 0315 54.0 57.07 
0.126 38.4 40.95 
0.189 33.8 36.66 
0.5 22.5 22.88 
1.5 13.3 14.30 
3.0 9.4 10.45 
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The cumulative urinary tracer by t = 2.884 days was 
8.86% as compared with the value of 10.2% reported by Neer 
et al. (1967) after a similar interval of time (2.875 days). 
In addition 3.90% of the original tracer dose excreted in 
the faeces and 4. 30% in the sweat were predicted after 3 
days by the model. 
Simulation 15 serves also as a check on the computational 
stability and accuracy of the integration procedure since the 
results are known (Neer et al. 1967). At the conclusion of 
the simulation, after 16,593 interative steps, 99.78% of the 
original tracer dose was either still present in the model 
pools or was accounted for in the simulated excretion. Such 
a result is a necessary (though not sufficient) condition that 
the numerical procedure is correct. 
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All the CAMET2 simulations represent considerable 
simplications of the natural system and correspondence 
between the model predictions and the experimental results 
is not in itself proof either of the correctness of the 
model itself or the conclusions drawn. However, in some. 
respects, this simplicity has advantages over the 
experimental situation where the plasma calcium is a 
function of a large number of complexly interrelated 
variables, difficult if not impossible to control or 
measure, and about which assumptions must be made in the 
interpretation of the results. The present model is 
approaching the point where collaboration with investigat-
ors in the field of calcium metabolism will be of mutual 
benefit, especially in the collection of suitable data, 
the suggestion of new experiments and as a basis for the 
testing of ideas. 
The scope and self-consistency of the present model 
would be improved by the following additions and 
alterations: 
(A] The effects of CT and PTH on bone resorption. 
[B] The reconstruction of the existing intestinal model and 
the correction of the absorption parameters. 
(C] An examination of the effects of small changes in the 
plasma calcium on hormonal secretion rates and renal 
calcium excretion. 
[D] A study of the distribution of calcium in the soft 
tissues of the body and their contribution to the 
homeostasis of calcium. 
[E] The introduction of vitamin D and its 
action on intestinal absorption. 
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[F] A variable plasma volume and its effects on the 
. glomerular filtration rate. 
Beyond this there is considerable scope for the 
incorporation of the principles of chemistry, physics 
and engineering in the replacement of some of the present 
empirical structure of the model which, while describing 
the system and permitting worthwhile deductions about 
calcium metabolism as a whole, does not directly add 
to the understanding of the basic mechanisms involved. 
For example, calcium exchange with bone and the 
different chemical forms of calcium in the plasma could 
be profitably investigated along these lines. 
2 09 
LIST OF SYMBOLS USED IN THE CAMET2 MODEL 
The following upper case symbols are used in the 
model equations to denote concentrations, rates etc. 
c concentration 
F fluid flow variable 
M quantity 
R rate 
s cumulative quantity 
SA specific activity 
T tracer calcium 
Extensive quantities are normalized to unit body weight. 
X 
denotes the mean value of the plasma 
calcium - in this model taken as 
2.5 m.moles/litre 
represents the first derivative of x 
with respect to time (dx/dt) 
The symbols used throughout the present work to represent the 
parameters and variables of the model are as follows: 
BI,l BI,2 
CI 
cbal 
cc 
cP 
empirical constant 
the fraction of the fluid entering the 
intestinal compartment I, from compartment 
(I-1) , that is absorbed into the body 
parameters controlling the volume of the 
intestinal compartment I 
the concentration of calcium in compartment 
I 
the calcium balance 
concentration of calcitonin 
concentration of parathyroid hormone 
Dt . m1n 
E h' rr 1 
E 
rrlo 
F 
Kacc Kd 
Kdc Kdp 
K 
oss 
K 
c 
K K pr rp 
MI 
M bca 
~coll 
M 
c 
M p 
MTtot 
RI,J 
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the minimum allowable step length 
parameters controlling the absorption 
of calcium from intestinal compartment I 
the maximum value of the truncation 
error above which the step length is 
decreased. 
the minimum value of the truncation 
error below which the step length is 
increased 
parameter controlling the rate of stomach 
emptying 
duodenal secretion parameter 
first order rate constant for the 
transfer of calcium from compartment 
I to compartment J 
rate constants 
proportionality constants between the 
bone collagen and the bone calcium 
quantity of calcium in compartment I 
quantity of bone calcium 
quantity of bone collagen 
quantity of calcitonin 
quantity of parathyroid hormone 
quantity of tracer calcium in model 
compartments at t = 0 
rate of the unidirectional flow of 
calcium from compartment I to compartment 
J 
Rabs 
R . f c1.n 
R 
coacc 
R 
codec 
R feel 
R gsec 
R. f l.n 
R . f pl.n 
R 
sc 
R 
sp 
R . 
ur1.n 
RT 
ace 
rate of calcium absorption from the 
intestinal compartments 
rate of calcium deposition in the bone 
rate of calcitonin infusion 
rate of collagen synthesis 
rate of collagen destruction 
rate of calcitonin catabolism 
rate of calcium resorption from the bone 
rate of loss of calcium in the sweat 
rate of ingestion of dietary calcium 
rate of parathyroid hormone catabolism 
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rate of excretion of calcium in the faeces 
(strictly the rate of flow of calcium into 
the colon) 
rate of calcium excretion into the intestinal 
lumen 
rate of intravenous calcium infusion 
rate of infusion of parathyroid hormone 
rate of secretion of calcitonin 
rate of secretion of parathyroid hormone 
rate of loss of calcium in the urine 
basal secretion rate of calcium into the 
intestinal compartment I 
rate of tracer uptake by the bone (including 
incorporation in new bone as well as long 
term exchange) 
8acc 
s . ur~n 
cumulative skeletal uptake of calcium by bone 
formation 
cumulative resorption of bone calcium 
cumulative loss of calcium in the sweat 
cumulative ingestion of dietary calcium 
cumulative excretion of faecal calcium 
cumulative intestinal calcium secretion 
cumulative intravenous calcium infusion 
cumulative absorption of calcium from the 
intestinal compartments 
cumulative excretion of urinary calcium 
specific activity of tracer calcium in 
compartment I 
quantity of unmineralized collagen 
,, 
volume of compartment I 
volume of distribution of calcitonin 
volume of distribution of parathyroid hormone 
initial step length 
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APPENDIX II 
ABBREVIATIONS AND DEFINITIONS 
Accretion rate: Calcium uptake by the skeleton due to 
new bone. growth 
CaBP: calcium binding protein 
caZcaemia: the total plasma calcium concentration 
aaZciuria: the calcium in the urine 
compartment: a quantity of a substance with identical 
transport and metabolic kinetics 
CT: calcitonin (also known as thyrocalcitonin) 
dearetion rate: calcium removal from the skeleton due 
to bone resorption 
1~25-DHCC: 1,25-dihydroxycholecalciferol 
EDTA: ethylenediamine tetraacetic acid 
25-HCC: 25-hydroxycholecalciferol 
hyperparathyroidism: a condition resulting from an 
excess of circulating PTH 
hypoparathyroidism: a condition resulting from a 
deficiency of circulating PTH 
nephrectomy: the surgical removal of the kidney 
osteoblast: bone cells associated with bone formation 
osteoaZasts· multinucleated bone cells associated with 
bone resorption 
osteoid: unmineralized bone matrix 
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osteon: the basic structural unit of compact bone 
comprising a central Haversian canal 
214 
surrounded by concentric layers of bone lamellae 
parathyroideatomy: the surgical removal of the parathyroid 
glands 
phosphateamia: the total inorganic phosphorus concentrat-
ion (in all its various forms) in the 
plasma 
phosphaturia: the inorganic phosphorus in the urine 
PTH: parathyroid hormone 
Se: the endogenous faecal calcium 
thyroparathyroideatomy: the surgical removal of both the 
thyroid and the parathyroid glands 
unmixed aompartment: a compartment that mixes so slowly 
that in the duration of measurements 
an insignificant fraction of the 
material entering the compartment is 
found to leave it 
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APPENDIX III 
SOURCES OF MODEL PARAMETERS 
A complete list of the CAMET2 parameters is appended 
below together with the literature references from which 
they are directly derived (if any) and the section in which 
each parameter is considered. Some are derived from other 
model parameters or, where precise data is lacking, are 
choosen arbitarily to fall within physiological ranges. 
Sections marked with an asterisk refer to the work of 
Livesey {1970). 
Parameter 
A22 
A23 
A24 
A25 
AF6 to AF11 
B6 1 to Bll,l , 
B6 2 to B11,2 , 
E6,1 to Ell,l 
E6,2 to E11,2 
F 
Gl to G3 
Section 
6.2 
6.2 
4.3 
4.2 
4.2 
4.2 
4.2 
5.3* 
5.3* 
5.3* 
5.3* 
5 .. 3* 
5.1* 
5.4 
Reference 
Frost ( 19 6 9 ) 
Frost (1969) 
Levitt et al. (1958) 
Lamberg et al. (1960) 
Ardaillou et al. (1967) 
Nordin et al. (1967) 
Tashjian et al. (1970) 
Sherwood et al. (1968) 
Dillard et al. (1965) 
Dillard et al. (1965) 
Wensel et al. (1969) 
Wensel et al. (1969) 
Hunt & Pathak (1960) 
Altman (1961) 
Doubilet & Fishman (1961) 
Diamond ( 196 7) 
Hansky {1967) 
Schneyer & Schneyer (1967) 
Moore & Makhlouf ( 196 8) 
Wensel et al. (1969) 
Parameter 
~co11 
Section 
5.2* 
5.2* 
5.2 
4.2 
4.2 
6.2 
6.2 
5. 5* 
2.1 
4.2 
4.2 
6.2 
6.2 
5.4 
RF1 , 6 to RF1 , 11 5.4 
RG1 , 6 to RG1 , 11 
v1 
v5 
vc 
5.4 
5.4 
5.2* 
2.1 
4.2 
4.2 
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Reference 
Neer et al. (1967) 
Neer et al. ( 196 7) 
Isaksson et a1. (1967) 
Ardai1lou et a1. (1970) 
Melick & Martin (1969) 
Trotter & Peterson (1955) 
Eastoe (1956) 
Zipkin ( 19 70) 
Neer et a1. (1967) 
Trotter & Peterson (1955) 
Trotter & Peterson (1955) 
A1 tman ( 1961) 
A1 tman (1961) 
Schneyer & Schneyer (1967) 
Moore & Makh1ouf (1968) 
Wensel et a1. (1969) 
Ardai11ou et a1. (1970) 
Melick & Martin (1969) 
SUBROUTINE PLOTER 
Up to 4 graphs, each with either 1 or 2 model 
variables plotted against time, may be produced by 
means of PLOTER. Any model variable may be saved 
during the course of a simulation and subsequently 
plotted, both directly by the line printer (sub-
routine PLOT) and by using PLOTER to prepare a 
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deck of cards forming the input to the University of 
Canterbury PDPll X-Y plotter system. Parameters 
controlling the plotting (length of graph, variables 
plotted etc) are defined automatically in subroutine 
CONPAR but may be changed if necessary by use of 
sUbroutine OPTION (section 1. 7) • Log abscissa and/or 
log ordinate may be specified. There are no restrictions 
on the starting or ending times of the graph so long 
as these lie within the simulated time range. The · 
function of each of the plotting subroutines (which 
are specific to· the University of Canterbury Computer 
Centre) called by PLQTER are as follows -
AINIT 
AORIG 
AGRID 
ASCA 
ALAB 
ALINE 
AEND 
" . 
. 
. 
initializes plotter pen 
defines graph origin 
draws box with ticks 
draws a scale of integers 
draws a label of alphanumeric characters 
draws straight lines between a series of points 
indicates the end of the plot 
Library Subroutines called -
ALOGlO 
MAXO, AMAXl, AMINI 
CAMET2 Subroutines called -
LABEL acts as a list of labels for model variables 
of interest 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
****SuBROUTI~E PLCTER********************************************* 
* * * NOTATIC~ * 
* ======== * ~ * 
* * e~AXIII ~AXI~U~ ORCINATE VALUE OFT ITH ~ARIARLE 
* Br-'INIII MINII>'Ur.' ORCINATE VALUE OFT IT!-1 VARIABLE "~-
* CIBOOI ARRAY OF ORDINATE VALUES TC PLOTTEC * 
* I&J COUNTERS * 
* I~C INCREMENT IN SUCCESSIVE SCALE NUMBERS * 
* ISCA(l21 ARRAY CONTAINING ORDINATE SCALE CHARACTERS * 
* IXINC INCREMENT IN X DISPLACEI-'ENT * 
* IYINC INCREMENT IN Y OISPLACEr-'ENl * 
* JC ~AXlMUM NO OF ORCINATF SCALE NUMHERS GREATER * 
* THAN ZERC * 
* JC MAXIMUM NC CF ORCINATF SCALE ~UMBERS LESS 0 
* THA~! ZERC * 
* JGRAPH(l,JI IDENTIFIES· IrH VARIABLE !BY REALS ARRAY [\0) * 
* ON T~E JTH GRAPH * 
* JJHIGH GRAPH HEIG~T IN 1/lCOTHS C INCH * 
* JJLONG GRAPH LENG~TH IN 1/lOOTHS F INCH ~ 
* JLABl3ll ARRAY CONTAINING THE VARIA E LA~EL AND * 
* THE UNITS CF MEASURE~ENT * 
* JLABEL(40) ARRAY CONTAING T~E TITLE OF TH GRAPH * 
* JLINE(Il NO OF VALU~S OF THE ITH VARIAR SAVED FCR * 
* PLOTTI~G * 
* JLOGTlll El~UIILS 1 IF ITH VARIABLE IS TO HAVE LCG * 
* ABSCISSA * 
* JLOGIII II EQUALS 1 IF TTH VARIARLE IS T!J HIIVE LCG * 
* ORDINATE * 
* JLCNG(Jl LENGTH OF THE JTH GRAPH IN INCHES * 
* JNCRM(JI IF NOT EQUAL TO 1 BOTH VARIABLFS CN THE JTH * 
* GRAPH ARE SCALED TO THE ~AXIMUM ABSCLLTE * 
* ORDINATE VALUE * 
* JPLCT(I,JI IF 0 I'I:HIBITS THE PLOTTit\G CF THE ITH >:< 
* VARIABLE CN THE JTH GRAPH * 
* JSTCRE(I,JI ALLOWS THE ITH VARIABLE CN THE JTH GRAPH TC * 
* BE DISTING~ISHED FRON THE SA~E VAMIABLE * 
* PLOTTEC ELSEWHERE ~ 
* NL MAX!MU~ NO OF ORDINATE SCALE LABELS * 
* NO NO OF VARIABLES CN THE GRAPH (EITHER 1 CR 2) * 
* SC~Lf(]) SCALE FACTCR FOR THE ITH VARIABLE * 
* TFACT DIFFERE~CE BET~EEN SUCCESSIVE VRDINATE * 
~ SCALE NU~BERS * 
* TGqAPH(lC0,2)ARRAY nF TIMES ASSOCIATED hiTH THE OROINAT~ * 
* VALUES * 
* TLABELI151 ARRAY CONTAINING THE UNITS CF TIME * 
* T~AX GRAPH FINISHING TIME * 
* T~IN GRAPH STARTING TIME * 
* X!l00l ARRAY CONTAINING ABSCISSA VALUES TC BE * 
* PLOTTED * 
* xcq ORIGIN VALUE OF X * 
* XSCAL ABSCISSA SCALE * 
~ YllOOI ARRAY CONTAINING ORDINATE VALUES TC BE * 
~, PLOTTE'D * 
* yoq ORIGIN VALUE OF Y * 
* YSCAL ORDINATE SCALE * 
* * 
* * ****************************************************************** 
SLR~CLTI~E PLCTER 
NCN-EXECUTA~LE STATMENTS 
CCM~CN REALS(50COI,INTSI5COI . 
CG~VON/GRAP~/CI8COI,TGRAPbllC0,2),V~AXAI4t2l 1 VMINAI4 1 21 1 JLABELI4CI 
LCGICAL*l LCGLAR(l6l 1 TLABELC15l,JbOLDI7,41,ZEROI31,ISCAI12),JP0~(3 1 ~1b~R~~~~J~~~~~~Yl~~~!ill~~,~~~~lc~~t~~!lloovi21,TS1ARTI2J,x!ICCI, 
1YilOOI}KSTOREI4t21 
DIME~S 8N AFACTI41,BMAXI2),A~IN!ZltJGRAPHI2t4I,JK(2),JLINE!Zl,JLCG 
l T ( 2 I I J L CGV { 2 ) 'J LONG ( 4) t J NCR tl ( 4 I 'J Pl 0 T ( 2 t 4) I J PO s ( 2) ' JW ( 21 'JC cv I 2 ) ' s 
2 CAL E 1 2 l , YfJR r G i 2 l , Y sCI 2 1 , YC I 3 I, Y s I 2 I , J s TcR E 2, 41 , J A I 2 l , J3 !2 l 
rATQ ISCA/ 1 XlO 1 /,J~OLC/'tiiNUTESHOURS DAYS f/ONTHS •t,LC 
lG/ 1 LCG 1 / 1 LOGLAB/ 1 LOG TitlE IN DAY$ 1 /,TLAPEL/'TIME IN 1 /,Z~HC 2/ 1 0.0 1 / JLAe/• . 1 1 
DATA AFlCT/l440.,24.,l.,O.C~33/,YS/-l0.,90./,YC/Y0.,40.,-~0./ 
EQUIVALENCE II~RAPH(l,ll,INTSC5lll 1 1lLINEI11 1 1NTS!97ll,l ILDGT!l),I 1 N TS ( 6 9) I , ( I L OGV Ill t I NT S ( 6 71 I , ITS YAK T ( 11 , REAL::.! 1013 l I , I K S TC R E! 1 t 11 , 
2 I NTS I 73 l l 
E GU 1 v ALf=NC F. ( J GRA PI-I ( 1 t ll I I NT s l 2 211 I t ( JPL OT( 1 I 11 I IN T s ( 2 291 ) ' ( J LC"JG ( 1 
l ) , I 1\'T S ( 2 37 I I , ( JNORM I 1 l 1 IN T <; ( 2 41 I l t ( J S TnR E ( 1, 1 I, IN T S! 2 4 51 I 
EGUIVALENCE(X 7 REALS(48UO)I,!V,REALS(4900l I ECUIVJ\LENCE !VTI\G!li 7 JLA8llii,(UTAG!ll,JLAB(l7ll 
DC 6(J0 J=l t 4 
PLOf INHlBITICN 
IFCJPLOT(l 1 J).EQ.C.ANC.JPLCT!2,JI.EQ.O) GO TO 600 
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~ INITIALIZE GRAPHING PARAMETERS 
c 
c 
C. 
c 
c 
2 JCOM(l)=O 
JCOM(21=0 
DC 3 JL=1,2 IFIJPLOT(JL,J).EQ.OI GO TO 3 
DC 3 1=1!2 ~~IJG~~PHtjL,J).NE.IGRAPHIJN,III GO TO 3 
IFIJSTOREIJL,J).NE.KSTORE(JN,III GO TO 3 
JKIJLI=I 
JCOM I Jll=l 
JLINEIJLI=lLINECil 
JLOGTIJLI=ILOGTCII 
JLOGVIJLI=ILOGVIII 
JPQS(JLI=JN+!I-11*4 
AMINIJLI=VMINAIJN,II 
AMAXIJLI=VMAXAIJN,II 3 CONTINUE 
NC=JCOM(l)+JCQM(21 
CHECK FOR ERRORS 
IFINO.F.Q.OI GO TO 592 
IFI.NOT.IJCOMili.EQ.Q.ANO.JCOMI21.EQ.lll GO TO 7 
JGRAPH(l,JI=JGRAPH(2,JI 
JGRAPH(2,JI=O 
JPLOTCl,JI=l 
GO TC 2 
7 lFINO.EQ.2.AND.IJLOGTill.NE.JLOGTI2I.OR.JLOGVI11.NE.JLCGVI2lllNC=l 
INITIALIZE GRAPH,DEFINE LENGTH ANC ORIGIN 
JJ:JLCNGIJI*l00+600 
CALL AI NIT I JJ) 
CALL AORIGI300,2001 
IFIJLCGVIli.EC.ll GO TO 15 
SET UP ORDINATE SCALES 
DC 14 I=l1NC AL=A~AXliBMAXIII,-B~IN!l)) 
lF!AL.NE.O.Ol GO TO 12 
SCALEIIl=l.O 
GO TO 14 
12 J~=ALCGlO(Al)+.5 
IFIAL.LT.l.OlJN=ALOGlOIALI-.5 
SCALE(Il=lO.**JN 
IFIAL/SCALEIIl.GT.l.ISCALE(I):SCALEIIl*2· 
IF I All SCALE I I l. GT .1. l SCALE I I l =SCALE I I l * 2. 5 
IFIAL/SCALE(IJ.LT.l.ISCALE{li=SCALE(ll/2. 
IFIAL/SCALEIII.GT.l.)SCALE(II=SCALE(II*2• 
IF I SCALE II 1- B MIN I I I • LT. SOLE ( I I*. 2 51 SCALE ( I I= SCALE ( 1 l * 2. 
14 CONTINUE 
IF(JNOR~(JJ.EQ.l.OR.NO.EQ.ll GO TO 15 
SCALEill=AMAXliSCALEili,SCALEI2ll 
SCALE12l=SCALE(ll · 
SET UP TIME SCALE 
15 TMAX=INO-li*AMAXliTGRAPHIJLINEill-ltJKilll,TGRAPH(JLINEI2l-l,JKI2l 111+12-NCI*TGRAPHIJLINEil -l,JK(l)) 
TMIN=INO-ll*AMINl(TSTART(JKI1)1,TSTART(JK(2lli+12-NCI*TSTARTIJK(ll 
1) 
IFIJLCGT!li.EQ.ll GO TO 180 
TMAX1=TMAX-TMIN+.002 
IFITMAX1.LE •• 08331M=l 
IF(T~AXl.GT •• 0833.AND.TMAXl.LE.2.lM=2 
IFITMAXl.GT.2 •• AND.TMAXl.LE.48.IM=3 
IFITMAX1.GT.4B.IM=4 
TMAX=AFACT(Ml*TMAX 
TMIN=AFACT(M)*T~IN 
ITRAN=3.3219*ALCGlO(TMAXl*AFACTIMJ/6.)+.99 
INC=2** ITRAN 
IF I [ NC. G T. 8 l INC= 10 
ILO=(TMIN+.74*INCl/INC 
ILO=ILD*INC 
IFIIL0+.02.LT.TMINITMIN=ILO 
JJ=IILC-TMINI*4./INC+.95 
XOR=ILC-IJJ*I~CI/4. 
NX=ITMAX-XORI*4./INC+.95 
IF(JLCGV11l.EQ.ll GO TO 181 
C CALCULATE NUMBER OF LABELS ON EAC~ ORDINATE SCALE 
c 
143 JA(ll=O 
JA121=0 
JB Ill =0 JB(2J=O 
DO 161 I=l,NO 
IFIBMAXIII.GT.O.OJJAIIJ BMAXIII/SCALEIII*5.C+.99 IFIBMINIII.LT.O.OIJBIII -BMIN(Il/SCALEIII*5.0+.99 
IFIJAIIJ.GE.JBIIIIJAIII 5 
161 IFI-fl~INIII.GT.BMAXIIIl B(ll=5 
JC=~AXOIJAI1J,JAI2)) 
JD=MAXOIJBI1),JB(2)) 
NL=JC+JD+l 
JN=4*1"1L-1l 
IFIJN.GT.301JN=JN/2 GG TO 1q5 
C SET UP LOG TI~E SCALE 
180 ILO~ALOGlOITMIN)-.999 
JC=ALOGtO(T~AXl+.999 
JP=(JQ-ALOGlOITMftXll*4. 
IFIJO-ILC.LE.liJP=O 
NX=IJC-ILOl*4-JP 
IFIJP.GE.liJO=J0-1 
N=JO-ILO+l 
lf!JLOGV!li.EQ.Ol GO TO 143 
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c 
c 
c 
c 
181 
195 
SET UP LOG ORDINATE SCALE 
~t!~Kc~li~~~~~l~~~~~}ll;~~~~i~lilf2~2~i~~~~~~li:?~q 
lF(K.LT.OlK=K-1 
JS=K-JL · 
IF(JS.LE.lO)JY=l 
IFIJS.GT.10.ANO.JS.LE.20)JY=2 
IFIJS.GT.20.AND.JS.LE.48)JV=4 
lF(JS.GT.4BlJY=lO 
NL=JS/.JV+l.99 
JN=INL-11*2 
IF(Jl.LT.Oli<=JL 
SET UP AND PLOT GRAPH GRID 
lXINC=JLONG(J)*lOO/NX 
JJLONG=NX*IXINC 
IYINC=700/JN 
,JJHIGH=JN*IYIIIJC CALL AGRIDIO,O,NX,JN,IXINC,IYINC,l,2) 
C *PLCT GRAPH SCALES* 
C TIME SCALE 
c 
c 
c 
IF(JLOGT!ll.EQ.ll GO TO 207 
N=INX-JJ)/4.+1.01 
IX=JJ*IXINC-40 
IXINC=4*IXINC 
XOR=XCR/AFACT(Ml 
XSCAL=(NX*INC*1CO.)/(JJLONG*AFACTI~l*4.1 
CALL ASCAI IX,-22,IXINC,0 9 ILC,INC,N,l 1 2l GO TO 209 
LCG TIME SCALE 
207 IXINC=4*IXINC 
XOR=ILO 
XSCAL=NX*25./JJLONG CALL ASCAI-45,-25,IXINC,O,ILO,l,N,l,2l 
ORDINATE SCALE LABELS 
209 IF(JLCGVIll.EQ.ll GO TO 216 
JP=JJHIGH/(NL-11 
DC 279 I=l,l\0 
REHIND 8 
JQ=6 
K=O 
N=O 
C FIND FORMAT FCR SCALE NUMBERS 
c 
c 
c 
c 
c 
c 
c 
213 
214 
215 
216 
221 
213 
234 
235 
236 
237 
238 
239 
IF(SCALE(IJ.LT •• 09.0R.SCALE!Il.GT.999.J GO TO 213 
JL= 2 
JS=l IFISCALE!Il.LT •• 9) GO TO 221 
JL=l 
JS=2 
IF(SCALE(I).l1.9.9l GO TO 221 
JL=3 
IFISCALEII l.GT.99.lJS=l 
GC TC 221 
SCALE NUMBERS INVOLVING POWERS OF 10 
JL=l 
JS=2 
K=ALCGlOISC/lLE( Ill 
IF( SCALE(! ).LT.l.)K=K-1 
SCALE(! l=SCALEill*lO.**I-KI 
IF(SCALE(I).GT.9.)JS=l 
WRITE ( 8, 214 l K 
FORMAT( 13) 
REWIND 8 
READ(8 9 215l(JPOW(L),L=1 1 3l FORMATI3All 
IF(K.LT.lO.ANC.K.GE.OlN=l 
IF(K.LT.O.ANO.K.GT.-lO.OR.K.GE.lClN=2 
IFIK.LE.-10lN:3 
IF(JLOGVIll.EQ.ll GO TO 280 
.JQ=N+9 
JZ=I3-Nl*l0 
SET UP SCALING AND PLOTTING PARAMETERS 
TFACT=SCALE( I l/5. 
SCALE(l)=-JBIII*TFACT 
IY:o(JD-JB( I l l*JP-5 
YORIG(Il=-JC*TFACT*lO.**K 
YSCIIl=llOO.*INL-li*TFACT*lO.**Kl/JJHIGr 
JC=JBIIl+l Jjii=JA( I l+JB( I l+l 
IFISCALE(l l.LT.O.OIJS=JS-1 
IF( I.EQ.l) IX=-JQ*l0-5 
IF( I.EQ.2l IX=JJLONG-JS*l0+5 
JW(l)=(JQ-JSl*lO 
WRITE ORDINATE SCALE NUMBERS 
REHIND 8 
DC 239 JJ=l,JM 
GC T0(235,2331237J,JL 
WRITE(8 9 234JS~ALE1Il 
FORr~AT(F6.3) 
GO TO 239 
WRITEI8 9 236!SCALE(IJ FCRf'IAT(F6.2) 
GC TO 239 
WRITE(~ 9 238lSCALEIIl FCR1"ATIF6.ll SCALE I I I =SCALE (I l +TFACT 
ON DISC 
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c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
c 
240 
242 
249 
279 
280 
284 
315 
322 
"351 
READ SCALE NU~BERS FROM DISC AND CRAW THEM 
REWIND 8 
JX=IX-JZ+90 
D 0 2 4 9 J J= l t J fl 
READI8f240l!ISCAILl,L=lt6l 
FOR~AT 6All 
tFIJJ.NE.JOI GO TO 242 
JN=II-ll*(JJLONG+5)-35*12-II 
IF!I.EQ.2.ANO.JB!2l.GT.OlJN=JN+l0 
CALL AlABIJN,IYtZER0,3,1,2l 
GC TO 249 CALL ALABI IXtlV.ISCtqJQ,l,~l 
IF(JQ.LE.6l ljC TO 249 
JY=IV+5 CALL ALABIJX,JY,JPOW,3,1,2l 
IY=IV+JP 
DRAW ZERO AeSCISSA 
IFIJC*JO.EQ.Q,QR.I.EQ.2l GO TO 279 
Xjll=O. X 2 =JJLO~G 
Y(l)=JJHlGH-4*JC*IVINC 
Yl2l=Yill CALL ALINE(X,v,z,o.,o.,lCO.,lOO.,l) 
CONTINUE 
GO TC 315 
DRAW LOG ORDINATE SCALE 
IYINC=IYINC*2 
1~ < I~~a:J:t i L-ss 
lF(l.EQ.Z)IX=JJLONG+N*l0-45 
YCRIG! ll=JL 
YSCI Il=(JS*lCO. )/JJHIGH 
JW(Il=50 CALL ASCAIIX,-5,0,IYINC,JL,JY,Nltlt2l 
*LABELLING CF GRAPH* 
ORDifiATE Ut:ELS 
DO 323 I=ltNO CALL LABELtJGRAPH(l,Jl,VTAG 1 UTAG) IF(l.EQ.2) GO TC 322 
IX=-JW!ll-40 
IY=lOO IF(JLOGVIll.EC.lliY=180 
Xlll IX-10. 
X(2l=X!ll CALL ALINEIXtYSl2tO.,O.,lOO.tlOO.,ll IF(JLOGV!ll.EG. lcALL ALABI IX,lOO,LOG,3 1 2,4l CALL ALAB!IX 1 IY 1 JLAB 9 31,2,4l 
GRAPH TITLE 
IX~(JJLONG-12COl/2 
Cllll ALAB( !X,760 9 JLABEL,4Ct3 1 21 GO TO 323 IX=JJLONG+JW(2)+40 
X (l)=IX+lO. 
Xl2l=XIll 
X(3l=XIll 
IFIJLOGVI2l.EC.llCALL ALAB( IX,800,LOG,3,2,01 
CALL ALABI IX,720tJLABt3ll2tOl CALL ALINE(X,YC,3rO.,u., Ou.,100.,3) 
CONTINUE 
ABSCISSA LAEEL 
IF(JLOGT(ll.EC.ll GO TO 360 
~£al~t~I:~\!JHOLDIIiMJ 
IX=IJJLONG/20.-14)* 0 
CALL ALA8( IX,-70,TLABEL,15r2t2l 
GC TO 401 
LOG ABSCISSA LABEL 
360 IX=((JJLCNG/201-161*10 
401 
407 
408 
4C'l 
410 
430 
461 
489 
CALL ALABI IX,-7C,LOGLAB,l6,2,21 
*PLOT VARIAeLES* 
DC 489 I=l,J\0 
YOR=YORIGIII 
VSCAL=YSCtiJ 
JP=JLINE ( ll-1 
IFIJLCGT(l).EC.ll GO TO 408 
DC 407 JL=l,JP 
XIJU=TGRAPHIJL,JI<( [)I 
GO TO 410 
DC 409 JL=l,JP 
XtJLI=ALOGlOITGRAPH(JL,JKIIlll 
JN=(JPOS!Il-11*100 
DO 430 JL=l,JP 
Y(JLl=CIJL+JNl CALL ALINEIX 1 Y1 JP,XOR,VOR,XSCAL 1 YSCAL,ll 
DRA~ CROSSES CN PLOT OF SECOND VARIABLE 
IF(l.EQ.ll GO TO 489 
JP=JP/5 
DC 4.61 K=l t JP 
XtKl=XI5*KI 
Y(K)=YI5*Kl CALL ALINEIX,V,JPtXOR,VCR,XSCAL,VSCAL,2l 
CONTINUE 
C TER~INATE PLOT 
CALL AENO 
GC TC 600 592 WRITEI6 1 593)JGRAPHil,Jl,JGRAPHI2tJl 593 FCR~AT(//T20 1 'REALSI 1 tl4,'l ANO KEALS( 1 ,I4,'l WERE J\CT SAVED'//) 
600 CCNliNUE 
R<:TURN 
F.ND 
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